rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTACTAGCGGGGGAAGCTACGAGCAGTACTTCGGGCCG	CASSSTSGGSYEQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	3	2	3	18	31	44	33	47														CASSSTSGGSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGTATTCCAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSVFQPQSRANVLTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	51	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	11	5	18	30	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVFQPQSRANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGCTAACTGGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	21	1.9257044868914544E-4		44	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-03	01	3	0	9	2	7	0	18	32	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTACAAGCCAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLQARENTEAFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	1	5	1	18	33	43	38	44														CASSLQARENTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTAATAGCGGGAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLIAGENTGELFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	5	2	1	1	1	18	33	43	34	44														CASSLIAGENTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCTTGGCGGGAGGCCCCTACGAGCAGTACTTCGGGCCG	CASSFLAGGPYEQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	1	2	4	2	18	32	44	36	46														CASSFLAGGPYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAACGACTAGCGGGCGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	2.567605982521939E-4		47	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	4	8	3	4	18	34	47	37	51						01,02								X+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTACTCAGGGGCAGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	2.842706623506433E-4		43	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	4	5	4	18	31	42	36	46														X+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTCCGACTAGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLRLESTDTQYF	In	VDJ	2	58	5.318612392366874E-4	6.211379675937329E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	8	0	4	2	18	30	40	34	42						01,02								CASSLRLESTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCCTTTGGGGGGGTTGGGAACACTGAAGCTTTCTTTGGACAA	CASSLAFGGVGNTEAFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	51	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	1	5	4	19	35	47	40	51														CASSLAFGGVGNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLASSYNEQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	6	0	0	2	19	-1	37	35	39						01,02								CASSLASSYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAACTGGGACAGGGGTCGAGCAGTACTTCGGGCCG	CASSLTGTGVEQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	6	3	1	19	34	47	37	48														CASSLTGTGVEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCTGTGTATCTCTGTGAATCCGGGACTAGCGGGAGTTCGTACAATGAGCAGTTCTTCGGGCCA	CESGTSGSSYNEQFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV07	TCRBV07-05		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	0	2	4	5	4	19	23	42	28	46			01,02											CESGTSGSSYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGAGGGTTGGTGGGACGGGACAGAAGAGACCCAGTACTTCGGGCCA	CASSLEGWWDGTEETQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	54	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	5	3	16	0	19	33	-1	49	56														CASSLEGWWDGTEETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGGACCGCCCTCTGGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSEGPPSGAGELFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	3	0	7	6	1	12	23	36	42	37	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEGPPSGAGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCACCCTGGGCAAGAACACTGAAGCTTTCTTTGGACAA	CASSSTLGKNTEAFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	1	8	2	23	35	47	43	49			01,02										Vb 1	CASSSTLGKNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCTTAGCGGGAGGGCGCCATGAGCAGTTCTTCGGGCCA	CASSVLAGGRHEQFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	0	8	2	4	23	37	50	39	54			01,02										Vb 1	CASSVLAGGRHEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTGGACAGGGGGCTTTTCAGATACGCAGTATTTTGGCCCA	CASSWTGGFSDTQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	0	4	1	4	23	35	47	36	51			01,02										Vb 1	CASSWTGGFSDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCAAGCGGGGTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSASGVSYNEQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	3	1	2	2	23	36	45	38	47			01,02										Vb 1	CASSASGVSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGCAGCGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGSGSYNEQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	4	1	4	0	23	37	-1	41	47			01,02			01,02							Vb 1	CASSVGSGSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAAAACACATGGACAGACCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKTHGQTANTGELFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	5	0	9	4	23	35	50	44	54			01,02										Vb 1	CASSKTHGQTANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGAGGTCTAACACAGATACGCAGTATTTTGGCCCA	CASSVGRSNTDTQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	1	2	0	5	23	-1	44	39	49			01,02										Vb 1	CASSVGRSNTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCAGGTCCCCAGATACGCAGTATTTTGGCCCA	CASSVGRSPDTQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	4	1	4	23	39	44	40	48			01,02										Vb 1	CASSVGRSPDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCATGATAGGTACTCGTTACTTGTCGACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.650603845906961E-4		52	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	6	2	7	5	22	0	23	33	-1	55	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCTAGGACAGGGAACATTCAGTACTTCGGCGCC	CASSSRTGNIQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	1	3	7	4	0	23	35	-1	39	47			01,02										Vb 1	CASSSRTGNIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGACAGGAGTCTCTATGGCTACACCTTCGGTTCG	CASSVGDRSLYGYTF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	4	4	0	5	23	-1	47	39	52			01,02										Vb 1	CASSVGDRSLYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCGCAGGGTAGGCCGGGTACGAGCAGTACTTCGGGCCG	CAAG*AGYEQYF	Stop	VDJ	1	24	2.200805127875948E-4		36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	3	4	1	9	23	29	35	30	44			01,02										Vb 1	CAAG*AGYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGGGCTAGCGGGAGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	2.4759057688604415E-4		44	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	1	2	4	1	23	34	49	38	50			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAAAGAAGGAGTGGGGCAAGGAATGGACACTGAAGCTTTCTTTGGACAA	CASSVKEGVGQGMDTEAFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	57	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	3	11	9	23	38	54	49	63			01,02										Vb 1	CASSVKEGVGQGMDTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACTAGCGGGGTGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGLAGWSYNEQFF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	3	1	0	3	23	-1	50	39	53			01,02										Vb 1	CASSVGLAGWSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATCCCGCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	3.209507478152424E-4		38	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	1	10	0	6	4	0	23	38	-1	42	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCTGGGACTTGGGTCAAATGAGCAGTTCTTCGGGCCA	CASSPLGLGSNEQFF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	7	5	7	23	35	46	40	53			01,02			01,02							Vb 1	CASSPLGLGSNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGAGAAGGAGTGGGGCGAGGAATGGACACTGAAGCTTTCTTTGGACAA	CASSVREGVGRGMDTEAFF	In	VDJ	1	49	4.4933104694133935E-4	5.247544898636709E-4	57	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	3	11	9	23	38	54	49	63			01,02										Vb 1	CASSVREGVGRGMDTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTTCCCTAGCGGAGGTAGTGACGAGCAGTACTTCGGGCCG	CASSAFPSGGSDEQYF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	5	5	6	8	23	36	49	42	57			01,02			01,02							Vb 1	CASSAFPSGGSDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGATTAGGGTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGLGSSSYNEQFF	In	VDJ	2	73	6.694115597289342E-4	7.817770971438363E-4	51	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	5	3	0	4	5	23	39	47	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGLGSSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGCTCCCGGGTCTCCTATGGCTACACCTTCGGTTCG	CASSGSRVSYGYTF	In	VDJ	4	136	0.0012471229057963704	0.0014564614412542704	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	4	4	5	4	23	36	45	41	49			01,02			01,02							Vb 1	CASSGSRVSYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGGGGTAAGCCAGCCCCAGCATTTTGGTGAT	CASSEGVSQPQHF	In	VDJ	13	475	0.004355760148921147	0.005086905769086606	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	1	7	0	5	23	-1	42	36	47			01,02										Vb 1	CASSEGVSQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGGGCCTAGCGGCCGCAATGAGCAGTTCTTCGGGCCA	CASSLGPSGRNEQFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	5	6	3	3	19	35	45	38	48						01,02								CASSLGPSGRNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTATCGGCAGATTCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLSADSYQETQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV11	TCRBV11-01	01				TCRBJ02	TCRBJ02-05	01	2	4	5	0	4	6	19	34	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSADSYQETQYF+TCRBV11-01+TCRBJ02-05	TCRBV11-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCCCCCCCGCGGGATCGCGTTTAATGAGCAGTTCTTCGGGCCA	CASSPPRGIAFNEQFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	3	7	7	8	19	31	44	38	52														CASSPPRGIAFNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAGCCACGTTTGGTGGCAGAACTGGAGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGACGTACCCAGTACTTCGGGCCA	CASSQDRRTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	2	7	8	2	2	45	62	67	64	69				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDRRTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAGCCACGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTTATTCTGTGCCAGCAGCCAAGATAGACGTACCCAGTACTTCGGGCCA		Out	VDJ	1	12	1.100402563937974E-4		35	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	19	2	7	8	20	2	46	44	67	64	69				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTGACTAGTAGGGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSLTSRGGNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	0	7	9	1	29	42	58	51	59													Vb 16	CASSLTSRGGNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAGCCACGTTTGGTGGCAGAACTGGAGGATTCTGGAGTTATTTCTGTGCCAGCAGCCAAGATAGACGTACCCAGTACTTCGGGCCA		Out	VDJ	1	14	1.2838029912609695E-4		35	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	23	2	7	8	24	2	46	40	67	64	69				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGACTAGATACGAGCAGTACTTCGGGCCG	CASSQVGTRYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	8	4	2	1	29	45	55	47	56						01,02							Vb 16	CASSQVGTRYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACAGACGAATCAGCCCCAGCATTTTGGTGAT	CASSQQTNQPQHF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-05	01	2	2	7	4	2	1	29	44	49	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQQTNQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGACAGGGTATAGGGTCTGGCTACACCTTCGGTTCG	CASSPGQGIGSGYTF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	7	1	9	29	42	52	43	61													Vb 16	CASSPGQGIGSGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGAGCTATGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	2.751006409844935E-4		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	2	4	0	5	29	-1	50	45	55													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACAGGTCCTATGGCTACACCTTCGGTTCG	CASSQDRSYGYTF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	4	0	2	29	-1	50	46	52													Vb 16	CASSQDRSYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCCAGGGTCGATTGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	2.842706623506433E-4		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	6	3	9	29	46	54	49	63													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTATGGGGGTGCAAGGCACCATATATTTTGGAGAG	CASSPMGVQGTIYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	4	6	1	9	4	7	29	42	51	46	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPMGVQGTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGAACTAGCGGGAGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	3.209507478152424E-4		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	3	2	5	2	2	29	43	56	45	58													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGACTAGCGGGAGGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	38	3.4846081191369175E-4		52	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	2	1	0	1	1	29	46	60	47	61													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTCGGACTGGAAACTACGAGCAGTACTTCGGGCCG	CASSPRTGNYEQYF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	10	3	3	5	29	42	50	45	55						01,02							Vb 16	CASSPRTGNYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCGGGACAGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	48	4.401610255751896E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	0	2	0	29	42	-1	44	52													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGTAATTGCTAGCGGGACCGCACAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	55	5.043511751382381E-4		55	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	4	3	4	7	6	26	43	59	50	65													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGCGGGACTAGGCCACAATGAGCAGTTCTTCGGGCCA	CASSQDAGLGHNEQFF	In	VDJ	2	70	6.419014956304848E-4	7.496492712338156E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	5	3	3	29	46	57	49	60						01,02							Vb 16	CASSQDAGLGHNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGCAGCTACGAGCAGTACTTCGGGCCG	CASSQSSYEQYF	In	VDJ	2	77	7.060916451935333E-4	8.246141983571972E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	2	4	5	3	2	0	29	44	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQSSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCTCCGGGACAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRDNSYNEQFF	In	VDJ	2	78	7.152616665596831E-4	8.353234736605373E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	0	5	1	29	40	51	45	52													Vb 16	CASSLRDNSYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACACAGCCTATGGCTACACCTTCGGTTCG	CASSQDTAYGYTF	In	VDJ	2	79	7.244316879258328E-4	8.460327489638776E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	4	1	1	29	46	51	47	52													Vb 16	CASSQDTAYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAACAGGGACACTGAAGCTTTCTTTGGACAA	CASSQNRDTEAFF	In	VDJ	2	89	8.161319015873307E-4	9.531255019972799E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	3	1	0	29	44	-1	45	51													Vb 16	CASSQNRDTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCACAGCTATGGCTACACCTTCGGTTCG	CASSQDHSYGYTF	In	VDJ	4	133	0.0012196128416979211	0.0014243336153442496	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	4	2	0	29	46	-1	48	52													Vb 16	CASSQDHSYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTCCAGTTATGGCTACACCTTCGGTTCG	CASSQDSSYGYTF	In	VDJ	4	158	0.0014488633758516656	0.0016920654979277552	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	5	3	1	29	46	52	49	53													Vb 16	CASSQDSSYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGATACCAATCGGAGACTGAAGCTTTCTTTGGACAA	CASSRYQSETEAFF	In	VDJ	5	174	0.0015955837177100622	0.0018634139027811987	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	5	10	0	29	42	-1	52	56													Vb 16	CASSRYQSETEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGACGTACCCAGTACTTCGGGCCA	CASSQDRRTQYF	In	VDJ	47	1676	0.015368955809667037	0.017948745408398213	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	2	7	8	2	2	29	46	51	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDRRTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAAATGAAGAGACCCAGTACTTCGGGCCA	CASSPNEETQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	6	3	1	4	24	36	39	37	43														CASSPNEETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCCCCTAATGGGGCAGGGAAGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	1.100402563937974E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	6	14	4	24	35	54	49	58														X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGACTGAGGGGACACCCCTCCCACAATGAGCAGTTCTTCGGGCCA	CASRLRGHPSHNEQFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	5	6	8	24	35	47	41	55														CASRLRGHPSHNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGGGAAGGAAAAGACATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	1.4672034185839652E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	0	8	4	1	23	24	35	40	36	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAAGGAGCAGGGAGGGTCGGAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	17	1.558903632245463E-4		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	9	0	6	7	4	24	39	53	46	57														X+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGCCGGGGCAGGGGAAACTATGGCTACACCTTCGGTTCG	CASSLGRGRGNYGYTF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	2	11	1	24	36	53	47	54														CASSLGRGRGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGGGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSWGASYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	6	0	0	2	0	24	36	-1	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGASYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGTCAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASVRAGANVLTF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	10	4	3	2	4	0	24	31	-1	35	40														CASVRAGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCAAGAACGGAGGGGGCCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSRTEGASSTDTQYF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	0	10	4	24	36	53	46	57														CASSSRTEGASSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAACGGGTGGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSLTGGAGELFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	4	6	5	5	24	35	44	40	49						01,02								CASSLTGGAGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGAGGACAGCGAGCTAACTATGGCTACACCTTCGGTTCG	CASSRGQRANYGYTF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	0	4	4	24	35	45	39	49														CASSRGQRANYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGGGGTTTTTGGTGCGGAGGGCACTGAAGCTTTCTTTGGACAA	CASSVGGVFGAEGTEAFF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	4	3	17	24	36	45	39	62														CASSVGGVFGAEGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTCCTCCCAAGGGGGCAACCCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	48	4.401610255751896E-4		44	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	5	0	8	10	5	24	31	48	41	53														X+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCGACAGGGGGCGCGGAGGGCTCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	4	151	0.0013846732262886173		56	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	0	2	4	10	24	36	50	40	60														X+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAAACAGGGGTCTTCCTACGAGCAGTACTTCGGGCCG	CASRKQGSSYEQYF	In	VDJ	4	155	0.0014213533117532163	0.0016599376720177346	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	1	0	3	24	-1	45	39	48														CASRKQGSSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTATTGGCGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLLAGGYNEQFF	In	VDJ	8	281	0.002576776003888089	0.0030093063602386026	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	1	3	6	0	24	36	-1	42	50														CASSLLAGGYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACCAGGGGACAGCGAACGAGCTTTCTTTGGACAA	CASSEGPGDSERAFF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	10	6	6	23	39	52	45	58														CASSEGPGDSERAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGTGATTGTGAAGAAGTAACGGTCGACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	10	9.170021366149783E-5		53	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-03	01	6	2	7	5	22	0	22	33	-1	55	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-04+TCRBJ01-03	TCRBV07-04*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCTAAACCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	11	1.0087023502764761E-4		38	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	9	1	0	4	22	-1	37	34	41						01,02								X+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCGGACCGCGGGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	1.1921027775994718E-4		37	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	7	7	0	22	34	-1	41	47														X+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTGGCCCCTGGGACAGCAAACTCCTACGAGCAGTACTTCGGGCCG	CASSLAPGTANSYEQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	51	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	0	7	4	22	36	50	43	54														CASSLAPGTANSYEQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGGGACCGGGACAGGGATATGAAAAACTGTTTTTTGGCAGT	CASGPGQGYEKLFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	3	6	7	2	26	33	49	40	51													Vb 20	CASGPGQGYEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGTGACAGGGGGGGCCAGCCCCAGCATTTTGGTGAT	CAWGDRGGQPQHF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	1	7	0	3	26	-1	47	39	50													Vb 20	CAWGDRGGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGGACAGGGTCAGAAGCTTTCTTTGGACAA	CAWRGTGSEAFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	8	1	3	26	37	47	38	50													Vb 20	CAWRGTGSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCGGGGCGGGAGCGGACGACTGCAGTTCTTCGGGCCA	CAWSVRGGSGRLQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	12	5	9	26	40	52	45	61													Vb 20	CAWSVRGGSGRLQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTTGAGGGTCGTAACTGAAGCTTTCTTTGGACAA	CAWLRVVTEAFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	5	2	5	26	35	42	37	47			unresolved										Vb 20	CAWLRVVTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGACAGCAGATACGCAGTATTTTGGCCCA	CAWTTADTQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	4	1	0	26	36	-1	37	42													Vb 20	CAWTTADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCTGCCACAGGCCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	3.209507478152424E-4		41	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	4	0	5	2	26	35	45	40	47			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTTTGAGGCCACTGAAGCTTTCTTTGGACAA	CAWSVFEATEAFF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	1	4	4	1	26	40	48	44	49													Vb 20	CAWSVFEATEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAGGGGTTACGAGCAGTACTTCGGGCCG	CAWTRGYEQYF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	4	1	1	26	36	43	37	44													Vb 20	CAWTRGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCCCCGTCCGGGACCGCTATGGCTACACCTTCGGTTCG	CAWIPVRDRYGYTF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	4	0	7	4	9	2	26	36	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIPVRDRYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCGTCTCCATCCGCCGGGGAGCTGTTTTTTGGAGAA	CAWTPSPSAGELFF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	4	4	6	6	9	4	26	36	47	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTPSPSAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGACCGCCCGGAAACTGACAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	45	4.1265096147674027E-4		50	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	1	1	8	5	9	7	26	39	51	48	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGACAGGGATTTAATGAAAAACTGTTTTTTGGCAGT	CAWSVGQGFNEKLFF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	3	4	1	3	26	40	49	41	52													Vb 20	CAWSVGQGFNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGCGCGGTGAAAAACTGTTTTTTGGCAGT	CAWSVLRGEKLFF	In	VDJ	1	49	4.4933104694133935E-4	5.247544898636709E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	7	5	7	5	0	26	40	-1	45	49						01,02							Vb 20	CAWSVLRGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTAGTTGTGGTCGGGAGGGGACGAGCAGTACTTCGGGCCG	CAWS*LWSGGDEQYF	Stop	VDJ	2	58	5.318612392366874E-4		45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	0	5	10	1	26	38	56	48	57													Vb 20	CAWS*LWSGGDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTAAGGGGACTAGCGGGAGGCCCCTCACAGATACGCAGTATTTTGGCCCA	CAWSVKGTSGRPLTDTQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	57	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	0	1	2	4	5	24	38	57	42	62			01,02										Vb 20	CAWSVKGTSGRPLTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGTTAGTGGCTACGAGCAGTACTTCGGGCCG	CAWSVVSGYEQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	8	3	3	3	26	40	46	43	49			unresolved			01,02							Vb 20	CAWSVVSGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCTTGGGGAGACCCAGTACTTCGGGCCA	CAWRLGETQYF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	3	0	9	5	4	0	26	37	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRLGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGAAGGGTTCTCTGGAAACACCATATATTTTGGAGAG	CAWTEGFSGNTIYF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	5	3	0	4	2	26	36	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTEGFSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTAGAGTGGCCTAGCGGGAGGCCAGCGGGACATTCAGTACTTCGGCGCC	CA*SGLAGGQRDIQYF	Stop	VDJ	2	81	7.427717306581324E-4		48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	4	1	8	2	8	26	39	52	41	60			unresolved										Vb 20	CA*SGLAGGQRDIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCCTAGATTTTGTGGAGGCCAACGTCCTGACTTTCGGGGCC	CAWGLDFVEANVLTF	In	VDJ	2	87	7.977918588550311E-4	9.317069513905994E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	4	8	6	3	10	26	35	42	38	52						01,02							Vb 20	CAWGLDFVEANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD02-01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTGACAGGGGTTGCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	118	0.0010820625212056745		44	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	2	5	3	5	26	37	48	40	53			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTTACCTCGGCTCTTCAGGGCCAATGGGCGCAGTATTTTGGCCCA	CAFTSALQGQWAQYF	In	VDJ	5	174	0.0015955837177100622	0.0018634139027811987	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	10	14	8	26	33	52	47	60			unresolved										Vb 20	CAFTSALQGQWAQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGAGAGGGAGACCCAGTACTTCGGGCCA	CAWSERETQYF	In	VDJ	9	322	0.00295274687990023	0.003448386647675552	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	11	1	5	3	0	26	37	-1	40	44			unresolved										Vb 20	CAWSERETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCATACGGGGCTACGAGCAGTACTTCGGGCCG	CAWSVIRGYEQYF	In	VDJ	11	397	0.003640498482361464	0.0042515822954260684	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	3	4	0	26	40	-1	44	49			unresolved										Vb 20	CAWSVIRGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCCCCAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQAPGAYNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	2	3	0	23	39	-1	42	48														CASSQAPGAYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGCGTATCTCTGCGCCAGCAGCCAAGATCGAGAATGAGTAGCCTAGCGGGAGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	13	1.1921027775994718E-4		64	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	4	2	2	15	1	10	27	52	42	53														X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACACCCCGGAGAAATAAGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	1.2838029912609695E-4		58	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	0	5	3	0	16	0	23	40	-1	56	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTGCCAGGGGGTCTTACGAGCAGTACTTCGGGCCG	CASSQGARGSYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	4	4	3	23	39	50	43	53														CASSQGARGSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTGGGATAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGGIGAYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	2	2	7	0	23	39	-1	46	51														CASSQGGIGAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGGTCTCGCGGGACTGTAGAGACCCAGTACTTCGGGCCA	CASSQDGSRGTVETQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	4	10	2	23	40	56	50	58						01,02								CASSQDGSRGTVETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACCCAGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSQTQGENTEAFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	1	1	3	1	23	38	48	41	49														CASSQTQGENTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGTGGGACAGGGGGAAACACCATATATTTTGGAGAG	CASSQGGTGGNTIYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	3	4	4	0	23	37	-1	41	50														CASSQGGTGGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAAGCCCCACAGGGGGGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	2.0174047005529523E-4		52	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	1	5	8	3	23	40	56	48	59														X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGATTGCTGGGACGGACGAAGCTTTCTTTGGACAA	CASSPIAGTDEAFF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	4	0	7	8	8	4	23	36	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPIAGTDEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATCATGGGCAGATACGCAGTATTTTGGCCCA	CASSQSWADTQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	2	0	9	4	4	0	23	38	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSWADTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGCGGGACCTGGTATGGCTACACCTTCGGTTCG	CASSRGTWYGYTF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	7	3	5	0	5	23	-1	42	36	47														CASSRGTWYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGGGGAGTTATGGCTACACCTTCGGTTCG	CASSQEGSYGYTF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	2	5	1	1	23	40	46	41	47														CASSQEGSYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCCGAGCCTTGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CTSRALSGANVLTF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	8	6	7	1	2	4	23	32	37	34	41						01,02								CTSRALSGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATCCGGGGCTAGCGAAAAGCTCTAACACAGATACGCAGTATTTTGGCCCA	CASSHPGLAKSSNTDTQYF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	6	2	7	11	23	37	50	44	61						01,02								CASSHPGLAKSSNTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGAGTGGGTACGGAGGGAAGTACTTCGGGCCG	CASSQSGYGGKYF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	11	10	1	23	37	53	47	54														CASSQSGYGGKYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATGCTACTTCCGGGACAGGGAGATTGAAGGAAAAACTGTTTTTTGGCAGT	CASSHATSGTGRLKEKLFF	In	VDJ	1	54	4.951811537720883E-4	5.783008663803721E-4	57	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	8	10	9	23	37	56	47	65														CASSHATSGTGRLKEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACTATCAGGCACAGATACGCAGTATTTTGGCCCA	CASSQELSGTDTQYF	In	VDJ	2	55	5.043511751382381E-4	5.890101416837122E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	9	1	0	4	23	-1	44	40	48						01,02								CASSQELSGTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTAGCGGGAGGTTTCTACCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVSGRFLPSYNEQFF	In	VDJ	2	60	5.50201281968987E-4	6.425565182004134E-4	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	1	0	1	8	23	39	50	40	58														CASSQVSGRFLPSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAATTTAGACTAACCCGTGCCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	64	5.868813674335861E-4		53	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	9	6	5	9	23	40	50	45	59						01,02								X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGAACGGGCCTTGGCACTGAAGCTTTCTTTGGACAA	CASSQGTGLGTEAFF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	1	8	0	4	4	5	23	39	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGTGLGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCTCGACTGACGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSSTDGENTEAFF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	1	8	1	23	35	48	43	49														CASSSTDGENTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGGGGGGTCTACGAGCAGTACTTCGGGCCG	CASSQDGGVYEQYF	In	VDJ	4	133	0.0012196128416979211	0.0014243336153442496	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	3	1	1	23	40	48	41	49														CASSQDGGVYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCGACCGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	148	0.001357163162190168		37	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	4	2	7	0	0	2	23	-1	39	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCATAGCCCACTACAATGAGCAGTTCTTCGGGCCA	CASSLAIAHYNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	7	3	3	3	19	35	42	38	45						01,02							Vb 5.1	CASSLAIAHYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGACTAGCGGGAGGATTGATCACCGGGGAGCTGTTTTTTGGAGAA	CASGLAGGLITGELFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	1	1	4	0	6	19	-1	42	28	48													Vb 5.1	CASGLAGGLITGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATCGGCGGGAGGTACGGAGAGACCCAGTACTTCGGGCCA	CASSLIGGRYGETQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	1	4	4	5	19	34	46	38	51													Vb 5.1	CASSLIGGRYGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGGACAGGGAAAGAGACCCAGTACTTCGGGCCA	CASSLAGTGKETQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	3	3	2	1	19	35	46	37	47													Vb 5.1	CASSLAGTGKETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGGTCGCGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGSRPYNEQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	0	6	1	2	0	7	19	-1	40	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGGSRPYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCCCGGGACCATACAAGGAACCCAGTACTTCGGGCCA	CASSPGTIQGTQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	5	0	7	8	4	10	19	30	39	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPGTIQGTQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCACCGGGTAGCGGGAGTTCTGAGCAGTTCTTCGGGCCA	CASSPPGSGSSEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	9	8	3	19	31	48	39	51													Vb 5.1	CASSPPGSGSSEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCGGTTTGTGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	1.3755032049224674E-4		43	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	2	10	0	19	32	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAGCCTTCTTCAGGGGGCTTAGGGGCTTTCTTTGGACAA	CASSEPSSGGLGAFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	11	10	6	19	31	49	41	55													Vb 5.1	CASSEPSSGGLGAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGCTCAGCCAGGACGAGCAGTACTTCGGGCCG	CASSLELSQDEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	5	8	0	19	35	-1	43	47													Vb 5.1	CASSLELSQDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAGGACGGGTCGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGRVGNTGELFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	4	1	7	2	3	8	19	31	38	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPGRVGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTACGAGGGAAGGTCCTACTTGTTATCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	1.7423040595684587E-4		58	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	11	0	3	4	17	19	31	40	35	57													Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGGGCGGTAAATGGATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	1.7423040595684587E-4		49	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	0	7	0	4	2	11	19	35	42	37	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCGAGGTGCTGTAGGCACTGAAGCTTTCTTTGGACAA	CASSLARGAVGTEAFF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	1	4	3	9	19	35	42	38	51													Vb 5.1	CASSLARGAVGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCCCCCGGACAGGGGAATGATCAATGAGCAGTTCTTCGGGCCA	CASSLPPDRGMINEQFF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	2	6	5	6	19	34	48	39	54													Vb 5.1	CASSLPPDRGMINEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATTCCGCTTGGCTTCCCCTCTTATGATGGCTACACCTTCGGTTCG	CASSLIPLGFPSYDGYTF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	9	0	6	9	13	19	34	46	43	59													Vb 5.1	CASSLIPLGFPSYDGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCTCCGGGACGGGGGGGGAGACCCAGTACTTCGGGCCA	CASSFSGTGGETQYF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	0	5	8	0	19	33	-1	41	49													Vb 5.1	CASSFSGTGGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGGGTTGGCACAGATACGCAGTATTTTGGCCCA	CASSFGVGTDTQYF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	3	1	0	3	19	-1	38	33	41													Vb 5.1	CASSFGVGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGGACAGGACTACAATGAGCAGTTCTTCGGGCCA	CASSPGQDYNEQFF	In	VDJ	2	60	5.50201281968987E-4	6.425565182004134E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	4	3	2	1	19	31	41	33	42													Vb 5.1	CASSPGQDYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGCTTTGATAGACAGCACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	79	7.244316879258328E-4		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	0	9	2	19	31	45	40	47													Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGGGACTAGCGGGAGAAGCCTACGAGCAGTACTTCGGGCCG	CASSQGLAGEAYEQYF	In	VDJ	3	118	0.0010820625212056745	0.0012636944857941463	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	2	2	2	3	19	31	47	33	50													Vb 5.1	CASSQGLAGEAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGAAGACGGACTGGGGTGAAGCACCATATATTTTGGAGAG		Out	VDJ	5	197	0.0018064942091315073		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	1	10	9	6	9	19	32	43	38	52						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGACTAGCGGGAGTGCCAAGTATACGCAGTATTTTGGCCCA		Out	VDJ	11	397	0.003640498482361464		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	1	2	7	1	8	19	33	47	34	55													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTTACTAGCGGCCAAGCCTACGAGCAGTACTTCGGGCCG	CASSLTSGQAYEQYF	In	VDJ	15	528	0.004841771281327086	0.005654497360163638	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	5	2	3	5	19	31	42	34	47						01,02							Vb 5.1	CASSLTSGQAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGTAACTAGCGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASVTSGANTGELFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	3	3	0	3	0	25	34	-1	37	47													Vb 3	CASVTSGANTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCCTGTGGGGACAGGGGTTGGGTCACTATGGCTACACCTTCGGTTCG	CASSTLWGQGLGHYGYTF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	3	9	7	25	36	55	45	62													Vb 3	CASSTLWGQGLGHYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGTTCTCAGGGGTGAAAAACTGTTTTTTGGCAGT	CASSSVLRGEKLFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	2	7	7	0	25	38	-1	45	51													Vb 3	CASSSVLRGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCGGGGTTGGAACACTGAAGCTTTCTTTGGACAA	CASSFRGWNTEAFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	1	1	3	25	39	45	40	48													Vb 3	CASSFRGWNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTTTTAACAGCAGCTAACTATGGCTACACCTTCGGTTCG	CASSLLTAANYGYTF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	5	0	7	3	25	36	47	43	50													Vb 3	CASSLLTAANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGCGGGGGGGGGTTCCCAGCATTTTGGTGAT	CASSFAGGGSQHF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	7	0	11	1	4	25	39	49	40	53													Vb 3	CASSFAGGGSQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCGGGACTAGCGGATGAGACCCAGTACTTCGGGCCA	CASSSGLADETQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	5	3	2	25	36	50	39	52						01,02							Vb 3	CASSSGLADETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGACTCGGGGACAGGGGCCTTCGAGCAGTACTTCGGGCCG	CASTDSGTGAFEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	6	8	4	25	35	53	43	57													Vb 3	CASTDSGTGAFEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCTAGCGGGACTGATCCCGAGCAGTACTTCGGGCCG	CASTSSGTDPEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	3	6	3	7	25	35	47	38	54													Vb 3	CASTSSGTDPEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGGACTGCCTGGGGGGAGCTGTTTTTTGGAGAA	CASSSGTAWGELFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	10	8	2	6	25	38	46	40	52						01,02							Vb 3	CASSSGTAWGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGCGCGAAGCAGTCTCCGAAAAACTGTTTTTTGGCAGT	CASTREAVSEKLFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	7	4	5	8	9	5	25	35	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTREAVSEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCACTCCCCGGGATGGCTACACCTTCGGTTCG	CASSLTPRDGYTF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	6	9	0	25	37	-1	46	50						01,02							Vb 3	CASSLTPRDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTGAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSFLSGTDTQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	6	1	4	0	25	39	-1	43	47						01,02							Vb 3	CASSFLSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGACAGGGGGGAAGCTTTCTTTGGACAA	CASSPDRGEAFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	8	4	0	25	36	-1	40	49													Vb 3	CASSPDRGEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGCTTGGACGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSTLGRLNTEAFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	1	7	0	6	3	25	37	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTLGRLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGACGGGTAGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	1.4672034185839652E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	8	4	2	4	4	25	38	46	42	50						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGGCGGAGGGGTCAGCCCCAGCATTTTGGTGAT	CASSLGGRRGQPQHF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	2	6	0	6	1	7	25	40	47	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGRRGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTAACTAGCGGGAGAATATCTACGAGCAGTACTTCGGGCCG	CASSPN*RENIYEQYF	Stop	VDJ	1	17	1.558903632245463E-4		48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	2	3	5	5	25	36	52	41	57													Vb 3	CASSPN*RENIYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATAACGGGGGGGGCTCGTGAAAAACTGTTTTTTGGCAGT	CASITGGAREKLFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	8	0	7	3	5	25	35	46	38	51													Vb 3	CASITGGAREKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGCCGACTGGGGAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGRLGRSSYEQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	0	10	2	25	39	55	49	57													Vb 3	CASSLGRLGRSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCCGGCACGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSPGTANTGELFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	4	9	0	0	5	4	25	38	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSPGTANTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGACAGGGATGACGAGCAGTACTTCGGGCCG	CASSSDRDDEQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	5	1	3	25	38	47	39	50													Vb 3	CASSSDRDDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGACAGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGQVNTGELFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	4	1	0	1	25	-1	41	34	42													Vb 3	CASGQVNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATCCTCCAGGGCCCTATGGCTACACCTTCGGTTCG	CASSLYPPGPYGYTF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	4	6	2	25	41	52	47	54													Vb 3	CASSLYPPGPYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCATTACTAGCGGGAGATTCCAAGAGACCCAGTACTTCGGGCCA	CASSITSGRFQETQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	3	2	1	4	3	25	36	51	40	54													Vb 3	CASSITSGRFQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGGGTGGGACTAGGGGGTATGGCCTACGAGCAGTACTTCGGGCCG	CARVGLGGMAYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	0	8	2	3	9	25	33	44	36	53						01,02							Vb 3	CARVGLGGMAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCCAGGGTACGTCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQGTSAKNIQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	4	3	0	3	6	25	34	42	37	48													Vb 3	CASSQGTSAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTCGGACACAATACAATGAGCAGTTCTTCGGGCCA	CASSPRTQYNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	6	4	5	3	25	36	46	41	49													Vb 3	CASSPRTQYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGTCAACCGAACTTACCAATGAGCAGTTCTTCGGGCCA	CASSLWSTELTNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	10	6	9	3	25	42	54	51	57						01,02							Vb 3	CASSLWSTELTNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCTCTGTGCCCGGTAACTATCAGCCCCAGCATTTTGGTGAT	CASSTSVPGNYQPQHF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	10	5	17	0	25	36	-1	53	56						01,02							Vb 3	CASSTSVPGNYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATAGCGGGAGGTGGATACGAGCAGTACTTCGGGCCG	CASSLIAGGGYEQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	1	4	1	4	25	40	51	41	55													Vb 3	CASSLIAGGGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCTTATCGACCTCTCGATCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	2.3842055551989436E-4		52	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	2	7	1	8	8	25	39	50	47	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCCCCTAGCAGGGTGTAGCCGCACAGATACGCAGTATTTTGGCCCA	CASPLAGCSRTDTQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	8	4	3	1	7	7	25	34	46	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASPLAGCSRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACGGGGCGGTCTACGAGCAGTACTTCGGGCCG	CASSYGAVYEQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	4	7	0	3	2	3	25	38	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYGAVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACAACAGGGGCCCTACTCCCCCTACGAGCAGTACTTCGGGCCG	CASRQQGPYSPYEQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	2	3	10	25	36	46	39	56													Vb 3	CASRQQGPYSPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGACAGACTGGAAACACCATATATTTTGGAGAG	CASSRQTGNTIYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	5	2	1	1	25	37	43	38	44													Vb 3	CASSRQTGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCCAGCGGGAGTTTTGAGCAGTTCTTCGGGCCA	CASSLASGSFEQFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	9	3	3	25	40	51	43	54													Vb 3	CASSLASGSFEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCAGGGGGACACAAGCAGTACTTCGGGCCG	CASSFAGGHKQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	8	2	5	25	39	48	41	53													Vb 3	CASSFAGGHKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGTCCTACGAGCAGTACTTCGGGCCG	CASSLWSYEQYF	In	VJ	1	30	2.751006409844935E-4	3.212782591002067E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	0	0	0	1	0	1	25	-1	42	-1	43													Vb 3	CASSLWSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCCGGGACTCTTACAATGAGCAGTTCTTCGGGCCA	CASSARDSYNEQFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	4	4	2	25	37	47	41	49						01,02							Vb 3	CASSARDSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTACTCCGGGACAGCCTTACAATGAGCAGTTCTTCGGGCCA	CASTPGQPYNEQFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	5	4	6	3	25	33	46	39	49													Vb 3	CASTPGQPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGAACAGGGGCAAGCTGCCACCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	3.117807264490926E-4		53	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	0	3	12	25	36	46	39	58													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTTTGACAGGGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSFDRGVAKNIQYF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	1	0	5	2	25	38	52	43	54													Vb 3	CASSSFDRGVAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCATACGGACAGACTCCTACAATGAGCAGTTCTTCGGGCCA	CAIRTDSYNEQFF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	1	5	0	3	1	25	32	41	35	42													Vb 3	CAIRTDSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGCCCCCGGGAGAATCGTACACAGATACGCAGTATTTTGGCCCA	CASKPPGESYTDTQYF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	8	2	2	6	7	25	35	47	41	54													Vb 3	CASKPPGESYTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGTCTACAAATGAGCAGTTCTTCGGGCCA	CASSLGSTNEQFF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	3	6	2	7	0	6	25	-1	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGSTNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGTACCCTCCTACAAGCAGTACTTCGGGCCG	CASSPVPSYKQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	3	6	8	14	0	25	36	-1	50	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPVPSYKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTTCTTCTACGGACAGGGGCAACGAGCAGTACTTCGGGCCG	CASISSTDRGNEQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	2	5	10	2	25	35	54	45	56													Vb 3	CASISSTDRGNEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATTGGGGCTGGGGTCGACACAGATACGCAGTATTTTGGCCCA	CASSLIGAGVDTDTQYF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	2	3	9	25	40	48	43	57													Vb 3	CASSLIGAGVDTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGTAGCGGGGAGCTGTTTTTTGGAGAA	CASSFGSGELFF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	8	7	3	0	25	39	-1	42	45						01,02							Vb 3	CASSFGSGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGATGAGACTAGCGGGATTACAGATACGCAGTATTTTGGCCCA	CASSFDETSGITDTQYF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	2	3	3	6	2	25	39	56	45	58													Vb 3	CASSFDETSGITDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACCCCACAGTTACAGCCCCAGCATTTTGGTGAT	CASSLTPQLQPQHF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	5	7	5	3	25	40	49	45	52													Vb 3	CASSLTPQLQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAAGTCTTCTGCCGCGGGGGGCGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	54	4.951811537720883E-4		49	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	7	1	0	11	4	25	32	51	43	55													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCAGCGGGAGCTTTGCAGATACGCAGTATTTTGGCCCA	CASSLSGSFADTQYF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	4	4	5	25	36	48	40	53													Vb 3	CASSLSGSFADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCCGTCTCGAGGGTAGACCTTCTCCAAGAGACCCAGTACTTCGGGCCA	CASRPVSRVDLLQETQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	1	9	10	25	36	50	45	60													Vb 3	CASRPVSRVDLLQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGGGACAGGGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	61	5.593713033351368E-4		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	0	2	3	25	36	47	38	50													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSLRGPDTQYF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	4	0	2	25	-1	45	40	47													Vb 3	CASSLRGPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTGGCCGGGGGGTCGACTATGGCTACACCTTCGGTTCG	CASSPGRGVDYGYTF	In	VDJ	2	68	6.235614528981852E-4	7.282307206271352E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	1	3	6	3	25	37	50	43	53													Vb 3	CASSPGRGVDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTACATGGACAGGGGAGTACGAGCAGTACTTCGGGCCG	CASSPTWTGEYEQYF	In	VDJ	2	81	7.427717306581324E-4	8.67451299570558E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	4	7	2	25	37	53	44	55													Vb 3	CASSPTWTGEYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTCGGGCAACTACGAGCAGTACTTCGGGCCG	CASSFSGNYEQYF	In	VDJ	2	88	8.069618802211809E-4	9.424162266939396E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	8	0	3	3	2	25	39	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFSGNYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCGTCGGGACTAGCAGAGCCTACGAGCAGTACTTCGGGCCG	CASSFPVGTSRAYEQYF	In	VDJ	2	90	8.253019229534805E-4	9.6383477730062E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	7	2	7	4	25	39	55	46	59						01,02							Vb 3	CASSFPVGTSRAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATACCGACAGGGGGTTATAGAGGGACTGAAGCTTTCTTTGGACAA	CASIPTGGYRGTEAFF	In	VDJ	3	92	8.4364196568578E-4	9.852533279073004E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	1	5	4	10	25	35	48	39	58													Vb 3	CASIPTGGYRGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCAACGGGGACAGGGGACATCAGCCCCAGCATTTTGGTGAT	CASTNGDRGHQPQHF	In	VDJ	3	93	8.528119870519299E-4	9.959626032106407E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	2	5	6	2	25	35	51	41	53													Vb 3	CASTNGDRGHQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGTACCCTCCTACGAGCAGTACTTCGGGCCG	CASSPVPSYEQYF	In	VDJ	3	100	9.170021366149783E-4	0.0010709275303340223	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	3	7	0	6	1	25	36	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPVPSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTAGCGGGAGACGAAATGAGCAGTTCTTCGGGCCA	CASSLSSGRRNEQFF	In	VDJ	3	109	9.995323289103263E-4	0.0011673110080640842	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	2	7	0	4	25	-1	51	41	55													Vb 3	CASSLSSGRRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGGACTAGCGTGGGAGACCCAGTACTTCGGGCCA	CASSPGLAWETQYF	In	VDJ	3	112	0.0010270423930087756	0.001199438833974105	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	6	5	3	3	25	36	49	39	52						01,02							Vb 3	CASSPGLAWETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTTCAGAACCAATCAGCCCCAGCATTTTGGTGAT	CASSLFRTNQPQHF	In	VDJ	3	124	0.0011370826494025731	0.0013279501376141877	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	5	3	3	3	25	39	45	42	48													Vb 3	CASSLFRTNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCGACACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRHSYNEQFF	In	VDJ	3	125	0.0011462526707687228	0.001338659412917528	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	0	4	0	25	37	-1	41	45													Vb 3	CASSPRHSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACCGGGACAGGGGGCGAAAAACATTCAGTACTTCGGCGCC	CASSSPGQGAKNIQYF	In	VDJ	4	132	0.0012104428203317714	0.0014136243400409095	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	0	4	4	1	25	38	54	42	55													Vb 3	CASSSPGQGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCTCTGGGCACAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSALGTSSYEQYF	In	VDJ	4	159	0.0014580333972178156	0.0017027747732310955	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	0	5	5	25	37	46	42	51													Vb 3	CASSALGTSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTTGGACAGGAAAAACTATGGCTACACCTTCGGTTCG	CASSFLDRKNYGYTF	In	VDJ	6	218	0.0019990646578206526	0.0023346220161281684	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	2	3	3	25	39	49	42	52													Vb 3	CASSFLDRKNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAACAGGATTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQQDSSTDTQYF	In	VDJ	22	806	0.007391037221116725	0.00863167589449222	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	4	0	2	5	25	37	44	39	49													Vb 3	CASSQQDSSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCATTACAGGGGGCTATATCCACGAGCAGTACTTCGGGCCG	CASSLLITGGYIHEQYF	In	VDJ	28	993	0.009105831216586735	0.010634310376216842	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	5	6	7	25	40	55	46	62													Vb 3	CASSLLITGGYIHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCACTAACTAGAGGAGGTGGTTAGCATTCAGTACTTCGGCGCC		Out	VDJ	1	14	1.2838029912609695E-4		47	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	3	8	9	4	13	18	30	39	34	52						01,02								X+TCRBV12-02+TCRBJ02-04	TCRBV12-02*01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCACTCCCAAAGCGGGACAGGACCTCTACGAGCAGTACTTCGGGCCG	CATPKAGQDLYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	0	4	3	12	4	18	23	43	35	47														CATPKAGQDLYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCAAGTCGCTTAGGAACGACAGCCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	1.2838029912609695E-4		47	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	5	3	4	3	19	35	44	39	47														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCACGCACCAAACCGGGACTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CATHQTGTSGSYEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	12	0	2	3	13	0	18	23	-1	36	50														CATHQTGTSGSYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCACTCTTGGGGGAAGATTGGAAAATGAGCAGTTCTTCGGGCCA	CATLGGRLENEQFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-01	01	12	6	1	7	7	10	18	23	35	30	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATLGGRLENEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCAAGCCCCTGTGGGAGCGGAGGGCAAATTTGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	1.9257044868914544E-4		47	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	10	0	10	13	8	18	26	45	39	53														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCACACTGCCGCAGGGATCTCGCACAGATACGCAGTATTTTGGCCCA	CATLPQGSRTDTQYF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	4	3	1	10	5	18	23	38	33	43														CATLPQGSRTDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTTTGGGGCCGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	51	4.676710896736389E-4		43	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	7	0	1	2	1	18	32	39	34	40														X+TCRBV12-02+TCRBJ02-04	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCGCCCGGGACAGGACTATCTATGGCTACACCTTCGGTTCG	CASRARDRTIYGYTF	In	VDJ	2	65	5.960513887997359E-4	6.961028947171145E-4	45	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	4	4	5	18	30	42	34	47														CASRARDRTIYGYTF+TCRBV12-02+TCRBJ01-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTGTATCTCTGTGCCAGCAGCCGGGAGGGGGGCACCACTGAAGCTTTCTTTGGACAA	CASSREGGTTEAFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV05	TCRBV05-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	0	4	0	6	19	-1	39	31	45													Vb 5.3	CASSREGGTTEAFF+TCRBV05-05+TCRBJ01-01	TCRBV05-05*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTTGGGGGAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSFGGGDNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	42	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	5	3	1	23	37	47	40	48													Vb 14	CASSFGGGDNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGAGAAGGGGGGCTAGCGGGAGTATCGGGGAGCACAGATACGCAGTATTTTGGCCCA	CAREGGLAGVSGSTDTQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	57	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	4	2	0	10	8	23	31	51	41	59													Vb 14	CAREGGLAGVSGSTDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTCCCCCGGCCGCCAGGCAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSPGRQATGANVLTF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	54	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	4	2	11	3	23	36	51	47	54													Vb 14	CASSSPGRQATGANVLTF+TCRBV27-01+TCRBJ02-06	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCCCGCGACAGGGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSPATGGGYEQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	3	5	3	23	35	49	40	52													Vb 14	CASSPATGGGYEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGGCCGGGACAGGCTACCGGGGAGCTGTTTTTTGGAGAA	CASRPGQATGELFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	42	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	5	3	2	23	34	45	37	47													Vb 14	CASRPGQATGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTAGACTGCAAGGGACTAGCGGGGTGAAGCAGTATTTTGGCCCA	CASSRLQGTSGVKQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	48	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	11	9	4	23	35	57	44	61													Vb 14	CASSRLQGTSGVKQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATCTGGTAGGGGGTACTTTTACGAGCAGTACTTCGGGCCG	CASSLSGRGYFYEQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	1	4	4	6	23	40	50	44	56													Vb 14	CASSLSGRGYFYEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATCGCCGGCAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSPAAYNEQFF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	45	TCRBV27	TCRBV27-01	01				TCRBJ02	TCRBJ02-01	01	0	4	5	2	5	0	23	40	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSLSPAAYNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGGGGGGGCAAACTCCTACGAGCAGTACTTCGGGCCG	CASGGANSYEQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	39	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	9	0	0	0	4	23	-1	39	32	43													Vb 14	CASGGANSYEQYF+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTGCCAGGACGGTACGGAGAACACTGAAGCTTTCTTTGGACAA	CASSCQDGTENTEAFF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	48	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-01	01	4	1	7	1	4	8	23	36	44	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSCQDGTENTEAFF+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAATGGGCACCGGGGAGCTGTTTTTTGGAGAA	CSVVMGTGELFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	4	0	9	4	4	0	25	35	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVMGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCCTCCGATGAGAGGCGAGCTTTCTTTGGACAA	CSVPSDERRAFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	10	11	2	25	34	49	45	51													Vb 4	CSVPSDERRAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTCAGTCAGGGCACACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	1.0087023502764761E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	3	6	4	25	35	46	41	50													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATTCTCTGCAGCGTTGAGTTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.100402563937974E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	19	6	6	0	7	10	43	38	49	45	59						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGTTGAGTTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.100402563937974E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	21	6	6	0	9	10	43	36	49	45	59						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCACCGTAGCTCATAACAGTAAGGAAAAACTGTTTTTTGGCAGT	CTVAHNSKEKLFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	5	8	8	4	25	33	45	41	49													Vb 4	CTVAHNSKEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGTAACAGGGCCGAACACTGAAGCTTTCTTTGGACAA	CSVVTGPNTEAFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	4	2	25	33	43	37	45													Vb 4	CSVVTGPNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGGGCATTGGGGTGCTGAAGCTTTCTTTGGACAA	CSVAGHWGAEAFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	6	0	10	25	-1	40	35	50													Vb 4	CSVAGHWGAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAGGGTTGCCGGGGAGCTGTTTTTTGGAGAA	CSVERVAGELFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	0	6	0	3	25	-1	41	36	44													Vb 4	CSVERVAGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACAGGGGCCGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.3755032049224674E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	1	0	4	25	-1	43	35	47													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCCGGACAGGGGGTGGAGAGGACTGAAGCTTTCTTTGGACAA	CSAPGQGVERTEAFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	1	5	5	8	25	32	47	37	55													Vb 4	CSAPGQGVERTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGACGGGACAGCCCTACAATGAGCAGTTCTTTGGGCCA		Out	VDJ	1	16	1.4672034185839652E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02			7	0	5	22	3	21	25	32	42	35	63								TCRBJ02-01,TCRBJ02-05					Vb 4	X+TCRBV29-01+TCRBJ02-X	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACTAAGGGAGGCACTGAAGCTTTCTTTGGACAA	CSVTKGGTEAFF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	4	6	0	25	33	-1	39	45													Vb 4	CSVTKGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAGCTACTCACGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CSGATHGSQETQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	8	2	1	10	0	25	32	-1	42	48													Vb 4	CSGATHGSQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGGGGGGCCGGGTCCACCGGGGAACTGTTTTTTGGAGAA	CSVGGAGSTGELFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	9	0	14	1	17	25	33	41	34	58													Vb 4	CSVGGAGSTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGGACTAGCGGGAGGGTATGAGCAGTTCTTCGGGCCA	CSVDGLAGGYEQFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	0	8	1	1	25	36	52	37	53													Vb 4	CSVDGLAGGYEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCCGGGAGCGGCGAGACCCAGTACTTCGGGCCA	CSVEPGSGETQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	2	5	2	4	25	37	45	39	49													Vb 4	CSVEPGSGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGAGTCTCTGGAAACACCATATATTTTGGAGAG	CSVDGVSGNTIYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	10	2	0	1	1	25	36	41	37	42													Vb 4	CSVDGVSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACTTTGGGAACACTGAAGCTTTCTTTGGACAA	CSVEDFGNTEAFF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	1	10	1	0	4	25	-1	41	36	45						01,02							Vb 4	CSVEDFGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACATCGCCCGACAGGGTAGTGATGGCTACACCTTCGGTTCG	CSVEDIARQGSDGYTF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	6	8	5	25	39	54	47	59													Vb 4	CSVEDIARQGSDGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGTTTTTCGCACAGGGGCACTGAAGCTTTCTTTGGACAA	CSASFSHRGTEAFF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	4	12	0	25	32	-1	44	51													Vb 4	CSASFSHRGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGAGGTCAGGGACAGACACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	2.567605982521939E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	2	8	3	25	34	49	42	52													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGGGGACACAGATACGCAGTATTTTGGCCCA	CSVRGDTDTQYF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	2	0	1	25	-1	41	34	42													Vb 4	CSVRGDTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACGTTGACAGAGGTGGGGCTACACCTTCGGTTCG	CSVGR*QRWGYTF	Stop	VDJ	1	30	2.751006409844935E-4		39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	8	6	6	25	35	46	41	52													Vb 4	CSVGR*QRWGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCCCCGGATGGCCGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSVPPDGRSYNEQFF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	5	1	8	1	5	7	25	34	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVPPDGRSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAGGGGCTTAAATGAGCAGTTCTTCGGGCCA	CSVERGLNEQFF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	3	5	2	7	1	4	25	36	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVERGLNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAAGGGACATCCAAGAGACCCAGTACTTCGGGCCA	CSVARDIQETQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	6	1	3	1	25	35	44	38	45													Vb 4	CSVARDIQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGATTGACTAGCATACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC	CSVVID*HTKRANVLTF	Stop	VDJ	1	38	3.4846081191369175E-4		51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	2	7	5	5	9	25	35	47	40	56						01,02							Vb 4	CSVVID*HTKRANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAAGCACAGGGGGCGGTTGGACAGATACGCAGTATTTTGGCCCA	CSGSTGGGWTDTQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	0	3	5	6	25	32	46	37	52													Vb 4	CSGSTGGGWTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCAAGCTAGCGGGAGGGTATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.2182098284289E-4		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	0	4	6	3	25	33	51	39	54													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCTCGGGACTATTCGAACATTCAGTACTTCGGCGCC	CSSRDYSNIQYF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	8	0	9	7	4	4	25	31	42	35	46						01,02							Vb 4	CSSRDYSNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGCCGGGACAGGGTCCCACGAGCAGTACTTCGGGCCG	CSGAGTGSHEQYF	In	VDJ	1	49	4.4933104694133935E-4	5.247544898636709E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	5	5	4	25	32	46	37	50													Vb 4	CSGAGTGSHEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACGGCTCATTCCCTGGAAACACCATATATTTTGGAGAG	CSVEDGSFPGNTIYF	In	VDJ	1	53	4.860111324059385E-4	5.675915910770318E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	3	1	7	2	0	10	25	-1	40	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDGSFPGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCCATACGGGGGGAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSPYGGSSSYNEQFF	In	VDJ	2	56	5.135211965043878E-4	5.997194169870525E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	8	1	0	5	5	25	31	43	36	48													Vb 4	CSPYGGSSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGACCGGGGCACCTGAGGGTAATGAAAAACTGTTTTTTGGCAGT	CSATGAPEGNEKLFF	In	VDJ	2	58	5.318612392366874E-4	6.211379675937329E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-04	01	7	7	0	4	5	9	25	32	42	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSATGAPEGNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAAACAGCGTTCTCTGGAAACACCATATATTTTGGAGAG	CSVEDQTAFSGNTIYF	In	VDJ	2	71	6.510715169966346E-4	7.603585465371559E-4	48	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	0	3	5	0	4	4	25	39	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDQTAFSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACTAGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CSVELASYNEQFF	In	VDJ	2	73	6.694115597289342E-4	7.817770971438363E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	6	1	0	0	25	-1	-1	37	43						01,02							Vb 4	CSVELASYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGGGATTGGGGTAAATGAAAAACTGTTTTTTGGCAGT	CSVVGIGVNEKLFF	In	VDJ	2	77	7.060916451935333E-4	8.246141983571972E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-04	01	4	0	8	5	2	8	25	35	41	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVGIGVNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTACGACGAGCACTGAAGCTTTCTTTGGACAA	CSVVTTSTEAFF	In	VDJ	3	96	8.803220511503792E-4	0.0010280904291206615	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	2	7	4	4	3	25	35	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVTTSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGATGGGACAGGGGATTAACTATGGCTACACCTTCGGTTCG	CSVEMGQGINYGYTF	In	VDJ	4	142	0.001302143033993269	0.0015207170930743117	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	1	3	2	25	36	49	39	51													Vb 4	CSVEMGQGINYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGCAGCGGGACAGGGCGCGAGCAGTACTTCGGGCCG	CSVGSGTGREQYF	In	VDJ	5	172	0.0015772436749777628	0.0018419953521745184	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	6	7	2	25	33	49	40	51													Vb 4	CSVGSGTGREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACCTTCACTAGGTCCCACCACGAGCAGTACTTCGGGCCG	CSVTFTRSHHEQYF	In	VDJ	5	196	0.0017973241877653574	0.0020990179594546836	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	8	5	7	8	25	33	45	40	53						01,02							Vb 4	CSVTFTRSHHEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEESSYNEQFF	In	VDJ	14	517	0.004740901046299438	0.005536695331826895	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	0	0	2	25	-1	40	36	42													Vb 4	CSVEESSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGAACTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVELSSYNEQFF	In	VDJ	16	580	0.005318612392366875	0.006211379675937329	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	8	0	2	0	25	37	-1	39	42						01,02							Vb 4	CSVELSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVELSSYNEQFF	In	VDJ	64	2294	0.0210360290139476	0.024567077545862473	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	2	0	3	0	25	36	-1	39	42													Vb 4	CSVELSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTTATAGTCCGGACAAGGGGTACGAGCAGTACTTCGGGCCG	CASYSPDKGYEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	1	6	4	9	5	23	31	45	40	50													Vb 22	CASYSPDKGYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTCACCCGCTATGGCTACACCTTCGGTTCG	CASSVTRYGYTF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	4	3	7	4	2	3	23	36	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVTRYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATAGCAGGGACCCTAAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASIAGTLNSYNEQFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	48	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	7	0	7	0	5	6	23	33	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASIAGTLNSYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAGTCTAGCGGGAGTGCTCGAGTACTCCGGGGAGCTGTTTTTTGGAGAA	CASSESLAGVLEYSGELFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	57	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	4	2	6	3	12	23	38	51	41	63													Vb 22	CASSESLAGVLEYSGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACAAGGGACTAGCGGGAACAGATACGCAGTATTTTGGCCCA	CASSDKGLAGTDTQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	0	3	3	3	0	23	37	-1	40	53													Vb 22	CASSDKGLAGTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCGTACCGGGACTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CASSRTGTSGYNEQFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	4	4	7	0	23	34	-1	41	53						01,02							Vb 22	CASSRTGTSGYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTACAGGGCGAACACCATATATTTTGGAGAG	CASSYRANTIYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	7	2	2	23	34	42	36	44													Vb 22	CASSYRANTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGGACTACCAAGAGACCCAGTACTTCGGGCCA	CASSGDYQETQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	0	0	0	23	-1	-1	36	42						01,02							Vb 22	CASSGDYQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTAGACAGGGGGAAGGAGACCCAGTACTTCGGGCCA	CASSVDRGKETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	1	5	2	3	23	36	47	38	50													Vb 22	CASSVDRGKETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGCTAGCGGGAGTGCCCCAGATACGCAGTATTTTGGCCCA	CASRASGSAPDTQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	2	4	2	5	23	34	46	36	51													Vb 22	CASRASGSAPDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGATACCGGCTTTAGGCAAGAGACCCAGTACTTCGGGCCA	CASDTGFRQETQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	8	5	4	2	12	0	23	32	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASDTGFRQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGATAGACAGGGGGGACTATGGCTACACCTTCGGTTCG	CASRIDRGDYGYTF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	3	4	1	23	34	47	38	48													Vb 22	CASRIDRGDYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATTGGCAGGGGGCTAAATTAGAGACCCAGTACTTCGGGCCA	CASSDWQGAKLETQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	0	4	4	6	23	37	49	41	55													Vb 22	CASSDWQGAKLETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTACCGGGACAGGGTCTCAGCCCCAGCATTTTGGTGAT	CASSTGTGSQPQHF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	6	3	2	23	35	47	38	49													Vb 22	CASSTGTGSQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAATGGGGACATTAATCAGCCCCAGCATTTTGGTGAT	CASNGDINQPQHF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	6	4	3	2	23	33	42	36	44													Vb 22	CASNGDINQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGTCTAGCAACAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGSSNRNTGELFF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	7	1	3	5	23	36	44	39	49						01,02							Vb 22	CASSGSSNRNTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCTTGGCCCACTAGCGGGAGCTATGAGCAGTTCTTCGGGCCA	CASSSWPTSGSYEQFF	In	VDJ	1	54	4.951811537720883E-4	5.783008663803721E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	2	8	9	2	23	35	55	44	57													Vb 22	CASSSWPTSGSYEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTAATAGCGGGAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	68	6.235614528981852E-4		40	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	5	2	3	2	0	23	35	-1	37	46													Vb 22	X+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTCGAAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFEGNQPQHF	In	VDJ	6	233	0.0021366149783128997	0.002495261145678272	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	5	2	8	2	3	2	23	35	40	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSFEGNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGATCTCACGCACCCCCCAGCTGGGCAGTTCTTCGGGCCA	CASSEDLTHPPAGQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	48	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-01	01	3	4	5	12	17	4	28	42	62	59	66			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDLTHPPAGQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGACCCTCGACTAGCGGGAGGGCTGGCGAGCAGTACTTCGGGCCG	CASRPSTSGRAGEQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	48	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	0	6	6	4	28	39	59	45	63			01,02											CASRPSTSGRAGEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGACCGGGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSETGTTGELFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-02	01	3	0	7	4	4	0	28	42	-1	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETGTTGELFF+TCRBV06-04+TCRBJ02-02	TCRBV06-04		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCCGGACTGCTAACTATGGCTACACCTTCGGTTCG	CASSRTANYGYTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	39	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	0	2	1	28	39	46	41	47			01,02			01,02								CASSRTANYGYTF+TCRBV06-04+TCRBJ01-02	TCRBV06-04	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAACTTTCGCGGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	2.0174047005529523E-4		43	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	2	5	7	0	28	42	-1	49	56			01,02											X+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAATAGCAGATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	32	2.9344068371679304E-4		46	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	5	7	0	2	4	28	42	48	44	52			01,02			01,02								X+TCRBV06-04+TCRBJ02-04	TCRBV06-04	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCCAAAGCGGACCCCCCGTACAATGAGCAGTTCTTCGGGCCA	CASSPKADPPYNEQFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	4	5	8	26	38	48	43	56						01,02								CASSPKADPPYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCGGATACGCAGTATTTTGGCCCA	CASSYPDTQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	6	6	1	0	26	41	-1	42	44						01,02								CASSYPDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGATACGGAACCTACGAGCAGTACTTCGGGCCG	CASRYGTYEQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	36	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	2	1	8	2	0	1	26	-1	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYGTYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCAGACTAGCGGGAGTTTTCTACGAGCAGTACTTCGGGCCG	CASSRLAGVFYEQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	2	3	2	4	26	37	51	39	55														CASSRLAGVFYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTGTCACCCGGGGAGCTGTTTTTTGGAGAA	CASSLSPGELFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	36	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-02	01	4	3	7	6	4	0	26	39	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSPGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTATTGGATCCCAACCCGAGCCAATGAGCAGTTCTTCGGGCCA	CASSYWIPTRANEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	48	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	3	1	8	6	2	13	26	40	45	42	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWIPTRANEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGAAGCGGGAAGAGGTGATACGCAGTATTTTGGCCCA	CASSEEAGRGDTQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	3	6	5	6	26	38	50	43	56														CASSEEAGRGDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTCGGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSFGIYNEQFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	3	1	1	26	39	45	40	46														CASSFGIYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCGTTCGTAGATACGCAGTATTTTGGCCCA	CASSYPFVDTQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	6	5	1	5	26	41	44	42	49						01,02								CASSYPFVDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGCAGGAGGGGGCATGTACGATGAGCAGTTCTTCGGGCCA	CASSYAGGGMYDEQFF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	8	5	7	26	41	53	46	60														CASSYAGGGMYDEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCTTAGACTTGGCAGGGGGTAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDLAGGSSGANVLTF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	57	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	1	0	6	3	19	35	48	41	51														CASSLDLAGGSSGANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCAACCCGACAGGGATAATGAAAAACTGTTTTTTGGCAGT	CASSQPDRDNEKLFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	4	6	1	19	31	44	37	45														CASSQPDRDNEKLFF+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCGAGAACAGGGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPRTGGLAKNIQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	51	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	1	0	6	3	19	31	45	37	48														CASSPRTGGLAKNIQYF+TCRBV07-07+TCRBJ02-04	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGAGAAAGGAAGGCGGACCTACGAGCAGTACTTCGGGCCG	CASSEKGRRTYEQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	2	11	1	19	31	46	42	47						01,02								CASSEKGRRTYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCCCTAGCGGGATACGACAAAGATACGCAGTATTTTGGCCCA	CASSSLAGYDKDTQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	3	5	2	8	19	32	43	34	51														CASSSLAGYDKDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATACAATGAGCAGTTCTTCGGGCCA	CASSQYNEQFF	In	VJ	1	30	2.751006409844935E-4	3.212782591002067E-4	33	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-01	01	2	0	0	4	0	0	29	-1	-1	-1	44			01,02											CASSQYNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGGCGGGAGGACCCATCGATACGCAGTATTTTGGCCCA	CASSQSAGGPIDTQYF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	48	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	1	6	1	7	29	46	55	47	62			01,02											CASSQSAGGPIDTQYF+TCRBV16-01+TCRBJ02-03	TCRBV16-01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCTCCAGGGAAACTACGAAAAACTGTTTTTTGGCAGT	CASSLQGNYEKLFF	In	VDJ	2	65	5.960513887997359E-4	6.961028947171145E-4	42	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	3	8	2	7	29	42	49	44	56			01,02											CASSLQGNYEKLFF+TCRBV16-01+TCRBJ01-04	TCRBV16-01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGTGGAGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQSWRSGANVLTF	In	VDJ	3	119	0.0010912325425718242	0.0012744037610974866	48	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	10	1	1	2	0	29	46	-1	48	53			01,02											CASSQSWRSGANVLTF+TCRBV16-01+TCRBJ02-06	TCRBV16-01	TCRBD02-01*02	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAGGATTTCAGGTGGGAACAAAGTCGGGCCACGGGGCC		Out	VDJ	1	10	9.170021366149783E-5		43	TCRBV06	unresolved					TCRBJ02	TCRBJ02-06	01	5	0	8	24	12	14	26	38	54	50	68		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTTTGCTAGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYFASRSYNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	7	0	3	2	26	42	50	45	52		TCRBV06-04,TCRBV06-07				01,02								CASSYFASRSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCTCAAGCCCCTCGAGCGGGAGGAACAATGAGCAGTTCTTCGGGCCA	CASSSSPSSGRNNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	1	5	9	1	22	37	55	46	56		TCRBV07-01,TCRBV07-08												CASSSSPSSGRNNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYRTGTATCKCTGTGCCAGCAGCTTAATCAGCACAGATACGCAGTATTTTGGCCCA	CASSLISTDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	39	TCRBV07	unresolved		unresolved			TCRBJ02	TCRBJ02-03	01	4	5	9	0	0	3	22	-1	37	35	40		TCRBV07-01,TCRBV07-06		TCRBD02										CASSLISTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGTCCCCCAGGGACGGTACCTACGAGCAGTACTTCGGGCCG	CASRSPRDGTYEQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	6	0	7	2	8	4	28	39	52	47	56		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSPRDGTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCCCGGGACAGGGCGCGCGAGCAGTACTTCGGGCCG	CASSPRDRAREQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	4	4	19	31	44	35	48		TCRBV11-01,TCRBV11-03												CASSPRDRAREQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCCCCCATCCCTAATTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.100402563937974E-4		40	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	9	1	8	2	22	31	42	39	44		TCRBV07-01,TCRBV07-04				01,02								X+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTTTGACTAGCGGGAGCTGGGGGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.100402563937974E-4		50	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	2	8	3	9	28	40	55	43	64		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGGGACAGGGAGGCAGATACGCAGTATTTTGGCCCA	CASSYGDREADTQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	3	4	1	3	23	38	48	39	51		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYGDREADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCCTTGGCGGACGGCCTACAACTATGGCTACACCTTCGGTTCG	CASSPWRTAYNYGYTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	48	TCRBV05	unresolved					TCRBJ01	TCRBJ01-02	01	4	1	7	2	7	7	19	31	42	38	49		TCRBV05-05,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWRTAYNYGYTF+TCRBV05-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAAACGGATGAATGGGGCTGAAGCTTTCTTTGGACAA	CASKRMNGAEAFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV12	unresolved					TCRBJ01	TCRBJ01-01	01	7	6	2	6	11	0	22	32	-1	43	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKRMNGAEAFF+TCRBV12-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCTCGGACAGGGGCAGGCAATGAGCAGTTCTTCGGGCCA	CASSSRTGAGNEQFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	6	3	4	18	31	43	34	47		TCRBV11-01,TCRBV11-03												CASSSRTGAGNEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGTGGGCCTGATCGCCTTCCCGGTTGTTGAAGCTTTCTTTGGACAA	CASSLVGLIAFPVVEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	54	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	8	0	7	1	20	19	35	40	36	60		TCRBV07-05,TCRBV07-07												CASSLVGLIAFPVVEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTCCCCCCAGCGGGGGTGGGAGACCCAGTACTTCGGGCCA	CASSSPQRGWETQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	6	2	5	6	3	26	39	53	45	56		TCRBV06-08,TCRBV06-09												CASSSPQRGWETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACCTGACAGGGACACATACGCAGTATTTTGGCCCA	CASSYLTGTHTQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	7	2	4	24	39	48	41	52		TCRBV06-05,TCRBV06-06,TCRBV06-07												CASSYLTGTHTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCGTCATCTCGGGAGGGCCTAGTAATTATGRGCAGTTCTTCGGGCCA	CASSVISGGPSNYXQFF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	0	12	7	14	22	34	49	41	63		TCRBV07-04,TCRBV07-06												CASSVISGGPSNYXQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCTGGACTAGCGGGAGGGCCCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFWTSGRARTGELFF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	54	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	1	0	5	2	5	18	32	49	34	54		TCRBV11-01,TCRBV11-03												CASSFWTSGRARTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCCCTGTCGGGAGGGCCGGGTGAGCAGTTCTTCGGGCCA	CASSSLSGGPGEQFF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	0	9	6	5	26	39	53	45	58		TCRBV06-07,TCRBV06-08												CASSSLSGGPGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGGGCGGCCCCTGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGAAPGGANVLTF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	48	TCRBV10	unresolved					TCRBJ02	TCRBJ02-06	01	4	8	0	3	0	9	26	-1	43	39	52		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGAAPGGANVLTF+TCRBV10-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCTAGGACTAGTATTCCCCACAGATACGCAGTATTTTGGCCCA	CASSLGLVFPTDTQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	8	2	0	7	18	-1	40	34	47		TCRBV07-01,TCRBV07-02				01,02								CASSLGLVFPTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGTTATAAAAGGTATGGGGGCCTAAGGAATGAGCAGTTCTTCGGGCCA	CASYKRYGGLRNEQFF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	48	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	6	0	7	12	6	26	35	53	47	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASYKRYGGLRNEQFF+TCRBV12-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCAGTACAGGGGCCAAATCAGCCCCAGCATTTTGGTGAT	CASSSVQGPNQPQHF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	4	4	3	23	36	47	40	50		TCRBV06-07,TCRBV06-08												CASSSVQGPNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSETANTEAFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	1	0	1	23	-1	42	38	43		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSETANTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTCCCGGACCGTTTTGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	3.0261070508294286E-4		38	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	5	1	7	7	4	6	28	40	48	44	54		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACAGTTATCCCCAACTATGGCTACACCTTCGGTTCG	CASTVIPNYGYTF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	39	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	3	5	2	4	8	26	31	39	35	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTVIPNYGYTF+TCRBV12-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCCGGCAGATGAGCAGTTCTTCGGGCCA	CASSYPADEQFF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	36	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	2	4	5	8	4	0	23	38	-1	42	45		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPADEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCGATGAGGGAGTCGAAGGAGATACGCAGTATTTTGGCCCA	CASDEGVEGDTQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	9	2	5	5	7	26	35	45	40	52		TCRBV06-07,TCRBV06-09												CASDEGVEGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGGGGTTCAGAGCGTAGGGGGAACAGATACGCAGTATTTTGGCCCA	CASSEGVQSVGGTDTQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	54	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	1	3	15	1	23	37	58	52	59		TCRBV10-01,TCRBV10-02												CASSEGVQSVGGTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTTCTGCGCCAGCAGTGAGTCTGTCCTACACCCCCCAAGTAGACTAGCGCGATACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	3.7597087601214113E-4		67	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	6	2	20	5	4	21	49	41	54		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCCAAAACGGGAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASQNGRAYNEQFF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	8	0	2	5	0	26	35	-1	40	48		TCRBV06-08,TCRBV06-09												CASQNGRAYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGTTCCAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSLVPGGYEQYF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	3	3	0	18	34	-1	37	44		TCRBV11-01,TCRBV11-03												CASSLVPGGYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTTCTGCGGGTAACGTGCCTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	49	4.4933104694133935E-4		47	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	4	4	3	10	26	38	46	41	56		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCCCCGCTCGGGAGCAAGAGACCCAGTACTTCGGGCCA	CASSPAREQETQYF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	2	2	6	0	19	31	-1	37	43		TCRBV07-02,TCRBV07-07												CASSPAREQETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCTTTGCTCGGGACAGGGTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDSLLGTGSSGANVLTF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	60	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	3	0	7	2	21	38	54	45	56		TCRBV06-04,TCRBV06-08												CASSDSLLGTGSSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTACAAGGGTTGTTTGGCTACACCTTCGGTTCG	CASSLQGLFGYTF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	2	5	3	7	2	5	18	33	39	35	44		TCRBV07-02,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQGLFGYTF+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTTCAGAGGTGGGATGAGCAGTTCTTCGGGCCA	CASSFQRWDEQFF	In	VDJ	2	69	6.32731474264335E-4	7.389399959304753E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	8	3	4	18	32	39	35	43		TCRBV07-02,TCRBV07-08												CASSFQRWDEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAGGGCAGGTAGCGAAGCAGTTCTTCGGGCCA	CASSLGQVAKQFF	In	VDJ	3	108	9.903623075441766E-4	0.0011566017327607442	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	6	11	6	1	20	36	47	42	48		TCRBV07-02,TCRBV07-08				01,02								CASSLGQVAKQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCGGGGGGGGGCACCACTGAAGCTTTCTTTGGACAA		Out	VDJ	8	288	0.0026409661534511374		41	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	4	0	5	19	-1	39	31	44		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCCCCTGGGCCGTTGTAGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	9	307	0.0028151965594079833		41	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	8	0	7	4	8	23	32	40	36	48		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTACCGGCCACAAGAGACCCAGTACTTCGGGCCA	CASSYRPQETQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	39	TCRBV22	TCRBV22-01	01				TCRBJ02	TCRBJ02-05	01	13	4	5	2	2	13	25	28	33	30	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRPQETQYF+TCRBV22-01+TCRBJ02-05	TCRBV22-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAGAGTCGGGGGCAGACAATGAGCAGTTCTTCGGGCCA	CASSLESGADNEQFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV05	TCRBV05-08	01				TCRBJ02	TCRBJ02-01	01	2	6	0	5	6	2	20	34	46	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLESGADNEQFF+TCRBV05-08+TCRBJ02-01	TCRBV05-08*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAATTAAAGGGGTTGAGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	12	1.100402563937974E-4		47	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	5	2	4	7	4	22	35	47	42	51														X+TCRBV07-01+TCRBJ01-03	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTGCAATCAGGGGTGGGAGAGACCCAGTACTTCGGGCCA	CASSLQSGVGETQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	45	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	4	6	4	22	35	47	41	51														CASSLQSGVGETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCCGGGACGGACTATGGCTACACCTTCGGTTCG	CASSSGTDYGYTF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	3	1	2	22	36	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTDYGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGTGGGACTACTATCCTACGAGCAATACTTCGGGCCG	CASSLVGLLSYEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	9	13	4	15	22	35	46	39	61						01,02								CASSLVGLLSYEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTACCGGGAACGAATCAGCCCCAGCATTTTGGTGAT	CASSLPGTNQPQHF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	8	3	4	3	3	22	35	43	38	46														CASSLPGTNQPQHF+TCRBV07-01+TCRBJ01-05	TCRBV07-01*01	TCRBD02-01*02	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGACAGGGTAAATGGCTACACCTTCGGTTCG	CASSEDRVNGYTF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	6	0	3	23	-1	45	38	48													Vb 12	CASSEDRVNGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTTACAGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSESYRGTGELFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	0	3	5	4	2	3	23	40	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESYRGTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCACACAGTAAACTATGGCTACACCTTCGGTTCG	CASSHTVNYGYTF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	5	2	4	2	23	34	42	38	44													Vb 12	CASSHTVNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCTATCCGAAGTCGCAATCAGCCCCAGCATTTTGGTGAT	CASSPIRSRNQPQHF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	9	2	1	9	23	35	39	36	48						01,02							Vb 12	CASSPIRSRNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAACAGATTATGAACACTGAAGCTTTCTTTGGACAA	CASREQIMNTEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	0	3	4	23	34	41	37	45													Vb 12	CASREQIMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTGGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSEWGNQPQHF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	1	6	2	4	0	1	23	-1	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEWGNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAAGAGCGAGGGGGCACGAGCAGTACTTCGGGCCG	CASSERARGHEQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	0	5	7	0	23	37	-1	44	51													Vb 12	CASSERARGHEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGACTAGCGGAAGCCTACGAGCAGTACTTCGGGCCG	CASRGLAEAYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	5	2	0	3	23	-1	45	34	48						01,02							Vb 12	CASRGLAEAYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCCACTCGACAGGGCCGAAGCACAGATACGCAGTATTTTGGCCCA	CASSATRQGRSTDTQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	3	0	6	4	23	36	49	42	53													Vb 12	CASSATRQGRSTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTGGGGGACCGGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSEWGTGTSGTDTQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	54	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	6	1	8	0	23	39	-1	47	57						01,02							Vb 12	CASSEWGTGTSGTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGCACGGTCTATGGCTACACCTTCGGTTCG	CASSEGTVYGYTF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	2	9	0	4	0	5	23	-1	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEGTVYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGAGGGGGGATTTGGAGCAGTACTTCGGGCCG	CASRRGDLEQYF	In	VDJ	5	196	0.0017973241877653574	0.0020990179594546836	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	6	5	1	7	1	6	23	34	41	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRRGDLEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGAGGGGGCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CAISERGRNTGELFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	5	0	1	0	1	23	-1	45	38	46													Vb 12	CAISERGRNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGACGGGGGGCCCACAGATACGCAGTATTTTGGCCCA	CAISDGGPTDTQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	1	2	0	2	24	-1	45	38	47													Vb 12	CAISDGGPTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGACAGGGGAATAGTGAGCAGTTCTTCGGGCCA	CAISEGQGNSEQFF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	9	0	5	23	-1	47	38	52													Vb 12	CAISEGQGNSEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGTCGCGGGGTCCGCCCCGCAGTACTTCGGGCCG	CAISEVAGSAPQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	3	9	3	8	23	38	47	41	55													Vb 12	CAISEVAGSAPQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCTTGAATACAATGAGCAGTTCTTCGGGCCA	CAISESLEYNEQFF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	0	2	8	4	4	1	23	40	46	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESLEYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTAAAAGGACTAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	9.170021366149783E-5		38	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	24	1	8	6	22	0	43	36	-1	58	65			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGACTAGCGGGAGGGGACACAGATACGCAGTATTTTGGCCCA	CASTRLAGGDTDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	2	0	2	3	2	27	37	54	40	56			01,02										Vb 17	CASTRLAGGDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAACAATGAGCAGTTCTTCGGGCCA	CASSMNNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	2	8	5	0	0	27	-1	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGACGGCCGACAAGAGACCCAGTACTTCGGGCCA	CASSMRDGRQETQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	0	7	2	2	6	27	41	48	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMRDGRQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATAGCGGAAAAGACACAGATACGCAGTATTTTGGCCCA	CASSNSGKDTDTQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	5	2	1	6	27	40	47	41	53			01,02			01,02							Vb 17	CASSNSGKDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAACCATAGCCCTGGCTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	1.1921027775994718E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	5	7	0	5	8	27	35	44	40	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGATCTTTCCGGGCCCGTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	1.1921027775994718E-4		49	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	4	8	0	3	9	4	27	40	53	49	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCGACAGGGGGTGGAGGAATGAGCAGTTCTTCGGGCCA	CASSFDRGWRNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	7	3	6	27	39	51	42	57			01,02										Vb 17	CASSFDRGWRNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTCGGACAGTATTAGATCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	13	1.1921027775994718E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	24	1	5	6	19	9	37	30	55	49	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGAGTGATTGAAGCTTTCTTTGGACAA	CASSTGVIEAFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	4	4	7	0	6	27	-1	44	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTGVIEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGTCGGACAGTATTAGATCCCGGGGAGCTGTTTTTTGGAGAA	CASSRTVLDPGELFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	6	1	9	36	48	55	49	64			01,02										Vb 17	CASSRTVLDPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGACAGGGTTCGACGAGCAGTACTTCGGGCCG	CASSTGTGFDEQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	5	2	4	27	40	51	42	55			01,02										Vb 17	CASSTGTGFDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGTAGCAAAGATAACTATGGCTACACCTTCGGTTCG	CASSISSKDNYGYTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	5	7	1	2	5	27	42	48	44	53			01,02			01,02							Vb 17	CASSISSKDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTAGCACAACCTCTAACTATGGCTACACCTTCGGTTCG	CASSLSTTSNYGYTF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	5	7	0	3	7	27	38	45	41	52			01,02			01,02							Vb 17	CASSLSTTSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGATCTTTTAGAGACCCAGTACTTCGGGCCA	CASSTDLLETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	4	1	8	4	1	6	27	40	44	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTDLLETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGGGGGTCGTCTGCTGGAAACACCATATATTTTGGAGAG	CAGGSSAGNTIYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	11	9	1	2	0	7	27	-1	39	33	46			01,02										Vb 17	CAGGSSAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTGGCAAGCCACGTTTGGTGCCAAAAGAACCCGACAGTTTCTATCTCTGTGCCAGTAGTCACCGSTACGAGCAGTACTTCGGGCCG	CASSHRYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	33	TCRBV19	TCRBV19-01		unresolved			TCRBJ02	TCRBJ02-07	01	5	8	5	4	3	0	48	60	-1	63	66			01,02	TCRBD01,TCRBD02									Vb 17	CASSHRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	unresolved	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGCTACCCCCTTCGGGATCGACTATGGCTACACCTTCGGTTCG	CAATPFGIDYGYTF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	11	8	3	3	11	3	27	33	49	44	52			01,02										Vb 17	CAATPFGIDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCTTCAGGGGGGGCACACTGAAGCTTTCTTTGGACAA	CASNLQGGHTEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	4	1	3	5	3	27	37	49	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNLQGGHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGTGAGTTCTGGGGCAGATACGCAGTATTTTGGCCCA	CASSGVSSGADTQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	6	2	4	0	12	27	-1	43	39	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGVSSGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAACTAGCGGGAGTCGGCTACGAGCAGTACTTCGGGCCG	CASSIELAGVGYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	2	3	0	4	27	-1	55	44	59			01,02										Vb 17	CASSIELAGVGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGTAGCGGCCGTTCAAGAGACCCAGTACTTCGGGCCA	CASSIGVAAVQETQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	5	2	3	5	27	43	52	46	57			01,02			01,02							Vb 17	CASSIGVAAVQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGGGGGACAGGGGGCTGTGACCGGGGAGCTGTTTTTTGGAGAA	CASRGGQGAVTGELFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	0	5	3	4	27	38	53	41	57			01,02										Vb 17	CASRGGQGAVTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAAATAGGGGCGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSIEIGAFTGELFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	2	4	6	4	27	41	52	47	56			01,02										Vb 17	CASSIEIGAFTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGACAGGGGGTCAACAATGAGCAGTTCTTCGGGCCA	CASSIRQGVNNEQFF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	1	5	1	3	27	42	52	43	55			01,02										Vb 17	CASSIRQGVNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCTTGGGACAGGGGGCCGGCGGGGAGCTGTTTTTTGGAGAA	CASSIPLGQGAGGELFF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	0	7	5	3	27	42	59	47	62			01,02										Vb 17	CASSIPLGQGAGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCAAACCGTGCAGTTCTTCGGGCCA	CASSIQTVQFF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	3	7	12	4	3	27	41	47	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIQTVQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCGGGGGACAGGGTCCGGAGACCCAGTACTTCGGGCCA	CASIGGQGPETQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	3	5	4	4	27	37	50	41	54			01,02										Vb 17	CASIGGQGPETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACAAACAGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASNKQGANTEAFF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	0	1	4	0	27	37	-1	41	50			01,02										Vb 17	CASNKQGANTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTCCGGCGACAGCTAAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	2.567605982521939E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	2	8	5	27	41	54	49	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAACAGGGGCCAATCTATGGCTACACCTTCGGTTCG	CASSIQQGPIYGYTF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	4	2	5	27	42	51	44	56			01,02										Vb 17	CASSIQQGPIYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGACAGGGTTTAATGAGCAGTTCTTCGGGCCA	CASSIGTGFNEQFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	1	3	27	41	51	42	54			01,02										Vb 17	CASSIGTGFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCAGGGGGATACACTGAAGCTTTCTTTGGACAA	CASSAGGYTEAFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	3	1	2	27	39	47	40	49			01,02										Vb 17	CASSAGGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGATATCAGCAAATCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	30	2.751006409844935E-4		50	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	27	39	-1	58	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCAATCCGGGACAGGGTAAAGATGGCTACACCTTCGGTTCG	CASINPGQGKDGYTF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	6	7	5	27	37	53	44	58			01,02										Vb 17	CASINPGQGKDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTTACCCGGACAGAAATTATACGCAATGAGCAGTTCTTCGGGCCA	CASLTRTEIIRNEQFF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	5	6	7	10	27	36	49	43	59			01,02										Vb 17	CASLTRTEIIRNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGAGAGGGGAGACCCAGTACTTCGGGCCA	CASSIGRGETQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	11	0	5	3	0	27	43	-1	46	51			01,02										Vb 17	CASSIGRGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTACGAAATCAGCCCCAGCATTTTGGTGAT	CASSLRNQPQHF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	9	4	0	3	27	-1	42	39	45			01,02			01,02							Vb 17	CASSLRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTTTCCGGCGGGAGTGCTTGGCACCGGGGAGCTGTTTTTTGGAGAA	CAFPAGVLGTGELFF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	11	7	2	4	6	7	27	33	46	39	53			01,02										Vb 17	CAFPAGVLGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACTAGCGGGAGAGTATATTCAGTACTTCGGCGCC	CASSILAGEYIQYF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	4	2	10	0	5	27	-1	52	42	57			01,02										Vb 17	CASSILAGEYIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAAAAGGGGGGGAGATCCTCCTACGAGCAGTACTTCGGGCCG	CASQKGGRSSYEQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	9	0	0	5	5	27	36	48	41	53			01,02										Vb 17	CASQKGGRSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAATGACAGGGGGATCTCTGGATACGCAGTATTTTGGCCCA	CASRMTGGSLDTQYF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	1	6	3	7	27	38	50	41	57			01,02										Vb 17	CASRMTGGSLDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGGCAGGAAAACTACACCTTCGGTTCG	CASSIGGQENYTF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	6	0	10	0	7	27	-1	49	43	56			01,02										Vb 17	CASSIGGQENYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTGGGAACACTGAAGCTTTCTTTGGACAA	CASSIGGNTEAFF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	10	1	1	3	27	41	44	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGGGAATACAATGAGCAGTTCTTCGGGCCA	CASREYNEQFF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	8	3	4	0	1	27	-1	41	36	42			01,02										Vb 17	CASREYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGAATCTAATGACTAGCGGGGAGCAGTTCTTCGGGCCA	CASSRNLMTSGEQFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	4	10	12	0	27	38	-1	50	60			01,02			01,02							Vb 17	CASSRNLMTSGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCTAGCGGGAGTACCGGGGAGCTGTTTTTTGGAGAA	CASSIASGSTGELFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	4	2	5	0	1	27	-1	53	43	54			01,02										Vb 17	CASSIASGSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCATTCGGACAGGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSAFGQGASYEQYF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	0	6	0	27	39	-1	45	56			01,02										Vb 17	CASSAFGQGASYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCATCGACAGGGCCTACGAGCAGTACTTCGGGCCG	CASSAIDRAYEQYF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	2	6	0	27	39	-1	45	52			01,02										Vb 17	CASSAIDRAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTACAGGGTAATGAGCAGTTCTTCGGGCCA	CASSLQGNEQFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	7	2	1	27	39	47	41	48			01,02										Vb 17	CASSLQGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGATGGACAGGGTGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTMDRVENTGELFF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	3	1	4	4	27	40	52	44	56			01,02										Vb 17	CASSTMDRVENTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCGGGACAGCTAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGTANSYNEQFF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	5	0	3	4	27	36	46	39	50			01,02										Vb 17	CASSGTANSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSMTGGNQPQHF	In	VDJ	1	51	4.676710896736389E-4	5.461730404703514E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	2	0	0	27	-1	-1	41	49			01,02										Vb 17	CASSMTGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTGCTAGGTACACAGATACGCAGTATTTTGGCCCA	CASSTARYTDTQYF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	8	2	3	3	27	40	47	43	50			01,02			01,02							Vb 17	CASSTARYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAGGGACAGAGCTTAAAGATACGCAGTATTTTGGCCCA	CASSLGTELKDTQYF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	5	0	7	27	-1	49	43	56			01,02										Vb 17	CASSLGTELKDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTTGAGAGCAACTACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	53	4.860111324059385E-4		38	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	3	9	7	10	0	27	36	-1	46	50			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAACTAGCGGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSVTSGEYNEQFF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	4	3	2	27	39	52	42	54			01,02										Vb 17	CASSVTSGEYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTAAAACCCTAGCGGGAGGGAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	63	5.777113460674364E-4		53	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	0	1	8	2	27	38	58	46	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCTGTCCGGGACAGAGAACATTCAGTACTTCGGCGCC	CASRLSGTENIQYF	In	VDJ	2	64	5.868813674335861E-4	6.853936194137742E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	5	7	7	2	27	38	52	45	54			01,02										Vb 17	CASRLSGTENIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTTCGACAGGCTTCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIVSTGFLSGANVLTF	In	VDJ	2	67	6.143914315320355E-4	7.175214453237949E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	2	4	0	4	6	24	40	50	44	56			01,02										Vb 17	CASSIVSTGFLSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTTCCGGGGTCACAAACTGAAGCTTTCTTTGGACAA	CASTLPGSQTEAFF	In	VDJ	2	71	6.510715169966346E-4	7.603585465371559E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	5	6	6	27	37	48	43	54			01,02										Vb 17	CASTLPGSQTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCGGCCTCCAATGAGCAGTTCTTCGGGCCA	CASSISASNEQFF	In	VDJ	2	77	7.060916451935333E-4	8.246141983571972E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	2	9	0	6	2	3	27	42	47	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISASNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCATATCTAGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSPYLETGELFF	In	VDJ	2	78	7.152616665596831E-4	8.353234736605373E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	8	5	6	2	27	39	49	45	51			01,02			01,02							Vb 17	CASSPYLETGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTCCGGGGCCCTTCGTTTGAAGCTTTCTTTGGACAA	CASRFRGPSFEAFF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	7	0	7	5	8	27	38	48	43	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRFRGPSFEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCAGGGGGCCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSRGPDTGELFF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	0	3	1	3	27	40	49	41	52			01,02										Vb 17	CASSSRGPDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGGCAGGGAACACCCGGGGAGCTGTTTTTTGGAGAA	CASRRQGTPGELFF	In	VDJ	2	83	7.61111773390432E-4	8.888698501772385E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	6	4	5	27	38	47	42	52			01,02										Vb 17	CASRRQGTPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCAGCCGGGACAGGGGGCTTCTATGAGCAGTTCTTCGGGCCA	CAAGTGGFYEQFF	In	VDJ	2	84	7.702817947565818E-4	8.995791254805787E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	0	0	8	4	4	27	32	48	36	52			01,02										Vb 17	CAAGTGGFYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAATGACGGCCTTGAAAGGCCCCAGCATTTTGGTGAT	CATNDGLERPQHF	In	VDJ	2	86	7.886218374888814E-4	9.209976760872592E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	10	2	7	9	5	11	27	34	42	39	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATNDGLERPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGGGGGGTATGGTGAAGCTTTCTTTGGACAA	CASKGGYGEAFF	In	VDJ	2	90	8.253019229534805E-4	9.6383477730062E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	0	7	1	5	27	37	45	38	50			01,02										Vb 17	CASKGGYGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGAGCGGGACGGAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRAGRSSSYEQYF	In	VDJ	2	90	8.253019229534805E-4	9.6383477730062E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	3	0	2	8	27	39	48	41	56			01,02										Vb 17	CASSRAGRSSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACTAGCGGGAGAGACCCAGTACTTCGGGCCA	CASRLAGETQYF	In	VDJ	3	93	8.528119870519299E-4	9.959626032106407E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	4	4	0	0	27	-1	-1	38	47			01,02			01,02							Vb 17	CASRLAGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGAAGGGGCGTCGTGAAAAACTGTTTTTTGGCAGT	CASSIGKGRREKLFF	In	VDJ	3	95	8.711520297842294E-4	0.0010173811538173212	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	5	2	7	3	5	27	43	51	46	56			01,02										Vb 17	CASSIGKGRREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGGGACTAGCGGGAGGTGGCGATGAGCAGTTCTTCGGGCCA	CASRGLAGGGDEQFF	In	VDJ	3	97	8.89492072516529E-4	0.0010387997044240015	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	0	1	8	3	5	27	35	53	38	58			01,02										Vb 17	CASRGLAGGGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCTCCGCGGGGGGCATCGGAGAGCAGTTCTTCGGGCCA	CASSSSAGGIGEQFF	In	VDJ	3	97	8.89492072516529E-4	0.0010387997044240015	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	1	10	6	7	27	39	53	45	60			01,02										Vb 17	CASSSSAGGIGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATACAGGGTCCACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNTGSTGANVLTF	In	VDJ	3	103	9.445122007134276E-4	0.0011030553562440429	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	3	3	2	2	4	27	37	45	39	49			01,02										Vb 17	CASNTGSTGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCAAGACAGGACCCAGAACACTGAAGCTTTCTTTGGACAA	CASSSQDRTQNTEAFF	In	VDJ	3	103	9.445122007134276E-4	0.0011030553562440429	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	5	5	27	40	51	45	56			01,02										Vb 17	CASSSQDRTQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCGGGACCGGCGCCGAAGCTTTCTTTGGACAA	CASSGGTGAEAFF	In	VDJ	3	109	9.995323289103263E-4	0.0011673110080640842	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	7	3	8	1	8	27	39	46	40	54			01,02										Vb 17	CASSGGTGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACACGACCGGGACTAGCGGATACAATGAGCAGTTTTTCGGGCCA		Out	VDJ	3	112	0.0010270423930087756		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02			4	0	5	19	7	16	27	40	58	47	74			01,02			01,02		TCRBJ02-01,TCRBJ02-05					Vb 17	X+TCRBV19-01+TCRBJ02-X	TCRBV19-01	TCRBD02-01	TCRBJ02	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGGGGACAGGGGGCAGAGACCCAGTACTTCGGGCCA	CASSLGGQGAETQYF	In	VDJ	3	113	0.0010362124143749255	0.0012101481092774452	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	0	4	5	0	27	39	-1	44	56			01,02										Vb 17	CASSLGGQGAETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCTAGCGGGAGTTGGACAGATACGCAGTATTTTGGCCCA	CASSIPSGSWTDTQYF	In	VDJ	3	124	0.0011370826494025731	0.0013279501376141877	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	3	2	4	27	41	53	43	57			01,02										Vb 17	CASSIPSGSWTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAGCCGGGTCGCCGCCTACAATGAGCAGTTCTTCGGGCCA	CASKSRVAAYNEQFF	In	VDJ	4	127	0.0011645927135010225	0.0013600779635242082	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	4	2	5	6	27	37	46	42	52			01,02			01,02							Vb 17	CASKSRVAAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCTAGGACCCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASARTPSYNEQFF	In	VDJ	4	143	0.001311313055359419	0.001531426368377652	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	8	1	7	0	4	3	27	36	44	40	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASARTPSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGCCAGGGTACCCAGATGGCTACACCTTCGGTTCG	CASSRPGYPDGYTF	In	VDJ	4	144	0.0013204830767255687	0.001542135643680992	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	6	3	7	27	40	48	43	55			01,02										Vb 17	CASSRPGYPDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGACAGGGATGCCTACGAGCAGTACTTCGGGCCG	CASSKDRDAYEQYF	In	VDJ	4	145	0.0013296530980917186	0.0015528449189843323	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	2	1	3	27	40	49	41	52			01,02										Vb 17	CASSKDRDAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTAGCGGTCCCATACAATGAGCAGTTCTTCGGGCCA	CASSILAVPYNEQFF	In	VDJ	5	174	0.0015955837177100622	0.0018634139027811987	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	4	1	5	27	41	49	42	54			01,02			01,02							Vb 17	CASSILAVPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCAGGCTCGGAGCTCCTACAATGAGYAGTTCTTCGGGCCA		Out	VDJ	5	185	0.0016964539527377098		49	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	4	4	0	2	7	27	41	47	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGCGACTAGCGTCGGACAAAACATTCAGTACTTCGGCGCC	CASSIVATSVGQNIQYF	In	VDJ	5	187	0.0017147939954700094	0.0020026344817246217	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	2	6	5	4	6	27	43	55	47	61			01,02			01,02							Vb 17	CASSIVATSVGQNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCAGAGACGGGGGGGGTAGGAGATACGCAGTATTTTGGCCCA	CASSETGGVGDTQYF	In	VDJ	5	190	0.0017423040595684587	0.0020347623076346424	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	0	5	7	5	27	36	51	43	56			01,02										Vb 17	CASSETGGVGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACAGATACGAGCAGTACTTCGGGCCG	CASSHRYEQYF	In	VDJ	5	196	0.0017973241877653574	0.0020990179594546836	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	4	1	1	27	39	44	40	45			01,02										Vb 17	CASSHRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGACAGGGGGCATATACGAGCAGTACTTCGGGCCG	CASSPTGGIYEQYF	In	VDJ	6	211	0.0019348745082576042	0.002259657089004787	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	4	2	3	27	39	51	41	54			01,02										Vb 17	CASSPTGGIYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGTACAGGGGCGTCTAGGACAGATACGCAGTATTTTGGCCCA	CASSRTGASRTDTQYF	In	VDJ	6	223	0.0020449147646514018	0.0023881683926448697	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	3	3	8	27	39	49	42	57			01,02										Vb 17	CASSRTGASRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAGGACAGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASKGQGDTGELFF	In	VDJ	6	232	0.0021274449569467497	0.0024845518703749316	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	1	3	2	0	27	37	-1	39	49			01,02										Vb 17	CASKGQGDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCCACCTGACGGGAGTGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASHLTGVGAGELFF	In	VDJ	10	354	0.003246187563617023	0.003791083457382439	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	11	8	2	6	10	6	27	33	49	43	55			01,02										Vb 17	CASHLTGVGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCACGGGGTCCGAGCAGTACTTCGGGCCG	CASSIVTGSEQYF	In	VDJ	12	443	0.004062319465204354	0.004744208959379719	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	3	6	3	2	27	43	51	46	53			01,02										Vb 17	CASSIVTGSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCGAACTAACAATGAGCAGTTCTTCGGGCCA	CASSARTNNEQFF	In	VDJ	13	468	0.004291569999358098	0.005011940841963224	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	9	5	6	0	27	39	-1	45	49			01,02			01,02							Vb 17	CASSARTNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGAGGGGTAAGGACACTGAAGCTTTCTTTGGACAA	CASSIGRGKDTEAFF	In	VDJ	14	492	0.004511650512145693	0.00526896344924339	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	0	3	0	6	27	-1	49	41	55			01,02										Vb 17	CASSIGRGKDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGACAGGGGGTATTTACGAGCAGTACTTCGGGCCG	CASSPTGGIYEQYF	In	VDJ	22	793	0.0072718269433567784	0.008492455315548797	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	4	3	4	27	38	50	41	54			01,02										Vb 17	CASSPTGGIYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCGCTACGAGCAGTACTTCGGGCCG	CASSHRYEQYF	In	VDJ	53	1927	0.01767063117257063	0.020636773509536608	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	3	7	3	1	2	27	39	42	40	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSHRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAAGGACTAGCAATGAGCAGTTCTTCGGGCCA	CASSKRTSNEQFF	In	VDJ	61	2210	0.02026574721919102	0.02366749842038189	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	8	6	3	0	27	40	-1	43	50			01,02			01,02							Vb 17	CASSKRTSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGACAGTATTAGATCCCGGGGAGCTGTTTTTTGGAGAA	CASSRTVLDPGELFF	In	VDJ	64	2307	0.02115523929170755	0.024706298124805893	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	6	1	9	27	39	46	40	55			01,02										Vb 17	CASSRTVLDPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCGAAACGGGACCCCAAGGGACGGCTACACCTTCGGTTCG	CASSDRNGTPRDGYTF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	8	7	10	23	37	49	44	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSDRNGTPRDGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGTCGGGCGGGAGCAACAATGAGCAGTTCTTCGGGCCA	CASRSGGSNNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	2	5	5	2	23	34	46	39	48													Vb 11	CASRSGGSNNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGGGACTAGTCGTAACGAGCAGTACTTCGGGCCG	CASSDGTSRNEQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	8	5	1	5	23	37	46	38	51						01,02							Vb 11	CASSDGTSRNEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGGGCAGGGGAATTACGAGCAGTACTTCGGGCCG	CASSDGQGNYEQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	4	4	3	23	37	47	41	50													Vb 11	CASSDGQGNYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCTGCCGGGGGGCTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	1.4672034185839652E-4		35	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	8	1	3	3	3	23	29	39	32	42													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTTTCATGACGGAGAACGGGTGCAGTTCTTCGGGCCA	CASFHDGERVQFF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	8	4	12	15	1	23	32	51	47	52						01,02							Vb 11	CASFHDGERVQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGATAGCGGGAGAGGTAGATACGCAGTATTTTGGCCCA	CASSEIAGEVDTQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	5	2	4	23	37	48	39	52													Vb 11	CASSEIAGEVDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGACCGGGAGGGAACCTATGGCTACACCTTCGGTTCG	CASSDREGTYGYTF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	0	4	4	3	23	34	46	38	49													Vb 11	CASSDREGTYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTGCGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSELRDTGELFF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	7	4	3	2	0	23	38	-1	40	45						01,02							Vb 11	CASSELRDTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGCTCCTAGTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDAPSTNTGELFF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	8	0	5	2	23	37	46	42	48						01,02							Vb 11	CASSDAPSTNTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGGACAGGCCCTTACAATGAGCAGTTCTTCGGGCCA	CASGTGPYNEQFF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	4	4	0	4	23	-1	40	32	44													Vb 11	CASGTGPYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTACCTCAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSTSTGQSRANVLTF	In	VDJ	1	53	4.860111324059385E-4	5.675915910770318E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	9	5	23	35	49	44	54													Vb 11	CASSTSTGQSRANVLTF+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATAGCCCCTGGAGGGGGCGCGGGAGACCCAGTACTTCGGGCCA	CASSE*PLEGARETQYF	Stop	VDJ	2	74	6.78581581095084E-4		51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	8	4	23	40	55	48	59													Vb 11	CASSE*PLEGARETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCCCTAGGAGAAGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	84	7.702817947565818E-4		49	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	4	0	8	4	11	5	23	36	51	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCGGGGACTACCTCACCGGGGAGCTGTTTTTTGGAGAA	CASTGDYLTGELFF	In	VDJ	6	211	0.0019348745082576042	0.002259657089004787	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	0	9	4	3	3	23	33	43	36	46						01,02							Vb 11	CASTGDYLTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCACATACCTCTCAGTACCTCTGTGCCTGCCGGGGGGGCTTCTACGAGCAGTACTTCGGGCCG	CACRGGFYEQYF	In	VDJ	37	1327	0.012168618352880762	0.014211208327532476	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	8	0	3	3	3	23	29	40	32	43													Vb 11	CACRGGFYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTCCTACCACCCCCAAGGGATGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSSYHPQGMGTGELFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	54	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	5	0	8	5	15	5	23	35	54	50	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSSYHPQGMGTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAACAGGGAATGGGGTCTGGAAACACCATATATTTTGGAGAG	CASSQQGMGSGNTIYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	3	1	0	7	23	-1	43	38	50													Vb 7.1	CASSQQGMGSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCGGGACTCTACTTACAGATACGCAGTATTTTGGCCCA	CASSPGTLLTDTQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	3	2	6	23	36	44	38	50						01,02							Vb 7.1	CASSPGTLLTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGAGGATTTGACTATGGCTACACCTTCGGTTCG	CASRGFDYGYTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	36	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	6	1	8	3	1	4	23	34	38	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASRGFDYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCACTTAGGCTACGAGCAGTACTTCGGGCCG	CASSHLGYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	36	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	3	5	4	3	3	0	23	37	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSHLGYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGCTCAAACTATGGCTACACCTTCGGTTCG	CASSQDRSNYGYTF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	0	4	6	2	5	0	23	40	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDRSNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGTTCACTTAGCGGGAGGGCCGTAGAGACCCAGTACTTCGGGCCA	CASSQGSLSGRAVETQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	5	0	4	9	4	23	37	57	46	61													Vb 7.1	CASSQGSLSGRAVETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTGGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSQVGGNEQFF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	9	0	7	1	0	23	39	-1	40	47													Vb 7.1	CASSQVGGNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCCCCGCGAGTGGGACTAGCGGGAGTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	49	4.4933104694133935E-4		59	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	2	2	11	2	22	35	60	46	62													Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAATGGACGGGCGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQWTGDSSYNEQFF	In	VDJ	2	61	5.593713033351368E-4	6.532657935037536E-4	51	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-01	01	2	1	7	0	1	9	23	38	43	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQWTGDSSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGTGCCGGGACAGGGTATACAGATACGCAGTATTTTGGCCCA	CASSRAGTGYTDTQYF	In	VDJ	2	83	7.61111773390432E-4	8.888698501772385E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	3	5	3	23	36	50	41	53													Vb 7.1	CASSRAGTGYTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGTCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDVSNQPQHF	In	VJ	4	161	0.001476373439950115	0.001724193323837776	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-05	01	0	0	0	1	0	4	23	-1	40	-1	44													Vb 7.1	CASSQDVSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTCTACAGGGGGCCGACGAGCAGTACTTCGGGCCG	CASSLQGADEQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	5	2	2	26	38	49	40	51			01,02										Vb 12	CASSLQGADEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTTGGAGACCCAGTACTTCGGGCCA	CASSELETQYF	In	VJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	33	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-05	01	1	0	0	5	0	2	26	-1	42	-1	44			01,02										Vb 12	CASSELETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGGGGGGGGCGGGAGACACAGATACGCAGTATTTTGGCCCA	CASSEGGAGDTDTQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	9	0	2	0	7	26	-1	48	41	55			01,02			01,02							Vb 12	CASSEGGAGDTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGGCGAGAAGTCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	1.9257044868914544E-4		40	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	7	6	6	0	8	26	-1	44	41	52			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCCCGTGGGCTACGAGCAGTACTTCGGGCCG	CASPVGYEQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	33	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	8	0	9	3	5	0	26	35	-1	40	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASPVGYEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CTCCTCCCAGACATCTGTATATTTCTGCGCCACCCCCGCAGCCGAGCACCCACCGACTGCGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	55	5.043511751382381E-4		56	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	10	2	10	1	22	2	25	32	58	54	60			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-04	TCRBV10-01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCTCTAGGCCCCACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	58	5.318612392366874E-4		47	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	8	0	3	6	26	37	44	40	50			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTATATTTCTGCGCCAGCACCCCCCCTGGAGGGAGCCCCCAAAAGGTTTTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTPPGGSPQKVFGANVLTF	In	VDJ	2	76	6.969216238273835E-4	8.139049230538569E-4	63	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	10	0	3	8	17	10	20	34	28	51			01,02										Vb 12	CASTPPGGSPQKVFGANVLTF+TCRBV10-01+TCRBJ02-06	TCRBV10-01	TCRBD02-01*02	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAATTCGTGTTAGGTGAAGCTTTCTTTGGACAA	CASSEFVLGEAFF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	39	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-01	01	3	5	4	7	9	0	26	40	-1	49	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEFVLGEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCCGCTAGCGGACTCCCGCAGTTCTTCGGGCCA	CASSESASGLPQFF	In	VDJ	3	102	9.353421793472778E-4	0.0010923460809407028	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	12	2	6	26	43	52	45	58			01,02			01,02							Vb 12	CASSESASGLPQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCCGCAGGGTACTGGAAACACCATATATTTTGGAGAG	CATSRDPQGTGNTIYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	2	4	2	18	35	44	39	46														CATSRDPQGTGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACATTGTCTGGAAACACCATATATTTTGGAGAG	CATSRGTLSGNTIYF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	6	1	0	3	18	-1	39	34	42														CATSRGTLSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGAGCGGGTCCGGGGAGCTGTTTTTTGGAGAA	CATSRDRSGSGELFF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	4	6	4	1	18	35	45	39	46						01,02								CATSRDRSGSGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGACAGGCCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSGTGRNTGELFF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	1	0	3	18	-1	38	30	41														CATSGTGRNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTATTAGGGCGTAGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	4.309910042090398E-4		43	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	5	5	3	1	4	5	18	30	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGATCTGGGGGTTGGGCCACAGATACGCAGTATTTTGGCCCA	CATSRGSGGWATDTQYF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	51	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	1	6	1	2	5	6	18	34	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGSGGWATDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCTCCTAGCGGGAGGGACGTTAGGTGAGCAGTTCTTCGGGCCA	CATSRELLAGGTLGEQFF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	0	9	4	8	18	35	51	39	59														CATSRELLAGGTLGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSGTSGANVLTF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-06	01	5	0	7	0	0	0	18	-1	-1	30	35				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGTSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGGGGGCAGGGGCACTAGCGGGAGCGAATGAGCAGTTCTTCGGGCCA	CATRGAGALAGANEQFF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	7	12	2	18	29	52	41	54														CATRGAGALAGANEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGCCCGGGTCCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	62	5.685413247012866E-4		46	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	8	4	3	3	5	18	32	39	35	44						01,02								X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGAGGACAGTCGAGCTCTGGAAACACCATATATTTTGGAGAG	CATSGGQSSSGNTIYF	In	VDJ	2	75	6.877516024612337E-4	8.031956477505167E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	5	0	0	5	18	-1	39	34	44														CATSGGQSSSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTAGGCCCTGATAGGGAGACCCAGTACTTCGGGCCA	CATSRVGPDRETQYF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	1	5	4	5	1	10	18	34	38	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVGPDRETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCAGGCGTGTCTCGCCGGACTACACCTTCGGTTCG	CATSSRRVSPDYTF	In	VDJ	2	82	7.519417520242823E-4	8.781605748738983E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	10	0	14	18	-1	36	32	50														CATSSRRVSPDYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAAGACTAGCGGGAGTCACCTATGAGCAGTACTTCGGGCCG	CATSRERLAGVTYEQYF	In	VDJ	3	97	8.89492072516529E-4	0.0010387997044240015	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	2	2	7	2	8	18	35	49	37	57														CATSRERLAGVTYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCCGGGGGCAGACTACAATGAGCAGTTCTTCGGGCCA	CATSRDPGADYNEQFF	In	VDJ	3	101	9.261721579811281E-4	0.0010816368056373626	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	6	0	3	3	3	18	35	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDPGADYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGCGGGATCGAACCCTACGAGCAGTACTTCGGGCCG	CATSRGIEPYEQYF	In	VDJ	3	104	9.536822220795775E-4	0.0011137646315473831	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	2	1	6	18	30	37	31	43														CATSRGIEPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCCTCTGTTGGCCAAAAACATTCAGTACTTCGGCGCC	CATSRDPLLAKNIQYF	In	VDJ	3	114	0.0010453824357410752	0.0012208573845807855	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	10	1	2	6	18	35	39	37	45						01,02								CATSRDPLLAKNIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTGCCACCAGCAGCCTCGGGTCGCCCTACGTTTTTTATTCGCCGGGTCCTGTGAGGGAACTGTTTTTTGGCAGT	CATSSLGSPYVFYSPGPVRELFF	In	VDJ	3	124	0.0011370826494025731	0.0013279501376141877	69	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	11	0	12	39	0	0	14	-1	53	58														CATSSLGSPYVFYSPGPVRELFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACGTCGACTAGCGGGAACGACGAGCAGTACTTCGGGCCG	CATSTSTSGNDEQYF	In	VDJ	5	168	0.0015405635895131635	0.0017991582509611574	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	3	5	4	3	18	31	46	35	49														CATSTSTSGNDEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTTTCGACAGGGGAAAACACTGAAGCTTTCTTTGGACAA	CATSVSTGENTEAFF	In	VDJ	8	287	0.002631796132084988	0.003073562012058644	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	2	5	2	18	30	43	35	45														CATSVSTGENTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCTTCGGCGGGAGGGTCAGGGGAGCTGTTTTTTGGAGAA	CATSRPSAGGSGELFF	In	VDJ	29	1050	0.009628522434457273	0.011244739068507235	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	7	0	8	6	3	18	33	48	39	51														CATSRPSAGGSGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTCAAGGGACTAGCGTCGACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	1.0087023502764761E-4		52	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	6	0	3	4	22	35	48	38	52						01,02								X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTCTGACAGGGGGGTTTGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	1.1921027775994718E-4		50	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	1	3	2	7	22	36	47	38	54														X+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTGTTGTTTGGACAGGGGGCCGGTCAGCCCCAGCATTTTGGTGAT	CASSLVLFGQGAGQPQHF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	54	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	0	6	8	3	18	34	53	42	56														CASSLVLFGQGAGQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGACCCAACACTGAAGCTTTCTTTGGACAA	CASSLGPNTEAFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	1	2	7	2	0	2	18	-1	37	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTCTCCCCCCATGGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSFLPPWGTYNEQFF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	51	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	3	6	1	2	11	1	18	32	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLPPWGTYNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTTGGAGGAGTTTCGAGCACAGATACGCAGTATTTTGGCCCA	CASSLVGGVSSTDTQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	51	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	1	0	2	7	18	34	41	36	48														CASSLVGGVSSTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAAGAGGGAGCAAGGGAAGCTTTCTTTGGACAA	CASSQEGAREAFF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	8	5	5	18	30	40	35	45														CASSQEGAREAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGATAGGGGGCCGCCCTCCGCAGTCTTGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLAIGGRPPQSWTGELFF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	63	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	0	5	3	18	18	35	45	38	63														CASSLAIGGRPPQSWTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCTTCTCCGGGACTAGCGGGAGAAATGAGCAGTTCTTCGGGCCA	CASSSFSGTSGRNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	51	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	2	7	8	1	18	31	53	39	54														CASSSFSGTSGRNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCCTCAATTCCCACAGATACGCAGTATTTTGGCCCA	CASSPSIPTDTQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	5	4	6	2	4	5	18	30	36	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSIPTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCAAGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSKGVNTEAFF	In	VDJ	2	73	6.694115597289342E-4	7.817770971438363E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	0	1	0	18	30	-1	31	37														CASSKGVNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACTTACAGGGGCTTGGAAACACCATATATTTTGGAGAG	CASSNLQGLGNTIYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	2	3	5	2	18	30	42	35	44														CASSNLQGLGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAAGATCGGGGGAGTCGGGACCCAGTACTTCGGGCCA	CASSPKIGGVGTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	2	7	8	6	18	30	44	38	50														CASSPKIGGVGTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTACTAGCGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSPTSGATDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	2	3	1	18	30	43	33	44														CASSPTSGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTATGGGCAGGGGGGCAAGGGACCCAGTACTTCGGGCCA	CASSLWAGGQGTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	1	7	4	6	18	33	44	37	50														CASSLWAGGQGTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTATTGATCGTCGACAATGAGCAGTTCTTCGGGCCA	CASSLLIVDNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	2	8	5	2	6	18	33	37	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLIVDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAGAACCGGGACTAGCGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSSRTGTSGAQETQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	1	8	1	18	31	52	39	53														CASSSRTGTSGAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGTTATGGGGGACTACGAGCAGTACTTCGGGCCG	CASSLGVMGDYEQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	6	1	3	9	1	18	32	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVMGDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCTCAGGGGACTCCAAAACATTCAGTACTTCGGCGCC	CASTLRGLQNIQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	7	4	2	5	4	5	18	28	38	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLRGLQNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTACTAGCGGGAGGACGCAGTATTTTGGCCCA	CASSQVTSGRTQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	1	9	6	0	18	30	-1	36	48														CASSQVTSGRTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGCCCGTTCCCACCTACGAGCAGTACTTCGGGCCG	CASSQGPVPTYEQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	5	3	2	2	10	18	30	36	32	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGPVPTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGGGGAGGCACCACTGAAGCTTTCTTTGGACAA	CASSRGGGTTEAFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	4	0	6	18	-1	38	30	44														CASSRGGGTTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACTCGGGAGTAAGTACGAGCAGTACTTCGGGCCG	CASSQLGSKYEQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	2	4	5	4	18	30	41	35	45														CASSQLGSKYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTACTCGGGACAAACCTACGAGCAGTACTTCGGGCCG	CASSSYSGQTYEQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	2	7	2	18	31	44	38	46														CASSSYSGQTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGCGTGGGGGGAAGTTTCTGGAAACACCATATATTTTGGAGAG	CASRAWGEVSGNTIYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	9	1	1	5	5	18	29	40	34	45														CASRAWGEVSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCATCGATTCCGGGAGGAACTCCTACGAGCAGTACTTCGGGCCG	CASSAIDSGRNSYEQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	1	0	11	2	18	30	48	41	50														CASSAIDSGRNSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCGGGAGGCTCCAAGAGACCCAGTACTTCGGGCCA	CASSLTGRLQETQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	1	1	2	2	18	33	42	35	44														CASSLTGRLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGATGGGGGACGCTCTGGAAACACCATATATTTTGGAGAG	CASSLDGGRSGNTIYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	0	0	7	0	3	1	18	35	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGGRSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCAGCGGGAGGGTTCACAGATACGCAGTATTTTGGCCCA	CASSLSAGGFTDTQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	0	2	2	2	18	33	45	35	47														CASSLSAGGFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGTGGGACAGGGGGCGTACGAGCAGTACTTCGGGCCG	CASSLVGQGAYEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	4	5	1	18	30	47	35	48														CASSLVGQGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGCTGGGGTGGTTAACATTCAGTACTTCGGCGCC	CASSLGAGVVNIQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	1	6	2	7	5	5	18	34	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGAGVVNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTCGGACTAGCGGGAGTGAAGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGVKTGELFF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	1	2	5	4	5	18	29	46	33	51														CASSLGLAGVKTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGCTCCGCGGCCATCGCTATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	1.650603845906961E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	5	5	10	18	30	39	35	49						01,02								X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACGGTGACTACCGCGAGCAGTACTTCGGGCCG	CASSWDGDYREQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	0	7	6	0	11	18	-1	36	31	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDGDYREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTCAATTGCTAACGGGAGAGAGACCCAGTACTTCGGGCCA	CASSPSIANGRETQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	2	4	14	0	18	30	-1	44	50														CASSPSIANGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACTCGGGGACAGAGACCCAGTACTTCGGGCCA	CASSLDSGTETQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	0	7	4	7	0	18	32	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDSGTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGCAATTGGACTAGCGGGAGAGGATGAGCAGTTCTTCGGGCCA	CASSLAIGLAGEDEQFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	8	9	3	18	30	52	39	55														CASSLAIGLAGEDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGCAGCGGTGGTAAAGAGACCCAGTACTTCGGGCCA	CASSGSGGKETQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	5	3	3	5	18	30	38	33	43						01,02								CASSGSGGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCGGGACAGCGGCCACTGAAGCTTTCTTTGGACAA	CASSLTGTAATEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	4	3	4	18	33	43	36	47														CASSLTGTAATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATACGCAGGGTATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	1.8340042732299566E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	6	4	1	18	35	44	39	45														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGCGGGCAGGGGGCGCTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.8340042732299566E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	0	1	7	3	18	34	49	41	52														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAACTAGCGGGAGGAACCAAGAGACCCAGTACTTCGGGCCA	CASSQTSGRNQETQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	1	0	3	1	18	30	45	33	46														CASSQTSGRNQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCTTCCCGGGACAGGGGCTTCTGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	2.0174047005529523E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	6	8	6	18	30	48	38	54														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGATGGGCCGGGGGGGCGAGCAGTACTTCGGGCCG	CASSSMGRGGEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	6	8	0	18	31	-1	39	47														CASSSMGRGGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGAAAGTGGGTACTAGCGGAAACCTACGAGCAGTACTTCGGGCCG	CASSLRKWVLAETYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	5	2	11	3	18	33	52	44	55						01,02								CASSLRKWVLAETYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGCGATTGCCACCGAGATGTATGGCTACACCTTCGGTTCG	CASSLSAIATEMYGYTF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	6	5	3	15	18	33	39	36	54						01,02								CASSLSAIATEMYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGAAGTTTCAGGGCTCGGGGGCTACACCTTCGGTTCG	CASSREVSGLGGYTF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	4	3	8	10	6	18	30	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSREVSGLGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATTGACAGGGGGGGAACTGAAGCTTTCTTTGGACAA	CASSIDRGGTEAFF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	5	3	3	18	30	42	33	45														CASSIDRGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGATGGCAGCACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGWQHSGANVLTF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	1	8	0	3	8	18	30	36	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWQHSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATTTAGGACTAGCGGACCATTAAACTCCTACAATGAGCAATTCTTCGGGCCA	CASSQFRTSGPLNSYNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	16	7	25	18	30	47	37	72						01,02								CASSQFRTSGPLNSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAGTGGGGGACAGGGGCCCCTTTGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	2.2925053415374458E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	7	5	7	18	31	46	36	53														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGACAGGGGGGTACGAGCAGTACTTCGGGCCG	CASSLETGGYEQYF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	1	4	0	1	18	-1	44	35	45														CASSLETGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTCCGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFLRDSSYEQYF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	0	5	0	18	32	-1	37	44														CASSFLRDSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACCGGGACTACCGGTAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASRTGTTGSSYNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	9	1	4	8	18	29	40	33	48						01,02								CASRTGTTGSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWDRANTGELFF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	0	0	0	18	-1	-1	31	40														CASSWDRANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGCAACCGGGACAGGGGGGCGGGCAGTACTTCGGGCCG	CASSAQPGQGGGQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	9	8	4	18	30	49	38	53														CASSAQPGQGGGQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCTAGCGGGAGGGCCTAGGTTGGAGACCCAGTACTTCGGGCCA	CASSLGLAGGPRLETQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	4	0	5	2	9	18	34	48	36	57														CASSLGLAGGPRLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTGGGGAGGAGCTACCTACGAGCAGTACTTCGGGCCG	CASSFWGGATYEQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	2	3	5	18	32	41	35	46														CASSFWGGATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATTTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQFLAKNIQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	5	4	6	0	0	6	18	-1	32	30	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCGGGACAGGGTATCAGCCCCAGCATTTTGGTGAT	CASSLTGTGYQPQHF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	5	3	1	18	33	45	36	46														CASSLTGTGYQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGTCTAGCGGGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSSRSSGGGTDTQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	1	6	2	18	31	47	37	49														CASSSRSSGGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGAGTGACCGGGATGCGGGTCGGTCATTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	2.659306196183437E-4		59	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	4	5	14	8	18	35	54	49	62						01,02								X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTTGTCTGGGGAGGGATACGAGCAGTACTTCGGGCCG	CASSSLSGEGYEQYF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	0	4	9	1	18	31	47	40	48														CASSSLSGEGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCACCGTTAAGGGGTACGACACCGGGGAGCTGTTTTTTGGAGAA	CASTTVKGYDTGELFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	5	2	3	9	4	18	28	42	37	46														CASTTVKGYDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGTTCCGGGGCGTAGATGAAAAACTGTTTTTTGGCAGT	CASSLMFRGVDEKLFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	2	7	0	6	7	4	18	33	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMFRGVDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCCTGGGACAGGGCCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	2.9344068371679304E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	1	4	2	18	31	44	35	46														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGGAGCGGGAGTAAGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	2.9344068371679304E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	6	2	1	5	4	18	32	45	37	49														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTATGGGGGAGGGTGAGCAGTTCTTCGGGCCA	CASSLVMGEGEQFF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	9	6	0	18	34	-1	40	47														CASSLVMGEGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTTTTCGCGGGAGAGGACGAGCAGTACTTCGGGCCG	CASSFLFAGEDEQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	5	7	3	18	32	46	39	49														CASSFLFAGEDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCAGGGCGGGAGTTCCCGTTGGGGCGAGCAGTACTTCGGGCCG	CASSLDQGGSSRWGEQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	6	5	12	18	35	47	40	59														CASSLDQGGSSRWGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGGGAGCGGAAACACCATATATTTTGGAGAG	CASSLTGSGNTIYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	3	4	0	3	18	-1	39	32	42														CASSLTGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGCAAAGGGGGACGGATACGCAGTATTTTGGCCCA	CASSLEQRGTDTQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	1	6	7	3	18	32	45	39	48														CASSLEQRGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGCGCGGAGTCCGGGAGCTGTTTTTTGGAGAA	CASSLERGVRELFF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	5	9	2	5	18	35	41	37	46						01,02								CASSLERGVRELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGAGGGATTGGGCTATGGCTACACCTTCGGTTCG	CASSLGEGLGYGYTF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	4	2	6	18	32	41	34	47														CASSLGEGLGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACGGACAGTTGATAGGAACATTCAGTACTTCGGCGCC	CASSLRTVDRNIQYF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	5	7	4	8	18	30	40	34	48														CASSLRTVDRNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGGGTCTCGGGGCTACACCTTCGGTTCG	CASSPGTGSRGYTF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	8	3	6	18	30	42	33	48														CASSPGTGSRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATGGGTGGGGACCCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSLDGWGPRSYEQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	0	7	0	9	4	18	32	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGWGPRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTCCAGGGGTATGGAGAGACCCAGTACTTCGGGCCA	CASSFQGYGETQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	4	4	5	18	29	39	33	44														CASSFQGYGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCCGCAGCGCAGGACACTGAAGCTTTCTTTGGACAA	CASSPSAAQDTEAFF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	4	3	12	0	18	30	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSAAQDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGCAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLWQGGTEAFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	4	4	1	18	32	43	36	44														CASSLWQGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTCAGCGTGACACAGATACGCAGTATTTTGGCCCA	CASSSQRDTDTQYF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	6	2	5	3	18	29	38	34	41						01,02								CASSSQRDTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGGGGAGTTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASRGELSSYEQYF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	6	5	2	0	0	7	18	-1	34	29	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGELSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACTGACACAGGGGAAGAATGGCTATGGCTACACCTTCGGTTCG	CASSPLTQGKNGYGYTF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	4	8	8	18	30	45	38	53														CASSPLTQGKNGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGAACCAGGGGGAAGAGAGACCCAGTACTTCGGGCCA	CASSLEPGGRETQYF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	4	2	3	18	35	44	37	47														CASSLEPGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAACCTCGGGGGATATGGCTACACCTTCGGTTCG	CASSANLGGYGYTF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	5	8	1	18	30	44	38	45														CASSANLGGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGCTAGCGGGAGGGCTGAGAGATACGCAGTATTTTGGCCCA	CASSLEGLAGGLRDTQYF	In	VDJ	1	49	4.4933104694133935E-4	5.247544898636709E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	0	5	4	5	18	35	51	39	56														CASSLEGLAGGLRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAACGGGTGGGCAGGGTGATGGCTACACCTTCGGTTCG	CASSLTGGQGDGYTF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	6	12	2	18	30	47	42	49														CASSLTGGQGDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGCACAGAAGGTCTACGAGCAGTACTTCGGGCCG	CASSPAQKVYEQYF	In	VDJ	2	55	5.043511751382381E-4	5.890101416837122E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	3	5	5	18	30	39	35	44														CASSPAQKVYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCCGGGGGCGCGTGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGPGARAGELFF	In	VDJ	2	56	5.135211965043878E-4	5.997194169870525E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	6	0	6	4	5	18	34	44	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPGARAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTAGACCCAGGGGGCCCGTGGGGGACACTGAAGCTTTCTTTGGACAA	CASSLRPRGPVGDTEAFF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	3	8	9	18	30	46	38	55														CASSLRPRGPVGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGGACAGAACCTACGAGCAGTACTTCGGGCCG	CASSSGDRTYEQYF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	2	3	2	18	31	41	34	43														CASSSGDRTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCCCAGGGAGGCTCTGGAAACACCATATATTTTGGAGAG	CASRPQGGSGNTIYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	9	1	0	6	0	18	29	-1	35	41														CASRPQGGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGGGACAGGGGTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	63	5.777113460674364E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	3	3	2	18	30	43	33	45														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGGGATGGGGGAGAAGAGACCCAGTACTTCGGGCCA	CASSRGDGGEETQYF	In	VDJ	2	71	6.510715169966346E-4	7.603585465371559E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	3	0	9	18	-1	37	30	46														CASSRGDGGEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTGATAGGGACTCTCCAAGAGACCCAGTACTTCGGGCCA	CASSVIGTLQETQYF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	1	6	2	18	30	42	36	44						01,02								CASSVIGTLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACAAGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASRQGASTDTQYF	In	VDJ	2	73	6.694115597289342E-4	7.817770971438363E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	2	0	3	2	18	29	37	32	39														CASRQGASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCTTCCCGTTCCAAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSVFPFQAYNEQFF	In	VDJ	2	89	8.161319015873307E-4	9.531255019972799E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	4	6	2	12	2	18	30	44	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVFPFQAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGATGGTCCGGGAGTTGGTATACGCAGTATTTTGGCCCA	CASSLGWSGSWYTQYF	In	VDJ	3	95	8.711520297842294E-4	0.0010173811538173212	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	2	7	7	5	18	34	47	41	52														CASSLGWSGSWYTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTCTCTCAGGGTACCAATGAGCAGTTCTTCGGGCCA	CASSLSQGTNEQFF	In	VDJ	3	97	8.89492072516529E-4	0.0010387997044240015	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	6	7	3	18	29	41	36	44														CASSLSQGTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGCCGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPQPGSNQPQHF	In	VDJ	3	102	9.353421793472778E-4	0.0010923460809407028	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	4	0	7	0	18	30	-1	37	41						01,02								CASSPQPGSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCGACTAGCGGACACCGAGACCCAGTACTTCGGGCCA	CASSLDRLADTETQYF	In	VDJ	3	105	9.628522434457273E-4	0.0011244739068507234	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	2	5	5	2	5	18	35	46	37	51						01,02								CASSLDRLADTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTGGGGTAGACACAGATACGCAGTATTTTGGCCCA	CASSRGVDTDTQYF	In	VDJ	3	108	9.903623075441766E-4	0.0011566017327607442	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	2	2	3	4	18	30	37	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGVDTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATAGGGGGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSHRGPSYEQYF	In	VDJ	3	124	0.0011370826494025731	0.0013279501376141877	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	0	0	3	1	18	30	40	33	41														CASSHRGPSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACTCTGGTGCGGCGGGCGGGCAGTTCTTCGGGCCA	CASSLDSGAAGGQFF	In	VDJ	3	126	0.0011554226921348728	0.0013493686882208682	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	4	12	10	3	18	35	50	45	53						01,02								CASSLDSGAAGGQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSFQGRNTEAFF	In	VDJ	4	128	0.0011737627348671722	0.0013707872388275485	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	1	2	18	32	39	33	41														CASSFQGRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGGGACAGTCTATAGCYAAAAACATTCAGTACTTCGGCGCC	CASSTGQSIAKNIQYF	In	VDJ	5	167	0.0015313935681470138	0.0017884489756578173	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	5	0	2	5	18	30	39	32	44														CASSTGQSIAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCCCCAGAATGAACGAGCAGTACTTCGGGCCG	CASSLPPRMNEQYF	In	VDJ	5	171	0.0015680736536116129	0.0018312860768711782	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	5	5	6	5	18	32	41	38	46														CASSLPPRMNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGCTAGGGGACGGGGAGCTGTTTTTTGGAGAA	CASSLWLGDGELFF	In	VDJ	5	172	0.0015772436749777628	0.0018419953521745184	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	5	2	7	5	1	18	33	43	38	44														CASSLWLGDGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTTCTGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGDTGELFF	In	VDJ	5	174	0.0015955837177100622	0.0018634139027811987	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	6	2	3	6	0	18	30	-1	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAACTTAATTGGTACAATGAGCAGTTCTTCGGGCCA	CASSLELNWYNEQFF	In	VDJ	5	191	0.0017514740809346087	0.0020454715829379827	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	1	8	4	0	10	18	-1	35	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLELNWYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGTAGCGGGAAGGATAAGCTACGAGCAGTACTTCGGGCCG	CASSLGVAGRISYEQYF	In	VDJ	6	205	0.0018798543800607056	0.002195401437184746	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	5	3	3	3	8	18	34	45	37	53														CASSLGVAGRISYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCGGGACAGGCCCTCAATGAGCAGTTCTTCGGGCCA	CASSPPGQALNEQFF	In	VDJ	6	224	0.0020540847860175513	0.00239887766794821	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	6	5	4	18	30	43	35	47														CASSPPGQALNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGGGCGACAGGGAACCTATGGCTACACCTTCGGTTCG		Out	VDJ	11	395	0.003622158439629164		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	4	7	3	18	35	49	42	52														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACTGGGGTATTAGGGACACTCAATGAAAAACTGTTTTTTGGCAGT	CASSQTGVLGTLNEKLFF	In	VDJ	14	504	0.004621690768539491	0.005397474752883473	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	5	15	3	18	30	51	45	54														CASSQTGVLGTLNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTGCAGGGGCGAGAGAGACCCAGTACTTCGGGCCA	CASSLVAGARETQYF	In	VDJ	16	570	0.005226912178705376	0.006104286922903927	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	4	5	4	18	32	43	37	47														CASSLVAGARETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGGGCAGTGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	18	665	0.006098064208489606		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	4	3	2	6	18	32	39	34	45						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGGGCGGGAGAAGAACAGATACGCAGTATTTTGGCCCA	CASSLAGGRRTDTQYF	In	VDJ	21	769	0.007051746430569183	0.008235432708268632	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	3	5	4	18	32	44	37	48														CASSLAGGRRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAGACAGGGGGCGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSGRQGAGSYEQYF	In	VDJ	26	933	0.008555629934617748	0.009991753858016428	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	1	4	4	18	30	44	34	48														CASSGRQGAGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATTTGGGACTAGCGGACCATTAAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQFGTSGPLNSYNEQFF	In	VDJ	43	1563	0.014332743395292112	0.016738597299120767	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	0	6	9	18	30	47	36	56						01,02								CASSQFGTSGPLNSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGGACAGGTTACACAGATACGCAGTATTTTGGCCCA	CASSLGGTGYTDTQYF	In	VDJ	50	1813	0.016625248736829558	0.019415916124955825	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	4	2	2	3	18	34	44	36	47														CASSLGGTGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCGACAGGGGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASATGVGNQPQHF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	2	2	1	3	26	36	45	37	48														CASATGVGNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAACAGGAGGAACAGGGGACCAAGCACTGAAGCTTTCTTTGGACAA	CANRRNRGPSTEAFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	3	2	4	11	6	26	31	49	42	55														CANRRNRGPSTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGCTAGTGGTTTGGTACTCATGGGAAGGGGACTAGCGGGAGTCCTTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	2.3842055551989436E-4		70	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	0	2	0	12	6	-1	15	41	27	47														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCTCCAGGGGGGGGACTTTGGCGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	2.659306196183437E-4		50	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	5	4	1	7	3	12	26	38	48	41	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACCACCGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASNHRGSTDTQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	8	3	0	10	1	26	31	46	41	47														CASNHRGSTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAATAGGGGCCGGTGAAGCTTTCTTTGGACAA	CASGLVIGAGEAFF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	7	3	4	26	43	51	46	55														CASGLVIGAGEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAGGGGGGGGAGGGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	51	4.676710896736389E-4		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	9	0	4	1	7	26	43	51	44	58						01,02								X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGTCAGGGGGAAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	52	4.7684111103978873E-4		46	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	1	4	2	3	26	42	51	44	54														X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTCTTGGAGGGCCGTGCCAGCCCCAGCATTTTGGTGAT	CLGGPCQPQHF	In	VDJ	2	60	5.50201281968987E-4	6.425565182004134E-4	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	14	10	0	7	3	6	26	29	38	32	44														CLGGPCQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGATCCGTAGACTACCCGGCACAGATACGCAGTATTTTGGCCCA	CASGLIRRLPGTDTQYF	In	VDJ	3	110	0.0010087023502764762	0.0011780202833674245	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	9	1	7	4	26	41	53	48	57						01,02								CASGLIRRLPGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGCCAGGAGCGGGCACCTCCCGAGCAGTACTTCGGGCCG		Out	VDJ	4	150	0.0013755032049224674		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	6	4	6	7	7	26	42	55	49	62						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGTCTCGACAGGGCTATCTACAATGAGCAGTTCTTCGGGCCA	CASSQGLDRAIYNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	3	3	6	4	20	35	48	41	52														CASSQGLDRAIYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGAAACCGGGACGGCCAACTATGGCTACACCTTCGGTTCG	CASSQETGTANYGYTF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	2	10	4	20	31	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQETGTANYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTAAAAGGCCGCAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	11	1.0087023502764761E-4		52	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	12	5	20	32	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCCGAGGAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGDSNQPQHF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	10	2	0	3	1	20	29	36	32	37														CASRGDSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTGGATATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDISGANVLTF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-06	01	6	1	8	0	3	3	20	31	37	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDISGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATAGGGCTGGCCAAGAGACCCAGTACTTCGGGCCA	CASSQDRAGQETQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	2	5	3	1	3	4	20	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRAGQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCTTGCTGGGCCTAGCGGACCCTACGAGCAGTACTTCGGGCCG	CASSLAGPSGPYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	5	2	11	2	20	31	49	42	51						01,02								CASSLAGPSGPYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAACCCGGGACTAGCGGAGAACCAAGCTGTCCGAGCAGTACTTCGGGCCG	CASSQTRD*RRTKLSEQYF	Stop	VDJ	1	25	2.2925053415374458E-4		57	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	5	6	4	14	20	35	50	39	64						01,02								CASSQTRD*RRTKLSEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGATAAGGGGGGGACATAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	2.751006409844935E-4		52	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	0	0	9	4	20	31	47	40	51														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCACCCCGGATGGGGGGCCGAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	52	4.7684111103978873E-4		40	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	10	6	0	5	9	4	20	27	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCCCGGGACAGGGTATGTAGCGGGACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	55	5.043511751382381E-4		58	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	2	4	12	20	33	46	37	58														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSQGGSGNTIYF	In	VDJ	2	64	5.868813674335861E-4	6.853936194137742E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	2	6	1	0	0	0	20	-1	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGCCCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	9	313	0.002870216687604882		40	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	9	0	3	0	3	20	-1	38	35	41														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCGAGGGAATTTCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDRGNFGNQPQHF	In	VDJ	18	635	0.005822963567505112	0.006800389817621042	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	0	2	4	7	20	35	44	39	51														CASSQDRGNFGNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGGACTAGCGGGATTTGAGCAGTTCTTCGGGCCA	CASSPGLAGFEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	3	9	3	2	26	37	53	40	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGLAGFEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGCCAGGCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLARRSGANVLTF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	4	0	3	2	26	40	47	43	49		TCRBV12-03,TCRBV12-04												CASSLARRSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCCGCCAGGGGGCTATACAATGAGCAGTTCTTCGGGCCA	CASSPARGLYNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	4	5	2	24	36	49	41	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPARGLYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGTTCCAAGCGGGGTGAAATTGATACGCAGTATTTTGGCCCA	CASSKRGEIDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	6	3	6	6	7	24	31	44	37	51	TCRBV06,TCRBV10													CASSKRGEIDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCCCCCAACCGGGACAGGTCACTACGAGCAGTACTTCGGGCCG	CASSPPTGTGHYEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	3	8	3	26	39	55	47	58	TCRBV03,TCRBV12													CASSPPTGTGHYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTCCCGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	9.170021366149783E-5		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	1	6	0	26	38	-1	44	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAGCTCCAAAGGTGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	9.170021366149783E-5		37	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	9	3	8	0	26	35	-1	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAGGCCATCCTAGCACAGATACGCAGTATTTTGGCCCA	CSAKGHPSTDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	5	4	0	3	7	26	34	40	37	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGHPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGTGTCGGGACAGGGAATAGGAGATACGCAGTATTTTGGCCCA	CSARAVSGQGIGDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	5	7	6	26	39	55	46	61		TCRBV20-01,TCRBV20-or09_02												CSARAVSGQGIGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAAGGGTGCAGGGTACTACGAGCAGTACTTCGGGCCG	CASSQDKGAGYYEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	8	2	23	40	53	48	55	TCRBV01,TCRBV04													CASSQDKGAGYYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGTTGACAGGGGGGTCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVVDRGVGTGELFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	1	4	7	5	22	33	49	40	54		TCRBV12-03,TCRBV12-04												CASSVVDRGVGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGTGGGGCCAGATACGCAGTATTTTGGCCCA	CASSLVGPDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	4	1	0	22	38	-1	39	44		TCRBV12-03,TCRBV12-04												CASSLVGPDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTYGGSCSTRTATYTCTGTGCCAGCAGCTTAGGCCCCCTCGACTCCTACGAGCAGTACTTCGGGCCG	CASSLGPLDSYEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	3	5	4	0	0	9	22	-1	39	36	48	TCRBV11,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPLDSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCACGTTTGGTGCCCCAACCAGACAGTCTTTACTTCTGTGCCAGCAGTTTGTTAGCGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLLAGGSYEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	1	0	3	0	36	49	-1	52	62	TCRBV06,TCRBV27	TCRBV06-07,TCRBV27-01												CASSLLAGGSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTATTGGCGTCTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLLASSSYEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	8	0	7	0	18	33	-1	40	44	TCRBV05,TCRBV07					01,02								CASSLLASSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCAGGGACAGTTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRDSFSGANVLTF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	0	1	3	18	30	38	31	41	TCRBV07,TCRBV11													CASSRDSFSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCGTAGGAGGGGATCAGCCCCAGCATTTTGGTGAT	CASSVGGDQPQHF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	1	5	2	5	1	0	18	34	-1	35	40	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSVGGDQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTAAACCGGACAGGGGGCTCAACGAGCAGTACTTCGGGCCA	CASSKPDRGLNEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	11	6	8	18	29	46	35	54	TCRBV07,TCRBV11													CASSKPDRGLNEQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCTCCCACCGGCTGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLPPAGMNTEAFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	5	9	0	0	8	5	19	31	42	39	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPPAGMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCGGACTAGACCACAATGAGCAGTTCTTCGGGCCA	CASSPGLDHNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	8	5	3	3	19	31	41	34	44		TCRBV05-06,TCRBV05-07				01,02								CASSPGLDHNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCAAAGACAGGGATGGGGATGGCTACACCTTCGGTTCG	CASSSKDRDGDGYTF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	6	4	6	22	36	47	40	53	TCRBV07,TCRBV11													CASSSKDRDGDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGRGGACTYGGCYSTGTATCTCTGTGCCAGCAGCTTAATCTTGGGTCGGCAGGGCGGTCACGAGCAGTATTTCGGGCCG	CASSLILGRQGGHEQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	16	14	16	22	35	54	49	70	TCRBV05,TCRBV07													CASSLILGRQGGHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGTGTACTTCTGTGCCAGCAGTTCCAAAAGGCTACAGACAGGGAAGCTCGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSSKRLQTGKLGSYNEQFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	63	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	1	13	9	10	23	43	36	52		TCRBV06-05,TCRBV06-06												CASSSKRLQTGKLGSYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCCTCCAGGGTGGTCAATGAGCAGTTCTTCGGGCCA	CASRPSRVVNEQFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	6	6	4	26	37	48	43	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPSRVVNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGTCGAGGACAGGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSLVEDRGSTDTQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	2	2	4	3	26	42	55	46	58		TCRBV12-03,TCRBV12-04												CASSLVEDRGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGCAGGGGCGTAGGTACACTGAAGCTTTCTTTGGACAA	CASSLQGRRYTEAFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	1	7	26	40	47	41	54		TCRBV12-03,TCRBV12-04												CASSLQGRRYTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGCGACAGGGGGCGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRRQGASGANVLTF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	0	1	2	1	24	35	47	37	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASRRQGASGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTAGTTCCCGGGACAGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	11	1.0087023502764761E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	2	7	0	24	36	-1	43	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCAACGACAGGGTTTTTCAGCCCCAGCATTTTGGTGAT	CSAANDRVFQPQHF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	6	7	4	26	34	48	41	52		TCRBV20-01,TCRBV20-or09_02												CSAANDRVFQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGATGGGGGATACGAGCAGTACTTCGGGCCG	CSATDGGYEQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	6	1	4	5	1	26	36	46	41	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAACTAGCGGGAGAATCTACGAGCAGTACTTCGGGCCG	CSARPTSGRIYEQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	3	2	3	3	3	26	38	52	41	55		TCRBV20-01,TCRBV20-or09_02												CSARPTSGRIYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGCCGGGATGACTCCTGACTATGGCTACACCTTCGGTTCG	CSGAGMTPDYGYTF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	8	3	3	4	9	26	33	42	37	51		TCRBV20-01,TCRBV20-or09_02												CSGAGMTPDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGAATAGGTATGGAAGTTTCTGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	11	1.0087023502764761E-4		50	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	1	8	6	10	9	22	33	46	43	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAATGGGTGGGGCGGGAAGTTTTGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.0087023502764761E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	3	4	9	7	23	33	48	42	55	TCRBV06,TCRBV27													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCACTGGGGGGTGATAGCGGGAGATAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	11	1.0087023502764761E-4		52				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	2	3	12	2	18	30	51	42	53	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCTGTGCCAGCAGCTTATCGGGTAAAACTAGCGGGAATTCACGCGATGGGCCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.0087023502764761E-4		68				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	3	3	4	9	17	2	17	36	26	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCCTTCTGGGACAGGGCAACGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.100402563937974E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	3	8	8	7	24	31	48	39	55	TCRBV06,TCRBV10													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGTCCAGGGACAGGAATACAATGAGCAGTTCTTCGGGCCA	CASSVQGQEYNEQFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	4	5	2	26	38	51	43	53	TCRBV03,TCRBV09													CASSVQGQEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCTTACTACGAGATACGCAGTATTTTGGCCCA	CASSLLRDTQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	9	5	2	2	26	38	44	40	46	TCRBV03,TCRBV09					01,02								CASSLLRDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCGGGACAGGGGGGCACCTACGAGCAGTACTTCGGGCCG	CSASPGQGGTYEQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	2	3	3	26	37	51	40	54		TCRBV20-01,TCRBV20-or09_02												CSASPGQGGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGCCCACAGGGGGAATTGGCTACGAGCAGTACTTCGGGCCG	CSAEPTGGIGYEQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	1	3	6	6	26	35	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSAEPTGGIGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTCCCCGGACTGAAGCTTTCTTTGGACAA	XASSPRTEAFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	33	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	5	3	0	25	37	-1	40	43	TCRBV26,TCRBV28					01,02								XASSPRTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGGACAGCAACTAAGTGGCTACACCTTCGGTTCG	CASSGQQLSGYTF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	7	0	8	22	-1	40	34	48		TCRBV12-03,TCRBV12-04												CASSGQQLSGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SRGGGACTCAGCTGTGTAYYTCTGTGCCAGCAGTTCCGGGACCGACTATGGCTACACCTTCGGTTCG	CASSSGTDYGYTF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	4	0	7	3	2	2	22	35	42	37	44	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTDYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCGTGGACCGAACCCTTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.100402563937974E-4		49	TCRBV24						TCRBJ02	TCRBJ02-01	01	4	1	7	5	4	10	24	38	46	42	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACGCCCAGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDTPSTNTGELFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	48	TCRBV24						TCRBJ02	TCRBJ02-02	01	3	4	5	0	5	2	24	39	47	44	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTPSTNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTGGTGGCGGGAGTCACAGATACGCAGTATTTTGGCCCA	CASSLVAGVTDTQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	2	4	1	18	32	43	36	44	TCRBV07,TCRBV11													CASSLVAGVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTCCACAGCCGGTCAGGGGTCTCTGAGCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	1.100402563937974E-4		59	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	3	11	10	19	32	49	43	59	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTCCTCTGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSSSGLNTEAFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	3	0	9	0	5	1	19	32	40	37	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSGLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTTGGGCTAGCGGGAGGGCCCATGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFGLAGGPMSSYNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	0	6	8	21	33	51	39	59	TCRBV24,TCRBV27													CASSFGLAGGPMSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTAACGGACAGGTCCATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASS*RTGPSGANVLTF	Stop	VDJ	1	13	1.1921027775994718E-4		51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	4	1	3	4	26	39	49	42	53		TCRBV12-03,TCRBV12-04												CASS*RTGPSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGACGGATACGTCACAGATACGCAGTATTTTGGCCCA	CASSLDGYVTDTQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV12						TCRBJ02	TCRBJ02-03	01	1	1	8	2	2	5	26	42	47	44	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGYVTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCAACAGGATTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQQDSSTDTQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	4	0	2	5	36	48	55	50	60	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSQQDSSTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGRKGACTCYGCYGTGTATYTCTGTGCCAGCAGCTTAGGAGGCGGGAGGGTATACAATGAGCAGTTCTTCGGGCCA	CASSLGGGRVYNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	0	4	7	2	26	38	54	45	56	TCRBV03,TCRBV07													CASSLGGGRVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGCGGCGGGAGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	1.1921027775994718E-4		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	2	1	6	2	26	40	53	46	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAAGACTAGCAGGGACAGATACGCAGTATTTTGGCCCA	CASSLRLAGTDTQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	7	3	1	4	22	37	45	38	49		TCRBV12-03,TCRBV12-04				01,02								CASSLRLAGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCCCGGGTTCGGGGACAGGGGATTTTGGAGAG	CASSFPGSGTGDF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	2	17	10	0	22	36	-1	46	56		TCRBV12-03,TCRBV12-04												CASSFPGSGTGDF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCTGATATGGGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	13	1.1921027775994718E-4		41	unresolved						TCRBJ01	TCRBJ01-05	01	6	0	8	3	7	0	23	34	-1	41	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATCTCTGTGCTAGCAGCTTGGTACCCCACGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSLVPHGGNEQFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	7	7	1	18	34	47	41	48	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02												CASSLVPHGGNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGACCCGGCCGAACCGGGGAGCTGTTTTTTGGAGAA	CASSQEGPGRTGELFF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	48							TCRBJ02	TCRBJ02-02	01	0	0	7	5	0	8	18	-1	40	35	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGPGRTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCACCACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSTTGGSGNTIYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	1	0	3	0	23	35	-1	38	46	TCRBV03,TCRBV09													CASSTTGGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCCTCGGGGGGCATCAAGAGACCCAGTACTTCGGGCCA	CASSPLGGHQETQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	2	6	3	26	37	50	43	53	TCRBV09,TCRBV12													CASSPLGGHQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCAGAGGCCGGGACAGGGTTAGGCTACACCTTCGGTTCG	CASSSEAGTGLGYTF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	8	3	26	39	56	47	59		TCRBV12-03,TCRBV12-04												CASSSEAGTGLGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ACGTTTGGTGGGAGACACGGCACKKATCTCTGCGCCAGCAGCCAGGGGATTAGCGGGATCGTTGCAGATACGCAGTATTTTGGCCCA	CASSQGISGIVADTQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	51	TCRBV04			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	3	4	6	6	30	44	58	50	64		TCRBV04-01,TCRBV04-03												CASSQGISGIVADTQYF+TCRBV04-X+TCRBJ02-03	TCRBV04	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGAACCCGCTGGGACAGCCTACGAGCAGTACTTCGGGCCG	CASSREPAGTAYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	2	7	0	26	43	-1	50	57		TCRBV03-01,TCRBV03-02												CASSREPAGTAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTTTGGACTGTTATCCTACGAGCAGTACTTCGGGCCG	CASSFGLLSYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	10	1	1	4	20	34	40	35	44	TCRBV07,TCRBV11					01,02								CASSFGLLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASGACTCSGCCSTGTATCTCTGTGCCAGCAGTCATGACGGCAGCTATGGCTACACCTTCGGTTCG	CASSHDGSYGYTF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	6	2	7	4	4	5	20	31	38	35	43	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHDGSYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTTAATGGGTCTGGGGGAAACACCATATATTTTGGAGAG	CSAFNGSGGNTIYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	0	9	4	7	6	26	34	44	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAFNGSGGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCAGGGGGTCTCGAATCGGCACGCTACGCAGTATTTTGGCCCA	CSARGQGVSNRHATQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	1	8	2	16	26	39	48	41	64		TCRBV20-01,TCRBV20-or09_02												CSARGQGVSNRHATQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTGCACTTATCGAGAACTATGGCTACACCTTCGGTTCG	CSARGALIENYGYTF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	3	10	2	4	7	26	39	46	43	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGALIENYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCGGACAGGTCCTATCAGCCCCAGCATTTTGGTGAT	CSASSDRSYQPQHF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	4	5	3	4	26	37	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSASSDRSYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAAGTGGAGTGGATCCCTGGAGATGAGCAGTTCTTCGGGCCA	CASSQEVEWIPGDEQFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	2	8	3	13	23	40	47	43	60	TCRBV04,TCRBV23													CASSQEVEWIPGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCACTCTGTCGGGACAGGGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.2838029912609695E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	4	10	1	24	35	54	45	55	TCRBV24,TCRBV27													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGGAGGACAGGGACCCAAGACTACGAGCAGTACTTCGGGCCG	CASRRTGTQDYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	3	2	8	24	35	45	37	53	TCRBV24,TCRBV28													CASRRTGTQDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGAGGGGGGGCGTATTGGATGGCTACACCTTCGGTTCG	CASSLSRGGVLDGYTF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	6	7	8	24	36	50	43	58	TCRBV24,TCRBV27													CASSLSRGGVLDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTGGCAAGCCACGTTTGGTGGGACTCGGCCGTGTATGGCTGTGCCAGCAGCCGGGGGGGGGCACCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	1.2838029912609695E-4		41				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	4	0	5	40	-1	60	52	65	TCRBV07,TCRBV11	TCRBV07-06,TCRBV11-03												X+X+TCRBJ01-01		TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTATGGCAGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSLWQGGTEAFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	4	5	0	19	34	-1	39	45	TCRBV07,TCRBV11													CASSLWQGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCCTAGCTCAGGCAAGGATACGCAGTATTTTGGCCCA	CASSPSSGKDTQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	7	6	1	9	19	31	37	32	46	TCRBV05,TCRBV07					01,02								CASSPSSGKDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTGGTCAGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSWSGGGETQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	3	5	1	4	7	0	19	32	-1	39	45	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWSGGGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCAGCCCAGGACAGACATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	14	1.2838029912609695E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	4	3	3	24	36	45	39	48	TCRBV03,TCRBV21													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGAGGGGGTCGGGGAAAACTCCTACGAGCAGTACTTCGGGCCG	CASSVEGVGENSYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	1	0	0	10	23	-1	45	39	55	TCRBV09,TCRBV12													CASSVEGVGENSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGGGGGCGGGAAATACGCAGTATTTTGGCCCA	CASSFGGAGNTQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	7	1	6	26	40	48	41	54		TCRBV12-03,TCRBV12-04												CASSFGGAGNTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGAGGGCCGTACAATGAGCAGTTCTTCGGGCCA	CASSQAGGPYNEQFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	0	4	0	3	26	-1	50	42	53		TCRBV03-01,TCRBV03-02												CASSQAGGPYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGACTAGTAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	15	1.3755032049224674E-4		44	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	8	0	2	4	26	34	43	36	47		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGTAGCTAACGGGAGTACCCAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	15	1.3755032049224674E-4		55	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	2	0	10	6	26	39	55	49	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAAAGACAGTACAATGAGCAGTTCTTCGGGCCA	CSARERQYNEQFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	4	5	0	26	37	-1	42	47		TCRBV20-01,TCRBV20-or09_02												CSARERQYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCAGACTAGCGGGAGAGGAGATACGCAGTATTTTGGCCCA	CSVQTSGRGDTQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	2	2	5	4	3	26	33	49	37	52		TCRBV20-01,TCRBV20-or09_02												CSVQTSGRGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCTCAGGAGCCTACCAAGAGACCCAGTACTTCGGGCCA	CSGAYQETQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	11	4	4	0	1	5	26	29	34	30	39		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGAYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGGCGCAGATTAGCGGGAGGGCCCATGAGCAGTTCTTCGGGCCA	CASRAQISGRAHEQFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	0	8	9	3	23	34	54	43	57	TCRBV24,TCRBV27													CASRAQISGRAHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCAGACAGGTTATGGCTACACCTTCGGTTCG	CATSAQTGYGYTF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	5	4	1	24	37	47	41	48		TCRBV24-01,TCRBV24-or09_02												CATSAQTGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
YSRRSSASWCMKCTYTGTAYTTCTGTGCCAGCAGTTTAGGACAGTGGACTGAAGCTTTCTTTGGACAA	CASSLGQWTEAFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	5	4	3	23	34	44	38	47	TCRBV09,TCRBV27													CASSLGQWTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGGATAGCGTAAAAACCTACGAGCAGTACTTCGGGCCG	CASRDSVKTYEQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	6	2	3	6	24	35	43	38	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASRDSVKTYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTGGGGGGACAGCCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGGTAYSGANVLTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	5	0	4	4	26	37	48	41	52	TCRBV03,TCRBV12													CASSGGTAYSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACAAAAGTAGCGGGAAAACCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	1.4672034185839652E-4		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	5	3	2	7	5	26	40	55	47	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACAGTTGGGTACGTTCAATCAGCCCCAGCATTTTGGTGAT	CSARDQQLGTFNQPQHF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	3	3	11	26	40	47	43	58		TCRBV20-01,TCRBV20-or09_02												CSARDQQLGTFNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGGGGAGCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	1.4672034185839652E-4		47	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	5	1	2	2	4	26	40	48	42	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGCCGACAGGGGGACTATGGCTACACCTTCGGTTCG	CSGRQGDYGYTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	1	3	3	0	26	33	-1	36	45		TCRBV20-01,TCRBV20-or09_02												CSGRQGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAATCCTAGCTGTATGGAAACTGTTTTTTGGCAGT	CASSQILAVWKLFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	4	7	11	3	7	23	38	46	41	53	TCRBV01,TCRBV04					01,02								CASSQILAVWKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGAACTAGCGGGAGGGAGACCCAGTACTTCGGGCCA	CATSEGTSGRETQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	3	1	5	4	0	24	38	-1	42	54		TCRBV24-01,TCRBV24-or09_02												CATSEGTSGRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTAATTATGGTTAGCGGGAGGGCCGGGGAGCAGTTCTTCGGGCCA	CASSLIMVSGRAGEQFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	0	10	8	5	18	33	52	41	57	TCRBV07,TCRBV11													CASSLIMVSGRAGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTCCGCTGGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSFPLGGADTQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	4	6	1	18	32	45	38	46	TCRBV05,TCRBV11													CASSFPLGGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCRGCCATGTATCKCTGTGCCAGTCACAGAGGGTCGGCCAAAAACATTCAGTACTTCGGCGCC	CASHRGSAKNIQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	9	11	0	1	5	3	19	27	37	32	40	TCRBV07,TCRBV11													CASHRGSAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGGGGGGGGCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGGPSTDTQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	0	1	5	19	33	41	34	46	TCRBV05,TCRBV07													CASSLGGGPSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTCCGGGACTAGCGGGAGAAGGAACAATGAGCAGTTCTTCGGGCCA	CASSSGTSGRRNNEQFF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	2	5	3	5	23	35	52	38	57	TCRBV09,TCRBV12													CASSSGTSGRRNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCTCGACGGATGGGAACACTGAAGCTTTCTTTGGACAA	CASSLSTDGNTEAFF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	1	8	1	7	3	26	39	49	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSTDGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTAGACTAGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	1.558903632245463E-4		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	8	2	3	0	26	39	-1	42	48		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGGACTAGCGGGAGAAAAGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.558903632245463E-4		52	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	1	2	0	1	9	26	33	47	34	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTACAGGTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLQVSSYNEQFF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	4	0	0	4	22	-1	41	37	45		TCRBV12-03,TCRBV12-04												CASSLQVSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTACAACAGCGGCAAACACAGATACGCAGTATTTTGGCCCA	CATSTTAANTDTQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	5	2	5	4	24	36	46	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSTTAANTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCTAGGACTAGCGGGATCTACGAGCAGTACTTCGGGCCG	CASRPRTSGIYEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	3	3	5	1	24	35	52	40	53		TCRBV24-01,TCRBV24-or09_02												CASRPRTSGIYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCCGCAAGAGGGGAAAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.558903632245463E-4		40	TCRBV24						TCRBJ02	TCRBJ02-01	01	12	5	2	5	8	4	24	30	43	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCCGCACAAGGCTCCCCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.558903632245463E-4		46	TCRBV05						TCRBJ02	TCRBJ02-07	01	4	3	6	5	6	11	19	31	40	37	51		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGTACATAGGAGCGGGAGGGCTCGTCGGACATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	1.558903632245463E-4		61	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	0	8	11	10	20	36	57	47	67	TCRBV09,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCATATCGCGGCAGGGCCCATCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDLHIAAGPISYNEQFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	60	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	0	10	5	21	39	54	49	59		TCRBV24-01,TCRBV24-or09_02												CATSDLHIAAGPISYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTCAGGCAGAGGGACAGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.650603845906961E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	10	0	26	37	-1	47	55	TCRBV07,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATAGTTCGACAGGGGGCTATGGCTACACCTTCGGTTCG	CASSHSSTGGYGYTF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	1	4	6	0	26	40	-1	46	55		TCRBV03-01,TCRBV03-02												CASSHSSTGGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGACATACATCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.650603845906961E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	5	0	19	26	-1	42	38	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGAGGGGGAGCCTCCCAAGAGACCCAGTACTTCGGGCCA	CSARGGASQETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	2	1	1	4	26	39	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSARGGASQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTACGGGGGCTAGCGGATTACTCCTACGAGCAGTACTTCGGGCCG	CSARDLRGLADYSYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	0	10	4	26	40	57	50	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLRGLADYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCAGTCGGGGATGCGAGATACGCAGTATTTTGGCCCA	CSASPQSGMRDTQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	5	8	5	26	37	50	45	55		TCRBV20-01,TCRBV20-or09_02												CSASPQSGMRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCAGACAGGGCCTATCAGCCCCAGCATTTTGGTGAT	CSASSDRAYQPQHF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	3	5	4	3	26	37	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSASSDRAYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGTTCTCGAGATTACACCGGGGAGCTGTTTTTTGGAGAA	CASSRDYTGELFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	9	11	2	3	5	3	22	30	38	35	41	TCRBV09,TCRBV12													CASSRDYTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACCAACCTAAGACAGGGGGTAGGGGCAGATACGCAGTATTTTGGCCCA	CASTNLRQGVGADTQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	1	4	9	6	23	33	51	42	57	TCRBV24,TCRBV27													CASTNLRQGVGADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAGGGAGGCCTAACTATGGCTACACCTTCGGTTCG	CATSDSGRPNYGYTF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	1	0	2	1	24	40	48	42	49		TCRBV24-01,TCRBV24-or09_02												CATSDSGRPNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGACTAGCGGGATTCGCTCTCCCTACGAGTAGTACTTCGGGCCG		Out	VDJ	1	18	1.650603845906961E-4		50	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	3	11	0	18	24	-1	48	37	66		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTAGACTTGGGGGATAGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	1.650603845906961E-4		49	unresolved						TCRBJ01	TCRBJ01-05	01	1	6	1	4	4	6	18	34	43	38	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCCCAGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSPGQQETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	5	2	3	0	18	30	-1	33	39	TCRBV05,TCRBV07													CASSPGQQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGAAGACCTCCTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CARRPPSGQETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	4	2	5	0	18	29	-1	34	42	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02				01,02								CARRPPSGQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCGTCCAACGGGACTAGCGGGAGGGCCATCAGATACGCAGTATTTTGGCCCA	CASSRPTGLAGGPSDTQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	0	4	8	4	18	30	54	38	58	TCRBV07,TCRBV11													CASSRPTGLAGGPSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCACCACTTTATCGGGTAGAACACTATGGCTACACCTTCGGTTCG	CASSSPLYRVEHYGYTF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	8	4	3	11	6	18	31	46	42	52	TCRBV05,TCRBV11					01,02								CASSSPLYRVEHYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAAACCCTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSLNPSGSYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	2	3	4	0	18	33	-1	37	47	TCRBV05,TCRBV11													CASSLNPSGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGAACTAGCTACAGATACGCAGTATTTTGGCCCA	CASSLAELATDTQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	7	3	3	1	18	35	44	38	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAELATDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACGAAGAGCGGGGGGAGAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.650603845906961E-4		56	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	1	3	7	4	25	42	58	49	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCACGGCGGGGGGGTATCGGAAGAGACCCAGTACTTCGGGCCA	CASSHGGGVSEETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	0	3	4	6	19	31	44	35	50	TCRBV07,TCRBV11													CASSHGGGVSEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCACCTTTACCACTAGCGGGACGTTTGATCACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	1.650603845906961E-4		58	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	3	2	4	10	19	33	47	37	57	TCRBV05,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCGGGATCGACTAGCGGGGAAAAGACCCAGTACTTCGGGCCA	CASSPGSTSGEKTQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	3	6	8	3	19	31	50	39	53	TCRBV05,TCRBV11													CASSPGSTSGEKTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTTGGACCCCGGAGGCACTGAAGCTTTCTTTGGACAA	CASSLDPGGTEAFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	4	7	0	26	40	-1	47	52	TCRBV03,TCRBV12													CASSLDPGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGATCGGCTCAGCCCCAGCATTTTGGTGAT	CASSQGSAQPQHF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	3	0	8	6	0	5	26	-1	44	40	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSAQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGAYEQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	36	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	6	1	2	0	0	26	-1	-1	40	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTAAGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASKTGNTEAFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	4	1	3	0	26	34	-1	37	43		TCRBV03-01,TCRBV03-02												CASKTGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAGGGTGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSAQGGGNQPQHF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	2	0	5	26	-1	40	34	45		TCRBV20-01,TCRBV20-or09_02												CSAQGGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAGAGCGGGAGGGACACCGGGGAGCTGTTTTTTGGAGAA	CSARKSGRDTGELFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	6	0	3	3	0	26	38	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSARKSGRDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCTCACGCGAAAGGGCTACCTACGAGCAGTACTTCGGGCCG	CSRERATYEQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	11	5	3	2	9	3	26	29	42	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSRERATYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCGGGGACGAGGACACTGAAGCTTTCTTTGGACAA	CASSGDEDTEAFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	0	7	3	2	4	22	33	40	35	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDEDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGGACGCTTGGGGGGACTGCGCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	1.7423040595684587E-4		47	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	0	10	2	10	4	22	30	46	40	50		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCTAAGCGCAAGTGAGCAGTTCTTCGGGCCA	CATSDLSASEQFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	6	9	3	4	24	39	46	42	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLSASEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCCGGGACCCGACCCCACACTGAAGCTTTCTTTGGACAA	CATPGTRPHTEAFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	9	0	7	3	3	8	24	33	41	36	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATPGTRPHTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGAGGGGGGCAGCACACCGGGGAGCTGTTTTTTGGAGAA	CATRGGQHTGELFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	9	5	1	3	2	5	24	33	41	35	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRGGQHTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCGAATCAGGGGGAGACCCAGTACTTCGGGCCA	CASRPNQGETQYF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	2	5	7	0	24	35	-1	42	48		TCRBV24-01,TCRBV24-or09_02												CASRPNQGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAACTGCGACAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNCDRAGANVLTF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	3	2	5	0	23	33	-1	38	45	TCRBV02,TCRBV09													CASNCDRAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCACAACGTAGGACAGGACTACGAGCAGTACTTCGGGCCG	CASSHNVGQDYEQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	3	7	1	23	37	51	44	52	TCRBV01,TCRBV23													CASSHNVGQDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGACAGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSRQGEETQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	1	3	2	0	26	37	-1	39	48		TCRBV03-01,TCRBV03-02												CASSRQGEETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGTCGGTGGGGGGACAGATACGCAGTATTTTGGCCCA	CSARDRVGGGTDTQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	1	3	10	0	26	40	-1	50	56		TCRBV20-01,TCRBV20-or09_02												CSARDRVGGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCTACAGGGCAGATACGCAGTATTTTGGCCCA	CSARPYRADTQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	4	5	0	26	37	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSARPYRADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTYRGKGACTCWGCTGTGTAYTTCTGTGCCAGCAGCAACCGTCCTTCCTACGAGCAGTACTTCGGGCCG	CASSNRPSYEQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	6	3	7	1	2	6	22	33	37	35	43	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNRPSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCCTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLALAGELFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	7	6	1	5	24	36	41	37	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLALAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTAGTATACGCGATTTCTCTCCCTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLVYAISLPLAKNIQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	60	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	7	6	0	5	14	19	35	43	40	57	TCRBV07,TCRBV11					01,02								CASSLVYAISLPLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCCCGGCAGTCAGAAGAACACTGAAGCTTTCTTTGGACAA	CASSPGSQKNTEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	4	5	1	5	6	18	30	38	35	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGSQKNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTAGGGGCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSLGAANTEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	2	1	0	4	19	-1	38	33	42	TCRBV05,TCRBV07													CASSLGAANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCCCCGAGGCGGGACCCTAATAACTTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.8340042732299566E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	3	6	13	22	34	46	40	59	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGGGGCTAGCGGCCACAGATACGCAGTATTTTGGCCCA	CASSLGLAATDTQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	2	5	1	22	35	47	40	48	TCRBV07,TCRBV11					01,02								CASSLGLAATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGTACGACAGGCCCCGCTATGGCTACACCTTCGGTTCG	CASSLYDRPRYGYTF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	5	5	22	35	46	40	51	TCRBV07,TCRBV11													CASSLYDRPRYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGACAACCGGGGACGGACCTAYGAGCAGTACTTCGGGCCG	CASSQDNRGRTYEQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	0	0	7	2	6	3	23	40	51	46	54	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDNRGRTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGCACGGCGAACACTGAAGCTTTCTTTGGACAA	CSAREGTANTEAFF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	5	4	1	0	6	26	-1	43	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGTANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGATGGCAAAAACATTCAGTACTTTGGCGCC	CSARSDGKNIQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	39	TCRBV20						TCRBJ02	TCRBJ02-04	01	2	1	8	22	2	22	26	38	43	40	65		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSDGKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCACCTTAGGGGAGAGCAGTACTTCGGGCCG	CATSHLRGEQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	2	7	7	1	24	35	47	42	48		TCRBV24-01,TCRBV24-or09_02												CATSHLRGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCACCTCGTCAAGCGGGAGTAGAGACCCAGTACTTCGGGCCA	CASSPPRQAGVETQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	6	2	4	12	1	24	35	55	47	56		TCRBV24-01,TCRBV24-or09_02												CASSPPRQAGVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTACTCATTACAGGGGGCTATATCCACGAGCAGTACTTCGGGCCG	CASSLLITGGYIHEQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	5	6	7	30	45	60	51	67	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLLITGGYIHEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCATGTATCKCTGTGCCAGAAGCCAAAAGGAGCACGGACTAGTAGTCAATGAGCAGTTCTTCGGGCCA	CARSQKEHGLVVNEQFF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	8	6	12	4	19	31	50	43	54	TCRBV07,TCRBV11					01,02								CARSQKEHGLVVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACGAGTCTCACCAATGAGCAGTTCTTCGGGCCA	CASSETSLTNEQFF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	2	6	6	6	23	34	43	40	49	TCRBV02,TCRBV09													CASSETSLTNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCAGGGGGCTTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	22	2.0174047005529523E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	0	2	3	2	26	34	45	37	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTACCTTACAGGGCCAAGAGACCCAGTACTTCGGGCCA	CSAITLQGQETQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	1	7	0	26	36	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSAITLQGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCCAAGCGGGAGTGGGGCAGATACGCAGTATTTTGGCCCA	CASSPSGSGADTQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	4	3	5	22	34	45	37	50	TCRBV09,TCRBV12													CASSPSGSGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCACGTTTGGTGCCCCAACCAGACAGCTCTTACTTCTGTGCCAGCAGTTTGTTAGCGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLLAGGSYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	1	0	3	0	36	49	-1	52	62	TCRBV06,TCRBV12,TCRBV27	TCRBV06-07,TCRBV12-03,TCRBV12-04,TCRBV27-01												CASSLLAGGSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTGGGGCGGGGGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSLGRGGAYEQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	0	2	6	2	24	35	50	41	52		TCRBV24-01,TCRBV24-or09_02												CASSLGRGGAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCATCGGGGCCGACCTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSIGADLAGELFF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	45	TCRBV05						TCRBJ02	TCRBJ02-02	01	4	7	0	6	3	8	19	31	39	34	47		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIGADLAGELFF+TCRBV05-X+TCRBJ02-02	TCRBV05		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGTGAGGAGGGGCGGACATCCCCGGGAGACCCAGTACTTCGGGCCA	CASSLVRRGGHPRETQYF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	54	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	0	5	3	14	19	35	44	38	58		TCRBV05-06,TCRBV05-07												CASSLVRRGGHPRETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCCTAACAGGCCTCCCTGAGCAGTTCTTCGGGCCA	CASTLTGLPEQFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	4	9	5	6	24	34	44	39	50	TCRBV06,TCRBV10													CASTLTGLPEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGAGAGGGACCTTACAATGAGCAGTTCTTCGGGCCA	CSGEGPYNEQFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	9	0	7	4	6	2	26	31	42	37	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGEGPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCCCGGACACTGAAGCTTTCTTTGGACAA	CSARSPDTEAFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	6	7	3	0	4	26	-1	41	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSPDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTCCGGACCGCAGGTGTAGCTTTCTTTGGACAA	CSASLRTAGVAFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	7	10	5	9	26	37	46	42	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLRTAGVAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACAGAGTCTGAGCAGTACTTCGGGCCG	CSAGTESEQYF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	7	0	5	26	-1	42	35	47		TCRBV20-01,TCRBV20-or09_02												CSAGTESEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAGACAGGGGCTATGGCTACACCTTCGGTTCG	CSVDRGYGYTF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	2	4	2	0	26	33	-1	35	43		TCRBV20-01,TCRBV20-or09_02												CSVDRGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGTAAACAACCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	2.10910491421445E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	3	6	2	7	3	24	31	41	38	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCACAGGGGGCCGCGGGGAAGCTTTCTTTGGACAA	CASSLATGGRGEAFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	0	8	1	6	18	35	45	36	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLATGGRGEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCACACAGGCGGCGGGAGGAACCCCAGTGCAGTTCTTCGGGCCA		Out	VDJ	1	23	2.10910491421445E-4		49				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	1	12	8	9	22	36	52	44	61	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												X+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGACAGCCGCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	2.10910491421445E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	5	6	0	4	23	-1	44	39	48	TCRBV09,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGTAGGCCGGGGAGGGCCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGRGGPNTGELFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	0	2	4	3	23	39	50	43	53	TCRBV03,TCRBV09													CASSVGRGGPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCGAAGGAAGAGGGACACCCCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	2.200805127875948E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	1	11	5	26	40	57	51	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGAAGCGGACAGGGGTAGGCTACACCTTCGGTTCG	CSATKRTGVGYTF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	8	8	2	26	34	51	42	53		TCRBV20-01,TCRBV20-or09_02												CSATKRTGVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAACTAGCGGGAGTTCCTACGAGCAGTACTTCGGGCCG	CSARPTSGSSYEQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	3	2	1	3	1	26	38	52	41	53		TCRBV20-01,TCRBV20-or09_02												CSARPTSGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAACATGGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASNMDSSYNEQFF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	7	1	8	0	4	3	22	32	39	36	42		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNMDSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGACAGGGGGCCGAGAGACCCAGTACTTCGGGCCA	CATSDSTGGRETQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	0	4	1	2	24	40	51	41	53		TCRBV24-01,TCRBV24-or09_02												CATSDSTGGRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGCTGGGAGAGGGGCAAATACGCAGTATTTTGGCCCA	CASSAGRGANTQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	5	5	2	7	8	3	18	30	43	38	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGRGANTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGGGGACAGAGACACAGATACGCAGTATTTTGGCCCA	CASSQEGDRDTDTQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	5	2	2	3	18	35	44	37	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGDRDTDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGCTTAATGGCTAGCGGGACCCAGTACTTCGGGCCA	CASSLMASGTQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	5	7	4	0	22	37	-1	41	48	TCRBV07,TCRBV23					01,02								CASSLMASGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGGTACCGGGACAGGGCCGCTATGGCTACACCTTCGGTTCG	CASSEVPGQGRYGYTF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	4	5	3	24	39	53	44	56	TCRBV06,TCRBV10													CASSEVPGQGRYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGCCGCAGGGGGCCGATACCGGGGAGCTGTTTTTTGGAGAA	CSAGPQGADTGELFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	5	7	4	26	34	49	41	53		TCRBV20-01,TCRBV20-or09_02												CSAGPQGADTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTCCAACAGGGAAAGTCTAAAGCAGTACTTCGGGCCG	CSARASNRESLKQYF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	3	8	6	9	26	39	51	45	60		TCRBV20-01,TCRBV20-or09_02												CSARASNRESLKQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCGGGACTAGCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	2.2925053415374458E-4		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	3	2	2	22	33	44	35	46	TCRBV09,TCRBV12					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTAGAGGCAGGGAGATCCACCAATGAGCAGTTCTTCGGGCCA	CASSLEAGRSTNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	48	TCRBV12						TCRBJ02	TCRBJ02-01	01	1	4	3	6	3	8	22	38	46	41	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAGRSTNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGAAAAGCGGGAGTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	2.2925053415374458E-4		43	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	6	2	1	5	1	24	33	46	38	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYGTGTATSTCTGTGCCAGAAGGACTAGCGGAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	2.2925053415374458E-4		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	5	3	0	2	19	-1	39	30	41	TCRBV05,TCRBV07,TCRBV11,TCRBV12					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACCCCGGGACAGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSQDPGTGNYNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	3	4	2	18	35	48	39	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDPGTGNYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTACCGGGACTAGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	2.2925053415374458E-4		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	8	1	3	1	18	31	42	34	43	TCRBV11,TCRBV23					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGAATTGGGTCGGGAAGCTTTCTTTGGACAA	CASSLELGREAFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	4	0	9	8	7	4	22	35	45	42	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLELGREAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGGGGTCTGCACCCAAATTACGAGCAGTACTTCGGGCCG	CSAKGGLHPNYEQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	5	1	4	0	14	26	-1	42	36	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGGLHPNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAACACAACGAGTGGGGACACTAAACATTCAGTACTTCGGCGCC	CSATTQRVGTLNIQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	6	6	14	2	26	36	56	50	58		TCRBV20-01,TCRBV20-or09_02												CSATTQRVGTLNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAACCGGGGACGAGGGGAGACCCAGTACTTCGGGCCA	CSARNRGRGETQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	0	7	5	5	5	26	38	48	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARNRGRGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCACGTTTGSYSMMMSMSASASCTCTKTACYTCTGTGCCAGCAACCGGGGCCATCTAACCTCTGGAAACACCATATATTTTGGAGAG	CASNRGHLTSGNTIYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	unresolved						TCRBJ01	TCRBJ01-03	01	11	7	0	0	6	8	24	31	42	37	50	TCRBV05,TCRBV24,TCRBV25,TCRBV27,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNRGHLTSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGTGGCTGGGCGAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRVAGRGSYNEQFF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	48	TCRBV24						TCRBJ02	TCRBJ02-01	01	7	8	0	0	7	4	24	35	46	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVAGRGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGACAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGTSNQPQHF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	6	1	3	0	24	36	-1	39	45		TCRBV24-01,TCRBV24-or09_02												CASSPGTSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ACGACTCGGCYSTGTATCTCTGTGCCAGCAGCCGGGGGGGGCACCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	2.3842055551989436E-4		40	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	4	0	4	19	-1	39	31	43	TCRBV05,TCRBV07													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGTCCCTCCTTTTGATGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	2.3842055551989436E-4		49	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	9	4	15	0	20	35	-1	50	53	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTCCTGGGGGCTAGCCGGCTACGAGCAGTACTTCGGGCCG	CASSSWGLAGYEQYF	In	VDJ	1	26	2.3842055551989436E-4	2.784411578868458E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	6	0	3	3	7	22	35	44	38	51	TCRBV07,TCRBV11													CASSSWGLAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTACAGGGGTCAGATACGCAGTATTTTGGCCCA	CASSVQGSDTQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	4	3	1	26	37	47	40	48	TCRBV12,TCRBV21													CASSVQGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCATGGAGAAACTACAATGAGCAGTTCTTCGGGCCA	CSARSWRNYNEQFF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	3	4	3	26	38	46	42	49		TCRBV20-01,TCRBV20-or09_02												CSARSWRNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGCGACTAGCGGGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	2.4759057688604415E-4		47	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	2	2	2	3	1	26	38	53	41	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAAAAACTACGGGGCCTACGAGCAGTACTTCGGGCCG	CSAPKNYGAYEQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	2	11	0	26	35	-1	46	51		TCRBV20-01,TCRBV20-or09_02												CSAPKNYGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATTGGAAATACGAGCAGTACTTCGGGCCG	CAISDWKYEQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	36							TCRBJ02	TCRBJ02-07	01	5	1	8	4	4	2	23	35	42	39	44	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDWKYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYRTGTATCTCTGTGCCAGCAGCAGACCGCCGAGCGGGAGCCGTCAATGAACAGTTCTTCGGGCCA		Out	VDJ	1	27	2.4759057688604415E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	13	9	11	22	34	51	43	62	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTATCTTCAAGCGTTAACAGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	2.567605982521939E-4		55	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	1	14	1	22	34	55	48	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCCAAGGACAGGTCGCAATGAGCAGTTCTTCGGGCCA	CATSDLPRTGRNEQFF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	6	4	3	24	42	53	46	56		TCRBV24-01,TCRBV24-or09_02												CATSDLPRTGRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCAGACTAGCGGGAAGCAAAAACATTCAGTACTTCGGCGCC	CASSPRLAGSKNIQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	7	2	3	3	5	2	24	35	51	40	53		TCRBV24-01,TCRBV24-or09_02												CASSPRLAGSKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01*02	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAAGACAGATTCCCTACGAGCAGTACTTCGGGCCG	CASSLRQIPYEQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	5	2	1	4	19	34	40	35	44	TCRBV07,TCRBV11													CASSLRQIPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGTGGACAGGGGTTCGGGGAGCTGTTTTTTGGAGAA	CASSLGGQGFGELFF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	2	7	4	2	18	32	45	36	47	TCRBV07,TCRBV11													CASSLGGQGFGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCGGGGGACAGACCAACTCTGGAAACACCATATATTTTGGAGAG	CAGGQTNSGNTIYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	12	0	5	0	3	5	18	23	33	26	38	TCRBV07,TCRBV12													CAGGQTNSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGACCCCCATCTTTACAGGGGGCGGATGGCTACACCTTCGGTTCG	CASRPPSLQGADGYTF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	6	12	2	19	30	51	42	53	TCRBV07,TCRBV11													CASRPPSLQGADGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTCCGGGACAGGGGTTGAAAAACTGTTTTTTGGCAGT	CASSSSGTGVEKLFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	7	5	1	26	39	54	44	55		TCRBV12-03,TCRBV12-04												CASSSSGTGVEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCTAAACACCAACAATGAGCAGTTCTTCGGGCCA	CASSQLNTNNEQFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	3	6	5	5	3	26	40	48	45	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLNTNNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCTTTTCACCATTTCAGGCTTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	29	2.659306196183437E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	5	14	4	26	38	56	52	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAGGGGGTCTACGAGCAGTACTTCGGGCCG	CSAEGVYEQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	5	1	3	2	1	26	34	42	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEGVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCAAAAACGACAGGGAAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	2.659306196183437E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	2	7	3	22	34	48	41	51	TCRBV09,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAAAGGGCAGGACCAAGAGACCCAGTACTTCGGGCCA	CATSKGQDQETQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	42	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	4	4	0	6	0	24	36	-1	42	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSKGQDQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCTGGCGGGAACTGAGCAGTTCTTCGGGCCA	CATSDLAGTEQFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	3	9	3	2	24	39	48	42	50		TCRBV24-01,TCRBV24-or09_02												CATSDLAGTEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAACAACGGTGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLTTVGQETQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	2	6	2	2	8	0	18	33	-1	41	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTTVGQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGTGGGAAATGGGCACTGAAGCTTTCTTTGGACAA	CSAPWEMGTEAFF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	8	4	5	6	26	34	43	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPWEMGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCGAGACAGGGGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CATSDFRDRGGTNEKLFF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	1	1	4	2	24	41	54	45	56		TCRBV24-01,TCRBV24-or09_02												CATSDFRDRGGTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGAGGACAGAGCACTGAAGCTTTCTTTGGACAA	CATSGGQSTEAFF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	4	2	2	24	37	45	39	47		TCRBV24-01,TCRBV24-or09_02												CATSGGQSTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCTGGACAGATGGGGTCGAGAGCAGTACTTCGGGCCG	CASSLDRWGREQYF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	7	2	10	18	30	38	32	48	TCRBV03,TCRBV11													CASSLDRWGREQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCAACTGACAGGGGGCATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	2.751006409844935E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	2	5	2	19	31	46	36	48	TCRBV05,TCRBV07													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCCTGGGGTAGCGAGGGGACCGTTCTTCGGGCCA	CASSSPGVARGPFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	4	0	7	15	16	1	26	39	60	55	61		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGVARGPFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGATTCGGCAGCCTATCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	2.842706623506433E-4		44	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	1	8	4	1	14	26	36	40	37	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAAAATGGGACAGTCCTACGAGCAGTACTTCGGGCCG	CSAPKMGQSYEQYF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	1	8	0	26	35	-1	43	50		TCRBV20-01,TCRBV20-or09_02												CSAPKMGQSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCGGACTAGCGGGAGTCGAACAGATACGCAGTATTTTGGCCCA	CASSRTSGSRTDTQYF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	2	3	2	4	22	33	48	35	52		TCRBV12-03,TCRBV12-04												CASSRTSGSRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGACACTATGGCTACACCTTCGGTTCG	CATSDRHYGYTF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	3	2	7	3	1	0	24	39	-1	40	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDRHYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTACCAGCAGCCAAGATCAGGGGGGCGGCGGGAGTCGGTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	2.842706623506433E-4		56							TCRBJ02	TCRBJ02-07	01	0	4	1	5	1	17	18	35	43	36	60	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07			TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGTGATCGGACTAGCGGGATCCGGTACGAGCAGTACTTCGGGCCG	CARSDRTSGIRYEQYF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	3	4	5	5	18	29	46	34	51	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02												CARSDRTSGIRYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGCAGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLAGSSTDTQYF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	45							TCRBJ02	TCRBJ02-03	01	0	4	5	0	3	1	18	35	41	38	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGSSTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCGACCCTAGGGGGGTGAGAAATTACGAGCAGTACTTCGGGCCG	CASTDPRGVRNYEQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	7	5	1	4	8	9	24	34	48	42	57	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTDPRGVRNYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCAACAGGGGCGTTCTCCTACGAGCAGTACTTCGGGCCG	CSATGAFSYEQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	3	2	0	4	4	26	31	42	35	46		TCRBV20-01,TCRBV20-or09_02												CSATGAFSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAAGGAGTCGTTAGCGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	2.9344068371679304E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	5	2	9	1	26	38	53	47	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGAGGAAGGGGGCGGGGGACGAGCAGTACTTCGGGCCG	CSARDTRKGAGDEQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	48	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	5	0	5	8	5	26	40	55	48	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTRKGAGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGCACCCCCTACAATGAGCAGTTCTTCGGGCCA	CSASGTPYNEQFF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	9	0	2	1	4	26	37	41	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGTPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAACCGGCGGAGGGTTCCCCTTACGAGCAGTACTTCGGGCCG	CSAQPAEGSPYEQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	4	8	7	26	35	49	43	56		TCRBV20-01,TCRBV20-or09_02												CSAQPAEGSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCTGCTTCGGAAGCAGATACGCAGTATTTTGGCCCA	CASSQAASEADTQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	1	1	8	4	7	2	23	39	49	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAASEADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGACCGGCCCCCAGCGGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	2.9344068371679304E-4		52	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	6	1	1	10	0	22	33	-1	43	52		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACATGGACAGGGAGAAAGAGACCCAGTACTTCGGGCCA	CATSDMDREKETQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	3	3	3	24	38	49	41	52		TCRBV24-01,TCRBV24-or09_02												CATSDMDREKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGGAACAGGGACCATGAACACTGAAGCTTTCTTTGGACAA	XASSQGTGTMNTEAFF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	0	2	4	22	38	46	40	50	TCRBV01,TCRBV04													XASSQGTGTMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGGGGCGGGAGATACGCAGTATTTTGGCCCA	CASSLGGAGDTQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV12						TCRBJ02	TCRBJ02-03	01	1	6	0	5	1	3	26	42	49	43	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGAGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCCCGGTGAACGAGCAGTACTTCGGGCCG	CASSQTPVNEQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	8	5	5	4	3	26	41	48	45	51		TCRBV03-01,TCRBV03-02				01,02								CASSQTPVNEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGACTGTAACATCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	3.0261070508294286E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	0	3	9	26	39	48	42	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCCTCCTGGCGGTTTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPGGFSYNEQFF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	5	1	6	4	26	39	49	45	53	TCRBV03,TCRBV11					01,02								CASSPPGGFSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACTACTAGCCTGGGATCTTACGAGCAGTACTTCGGGCCG	CSATTSLGSYEQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	7	4	4	9	26	34	44	38	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSATTSLGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCGCAGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CSAPRRTANTEAFF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	8	1	26	34	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSAPRRTANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGCTACTACGAGCAGTACTTCGGGCCG	CSARRYYEQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	9	3	2	0	26	38	-1	40	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRYYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCCAGGCACTTCTGGAAACACCATATATTTTGGAGAG	CSARDGPGTSGNTIYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	4	1	5	4	26	40	49	45	53		TCRBV20-01,TCRBV20-or09_02												CSARDGPGTSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAAGCCAGCGGGAAAGAGAGGCAATGAGCAGTTCTTCGGGCCA	CATSKPAGKRGNEQFF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	3	6	5	8	24	36	48	41	56		TCRBV24-01,TCRBV24-or09_02												CATSKPAGKRGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGGGCGCGGGGAATGAGCAGTTCTTCGGGCCA	CATSEGGAGNEQFF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	0	7	0	6	24	-1	45	38	51		TCRBV24-01,TCRBV24-or09_02												CATSEGGAGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAAGACAGGCGAGCAGTACTTCGGGCCG	CATSDKTGEQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	6	2	0	24	39	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CATSDKTGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCCGAGTGGGGGGACTCAAGAGACCCAGTACTTCGGGCCA	CASSPSGGTQETQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	10	2	10	0	24	35	-1	45	51	TCRBV24,TCRBV27					01,02								CASSPSGGTQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTAGGTCGGGACTCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSSRSGLLSYEQYF	In	VDJ	1	33	3.0261070508294286E-4	3.534060850102274E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	0	8	3	24	36	50	44	53		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSRSGLLSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTTCTGTGCCAGCACCCATACCCCGGACTAGCGGGAGGGCCGATCGTACGGGAGCACCAATGAGCAGTTCTTCGGGCCA	CASTHTPD*REGRSYGSTNEQFF	Stop	VDJ	1	33	3.0261070508294286E-4		69	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	0	6	6	18	4	18	39	24	57		TCRBV03-01,TCRBV03-02												CASTHTPD*REGRSYGSTNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTCAGGGCTCCATGAGCAGTTCTTCGGGCCA	CASSQVSGLHEQFF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	8	3	4	26	42	50	45	54		TCRBV03-01,TCRBV03-02												CASSQVSGLHEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCAAGGGCCGGAGTGGATACGCAGTATTTTGGCCCA	CSAPRAGVDTQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	5	3	6	4	8	26	34	42	38	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPRAGVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTATTTGGGGACGGCAATCAGCCCCAGCATTTTGGTGAT	CSARLFGDGNQPQHF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	0	7	2	8	1	26	37	50	45	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLFGDGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTACCTGAGACAGCCGCACAGATACGCAGTATTTTGGCCCA	CASST*DSRTDTQYF	Stop	VDJ	1	34	3.117807264490926E-4		45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	1	6	2	24	36	47	42	49	TCRBV06,TCRBV24													CASST*DSRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACCGGGACTACCTACGAGCAGTACTTCGGGCCG	CASSLTGTTYEQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	9	2	6	0	24	36	-1	42	49		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLTGTTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCCGCGGGGGGGCCTTCTACGAGCAGTACTTCGGGCCG	CASRGGAFYEQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	7	0	3	3	4	24	31	43	34	47	TCRBV06,TCRBV24													CASRGGAFYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCGGACCTGAGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSPDLRETGELFF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	5	8	2	18	30	43	38	45	TCRBV05,TCRBV11													CASSPDLRETGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGACTCAGCCCCAGCATTTTGGTGAT	CSARDGTQPQHF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	7	6	1	0	26	40	-1	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGTQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGACAGTTCAAGACAGATACGCAGTATTTTGGCCCA	CSARGGQFKTDTQYF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	3	2	6	26	39	47	41	53		TCRBV20-01,TCRBV20-or09_02												CSARGGQFKTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGAACTCCGAGCCCCTCCCACTAGCGGGAGGGTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	3.209507478152424E-4		59	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	3	0	5	17	2	22	33	63	50	65		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTACCCCGGGAACCAGTACTTCGGGCCA	CATSDLYPGNQYF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	8	3	10	5	1	24	42	52	47	53		TCRBV24-01,TCRBV24-or09_02												CATSDLYPGNQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCTCTGCGGGGGGACAATGATGGCAGTTCTTCGGGCCA		Out	VDJ	1	35	3.209507478152424E-4		44	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	12	5	9	24	36	49	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGATCGACTAGCGGGAGGTCGGGCACCGCAGTATTTTGGCCCA	CASSLDRLAGGRAPQYF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	2	1	10	2	8	18	35	50	37	58	TCRBV05,TCRBV11													CASSLDRLAGGRAPQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGGATCGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	3.301207691813922E-4		44	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	1	8	0	2	5	26	39	44	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCGAGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CATSARGSTDTQYF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	5	5	2	0	2	1	24	37	44	39	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSARGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCCCAGGGGAGCGGGAGATTAGTTCATACGAGCAGTACTTCGGGCCG	CASSPGEREISSYEQYF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	4	7	9	18	30	45	37	54	TCRBV05,TCRBV07													CASSPGEREISSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCATAAACAGGGGTGAGCAGTTCTTCGGGCCA	CASSINRGEQFF	In	VDJ	1	36	3.301207691813922E-4	3.85533910920248E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	9	4	0	23	35	-1	39	46	TCRBV09,TCRBV12													CASSINRGEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTGGAGAGTGGCGGGAGAACTCCTACGAGCAGTACTTCGGGCCG	CSASGEWRENSYEQYF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	2	0	12	2	26	34	53	46	55		TCRBV20-01,TCRBV20-or09_02												CSASGEWRENSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGGTCAGCCCCAGCATTTTGGTGAT	CSARDLGQPQHF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	10	6	4	0	26	40	-1	44	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCTTGGCCCAGGCCCCTAGCGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CLAQAPSGSYNEQFF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	4	5	1	13	1	26	29	49	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CLAQAPSGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGGCAGGTTACAATCAGCCCCAGCATTTTGGTGAT	CATSEGAGYNQPQHF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	3	0	7	24	-1	43	38	50		TCRBV24-01,TCRBV24-or09_02												CATSEGAGYNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TTACTTCTGTGCCACCAGTGATTTGTTGGGTATGTTCCGGCAGGGGAGACTAGCGGTAACTAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	3.39290790547542E-4		74	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	5	2	22	8	7	25	56	47	64		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATCCAGGGGGGACCAGAAGCAGATACGCAGTATTTTGGCCCA	CASSIQGGPEADTQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	4	3	9	26	38	48	41	57		TCRBV03-01,TCRBV03-02												CASSIQGGPEADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGAGGGACCCGAAACAGATACGCAGTATTTTGGCCCA	CSARDEEGPETDTQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	3	3	7	26	40	49	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDEEGPETDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGGAGACCCAGAGCGGGAGTCTCTCCTACGAGCAGTACTTCGGGCCG	CSARETQSGSLSYEQYF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	0	12	3	26	35	55	47	58		TCRBV20-01,TCRBV20-or09_02												CSARETQSGSLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCTTTCATACAGTGACGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	38	3.4846081191369175E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	3	5	0	8	6	24	33	45	41	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTAGGTGAGCAGTTCTTCGGGCCA	CASSQGVGEQFF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	36	TCRBV03						TCRBJ02	TCRBJ02-01	01	1	0	9	9	0	4	26	-1	45	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCCCGGGACGCCCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	39	3.5763083327984156E-4		47	TCRBV03						TCRBJ02	TCRBJ02-02	01	5	0	7	2	5	4	26	38	48	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATAGCGGGAGCAGTCGAAATGAGCAGTTCTTCGGGCCA	CSARNSGSSRNEQFF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	2	7	2	7	26	38	49	40	56		TCRBV20-01,TCRBV20-or09_02												CSARNSGSSRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCACAGAGGGGACTTCTTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSQRGLLSSYEQYF	In	VDJ	1	39	3.5763083327984156E-4	4.1766173683026867E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	0	8	6	24	36	50	44	56		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSQRGLLSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACCCCGGGACTAGAATTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	3.668008546459913E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	8	2	4	4	23	37	49	41	53	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTCCCGACAAGTCGCACAGATACGCAGTATTTTGGCCCA	CSASVPTSRTDTQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	6	1	6	4	26	37	47	43	51		TCRBV20-01,TCRBV20-or09_02												CSASVPTSRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTCCAGGACCGATACGCAGTATTTTGGCCCA	CASSLASRTDTQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	42							TCRBJ02	TCRBJ02-03	01	0	1	7	6	5	1	18	35	44	40	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLASRTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGGCCGACTAGCGAGACCCAGTACTTCGGGCCA	CASSLGPTSETQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	2	7	5	6	0	19	33	-1	39	46	TCRBV05,TCRBV11					01,02								CASSLGPTSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCTTGGACGGATCAATGAGCAGTTCTTCGGGCCA	CASSPLGRINEQFF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	42	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	1	7	6	5	4	26	39	48	44	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGRINEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGTCCACAGGTTGGCACGAGCAGTACTTCGGGCCG	CSARSTGWHEQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	4	5	7	5	26	34	46	41	51		TCRBV20-01,TCRBV20-or09_02												CSARSTGWHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAGGGGTAGGGGATGGCTACACCTTCGGTTCG	CSARPGVGDGYTF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	6	1	6	26	38	45	39	51		TCRBV20-01,TCRBV20-or09_02												CSARPGVGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGACAGCGCACAGATACGCAGTATTTTGGCCCA	CASSGQRTDTQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	1	0	1	24	-1	42	37	43		TCRBV24-01,TCRBV24-or09_02												CASSGQRTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGACTCCTGAGCCCTACGAGCAGTACTTCGGGCCG	CSAGTPEPYEQYF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	2	1	7	26	34	41	35	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGTPEPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACGACAGGGGGCCGGGAGACCCAGTACTTCGGGCCA	CSARTTGGRETQYF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	0	5	2	3	26	38	50	40	53		TCRBV20-01,TCRBV20-or09_02												CSARTTGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGTAGTCTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQRSLSGANVLTF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	5	8	1	2	4	26	41	46	43	50		TCRBV03-01,TCRBV03-02				01,02								CASSQRSLSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCCAGCCGCGGGAGTTTCAAATGAGCAGTTCTTCGGGCCA	CSAPPAAGVSNEQFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	2	7	10	5	26	34	51	44	56		TCRBV20-01,TCRBV20-or09_02												CSAPPAAGVSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCATGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CSARSWTGNTEAFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	1	4	0	26	38	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARSWTGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGCGGCTTCGATCAGCCCCAGCATTTTGGTGAT	CSASRGFDQPQHF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	5	5	2	5	26	37	43	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRGFDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGACGCCACTCCATCCATTACAATGAGCAGTTCTTCGGGCCA	CARRHSIHYNEQFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	3	10	4	5	8	22	30	38	35	46		TCRBV12-03,TCRBV12-04				01,02								CARRHSIHYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGGGACTAGGCGCAGATACGCAGTATTTTGGCCCA	CASRGLGADTQYF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	8	4	0	3	24	-1	43	35	46	TCRBV24,TCRBV27					01,02								CASRGLGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAACGAGTCTCCGGGACTAGCGGGACCTACCAGGGGGTTCGGGCCG		Out	VDJ	1	43	3.943109187444407E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	16	10	12	18	33	56	43	68	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGGGCACAGGGGTCCGATGAGCAGTTCTTCGGGCCA	CASSLGAQGSDEQFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	2	8	4	4	19	35	46	39	50	TCRBV07,TCRBV11													CASSLGAQGSDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTTACAGTGTAGATACGCAGTATTTTGGCCCA	CASSYSVDTQYF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	5	5	0	3	26	-1	43	39	46	TCRBV09,TCRBV12													CASSYSVDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGACTACGGGACCGCGGGAGAGCAGTACTTCGGGCCG	CAISDYGTAGEQYF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	3	7	10	0	24	38	-1	48	54	TCRBV06,TCRBV10													CAISDYGTAGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTCGGGACAACCCAATCATGGCTACACCTTCGGTTCG	CASSLASGQPNHGYTF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	6	6	3	8	18	35	44	38	52	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASGQPNHGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCCGACAGGGCGTCGGGCTATGGCTACACCTTCGGTTCG	CASSADRASGYGYTF	In	VDJ	1	44	4.0348094011059046E-4	4.712081133469698E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	4	2	7	23	36	45	38	52	TCRBV09,TCRBV12													CASSADRASGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGGGGAGGGGAGCCCGCACAGATACGCAGTATTTTGGCCCA	CASSLGRGARTDTQYF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	1	1	6	26	40	48	41	54		TCRBV12-03,TCRBV12-04												CASSLGRGARTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCAGGCCCGAGGTGAGCAGTTCTTCGGGCCA	CASSPQARGEQFF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	4	4	9	2	7	26	39	45	41	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQARGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTACATAAATCTCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	45	4.1265096147674027E-4		41	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	6	5	1	8	26	38	42	39	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGACTAGCGGGCACTATGAAGACATTCAGTACTTCGGCGCC	CSARTSGHYEDIQYF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	1	4	8	2	10	26	34	47	36	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSGHYEDIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCGGGGCGCAAGAGGCTACACCTTCGGTTCG	CSAIRGARGYTF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	7	0	8	3	6	26	36	44	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIRGARGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCACCGGGACCACCCAGCATTTTGGTGAT	CATSGTGTTQHF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	36	TCRBV24						TCRBJ01	TCRBJ01-05	01	5	0	7	11	5	2	24	37	47	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGTGTTQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACGGGGGGCACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	45	4.1265096147674027E-4		41	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	1	3	3	1	24	37	47	40	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCTACGGGACACGAAATCAGCCCCAGCATTTTGGTGAT	CASSLAYGTRNQPQHF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	6	4	9	3	24	36	51	45	54		TCRBV24-01,TCRBV24-or09_02												CASSLAYGTRNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTTTGTCGTCTTTCGGGACAGGCCAACTTAGAGGGCTACACCTTCGGTTCG	CSARFCRLSGQANLEGYTF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	8	14	11	24	36	58	50	69		TCRBV20-01,TCRBV20-or09_02												CSARFCRLSGQANLEGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCAAGGGGAACAGAGACAGAATACGAGCAGTACTTCGGGCCG	CASSSRGTETEYEQYF	In	VDJ	1	45	4.1265096147674027E-4	4.8191738865031E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	4	13	2	18	31	49	44	51	TCRBV07,TCRBV11													CASSSRGTETEYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCMTSTATCTCTGTGCAAGTCGCTGGGGACAGGCAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	45	4.1265096147674027E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	0	4	5	9	3	19	24	41	33	44	TCRBV05,TCRBV12													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCTGTCTGGGACTAGCGGGAGCGAGCAGTTCTTCGGGCCA	CASSPLSGTSGSEQFF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	2	10	8	1	26	39	61	47	62		TCRBV03-01,TCRBV03-02												CASSPLSGTSGSEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCCTACTAGCGGGAGTACTCTGGGGGCCG	CSAALLAGVLW	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	2	19	6	8	26	34	51	40	59		TCRBV20-01,TCRBV20-or09_02												CSAALLAGVLW+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTCCACTAGCGGGAGCTTATCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	46	4.2182098284289E-4		44	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	3	2	4	4	5	24	31	46	35	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATATGAGGGGAGCGGGCTACGAGCAGTACTTCGGGCCG	CASSQDMRGAGYEQYF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	4	3	9	0	23	40	-1	49	55	TCRBV01,TCRBV04					01,02								CASSQDMRGAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATCCATTTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	47	4.309910042090398E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	6	5	12	2	26	38	53	50	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTAAATCAGCCCCAGCATTTTGGTGAT	CASSQELNQPQHF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	9	4	2	0	26	43	-1	45	47		TCRBV03-01,TCRBV03-02				01,02								CASSQELNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAAAGGTTCCTTGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	48	4.401610255751896E-4		49	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	5	4	5	4	14	26	38	45	42	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGCAGGGTACTAACTATGGCTACACCTTCGGTTCG	CSARDPQGTNYGYTF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	0	4	2	26	40	49	44	51		TCRBV20-01,TCRBV20-or09_02												CSARDPQGTNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGAAGCGGGAGGGGGTTAGATACGCAGTATTTTGGCCCA	CATRSGRGLDTQYF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	6	0	5	3	4	24	33	46	36	50		TCRBV24-01,TCRBV24-or09_02												CATRSGRGLDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGTGGGGCATCAGAATAACTATGGCTACACCTTCGGTTCG	CASSLVGHQNNYGYTF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	7	0	1	3	7	19	33	41	36	48	TCRBV05,TCRBV11													CASSLVGHQNNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCAGGCAGTGAACACTGAAGCTTTCTTTGGACAA	CASSQQAVNTEAFF	In	VDJ	1	49	4.4933104694133935E-4	5.247544898636709E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	0	1	3	26	40	45	41	48		TCRBV03-01,TCRBV03-02												CASSQQAVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACACAGGGAGTAAGAAACATTCAGTACTTCGGCGCC	CSATQGVRNIQYF	In	VDJ	1	49	4.4933104694133935E-4	5.247544898636709E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	3	3	6	1	6	26	36	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSATQGVRNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCTTATGGGGACTCTTACGCGTGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	49	4.4933104694133935E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	10	10	8	9	26	37	51	45	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCGCCTCCCGGGAACCAAGGCCTACAATGAGCAGTTCTTCGGGCCA	CSANRLPGTKAYNEQFF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	2	9	7	26	36	50	45	57		TCRBV20-01,TCRBV20-or09_02												CSANRLPGTKAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	50	4.5850106830748916E-4		34	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	9	0	5	1	1	26	40	44	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAGGGGCTAGCATCGACGAGCAGTACTTCGGGCCG	CSARGASIDEQYF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	7	5	3	4	26	39	47	42	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGASIDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAACCGGGACGGCCGACACCGGGGAGCTGTTTTTTGGAGAA	CATRTGTADTGELFF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	45	TCRBV24						TCRBJ02	TCRBJ02-02	01	7	0	7	3	4	5	24	35	44	39	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRTGTADTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACAGGGGGAAGTGGCTAATGAAAAACTGTTTTTTGGCAGT	CSAGQGEVANEKLFF	In	VDJ	1	51	4.676710896736389E-4	5.461730404703514E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	1	3	1	6	26	34	45	35	51		TCRBV20-01,TCRBV20-or09_02												CSAGQGEVANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGTCCGGGGCCAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	51	4.676710896736389E-4		44	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	7	0	0	6	2	26	37	48	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGATACAGGGTACCTCTAGAGACCCAGTACTTCGGGCCA	CATSDGYRVPLETQYF	In	VDJ	1	51	4.676710896736389E-4	5.461730404703514E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	3	4	4	7	24	39	49	43	56		TCRBV24-01,TCRBV24-or09_02												CATSDGYRVPLETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGTTACTCCGGGACTAGCGGGAAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	51	4.676710896736389E-4		50	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	3	7	8	1	24	37	58	45	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCCGCAGGGCTGTCGGTCGAGCAGTACTTCGGGCCG	CASSLSAGLSVEQYF	In	VDJ	1	51	4.676710896736389E-4	5.461730404703514E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	6	6	8	23	36	47	42	55	TCRBV06,TCRBV24,TCRBV27													CASSLSAGLSVEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACGGGAGGGGATCTATAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	52	4.7684111103978873E-4		43	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	0	5	0	8	26	-1	44	36	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCATTACCGGGACTAGCGTCTACGAGCAGTACTTCGGGCCG	CSASSITGTSVYEQYF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	6	3	10	1	26	37	57	47	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSITGTSVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACGGGCGCGCACAGATACGCAGTATTTTGGCCCA	CASRRARTDTQYF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	39	TCRBV24						TCRBJ02	TCRBJ02-03	01	7	8	0	1	2	2	24	35	41	37	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRARTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGTAACTATGGCTACACCTTCGGTTCG	CASSFGNYGYTF	In	VDJ	1	53	4.860111324059385E-4	5.675915910770318E-4	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	5	1	0	0	26	-1	-1	40	43		TCRBV12-03,TCRBV12-04				01,02								CASSFGNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCAAGCGGGATACCTGTTGAAGATACGCAGTATTTTGGCCCA	CASGIPVEDTQYF	In	VDJ	1	53	4.860111324059385E-4	5.675915910770318E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	8	0	8	5	0	10	18	-1	31	27	41	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGIPVEDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTAGTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLAKNIQYF	In	VDJ	1	53	4.860111324059385E-4	5.675915910770318E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	8	5	8	0	0	3	23	-1	34	31	37	TCRBV02,TCRBV09					01,02								CASSLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATATTGGGACTATATATACAATGAGCAGTTCTTCGGGCCA	CASSLYWDYIYNEQFF	In	VDJ	1	54	4.951811537720883E-4	5.783008663803721E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	9	4	7	4	24	36	50	43	54		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLYWDYIYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGACAGGCAATCAGCCCCAGCATTTTGGTGAT	CSASTGNQPQHF	In	VDJ	2	55	5.043511751382381E-4	5.890101416837122E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	2	3	0	26	34	-1	37	42		TCRBV20-01,TCRBV20-or09_02												CSASTGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGGGGTTACCTTAACTATGGCTACACCTTCGGTTCG	CSARERGYLNYGYTF	In	VDJ	2	55	5.043511751382381E-4	5.890101416837122E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	1	1	6	26	40	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSARERGYLNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCATTAAGCGGGAGTGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	55	5.043511751382381E-4		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	6	2	4	7	2	26	40	55	47	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGACAGAATTGACTACGAGCAGTACTTCGGGCCG	CSARADRIDYEQYF	In	VDJ	2	55	5.043511751382381E-4	5.890101416837122E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	5	3	2	6	26	39	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSARADRIDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAGGGTGGGTGGGGAGTCGACACTGAAGCTTTCTTTGGACAA	CASSQGGWGVDTEAFF	In	VDJ	2	55	5.043511751382381E-4	5.890101416837122E-4	48	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	6	4	3	3	1	14	20	31	37	32	51	TCRBV01,TCRBV23			TCRBD01,TCRBD02										CASSQGGWGVDTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGATTCTACGGGACTAGCTATCTACGAGCAGTACTTCGGGCCG	CASSDSTGLAIYEQYF	In	VDJ	2	56	5.135211965043878E-4	5.997194169870525E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	3	9	3	26	37	55	46	58		TCRBV03-01,TCRBV03-02				01,02								CASSDSTGLAIYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAAGGAGGAGCTAGCGGGGCCAAAAACATTCAGTACTTCGGCGCC	CSASKGGASGAKNIQYF	In	VDJ	2	56	5.135211965043878E-4	5.997194169870525E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	4	4	1	11	0	26	37	-1	48	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSASKGGASGAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTCCAAATACACCACCCGGGGAGCTGTTTTTTGGAGAA	CASSLSPNTPPGELFF	In	VDJ	2	56	5.135211965043878E-4	5.997194169870525E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	6	6	12	4	24	36	51	48	55	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSPNTPPGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAAAGCGGGAGGGTAGCACAGATACGCAGTATTTTGGCCCA	CSATKREGSTDTQYF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	0	0	3	1	26	36	49	39	50		TCRBV20-01,TCRBV20-or09_02												CSATKREGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAAATCTAGGGTTCAGAGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	57	5.226912178705376E-4		52	unresolved						TCRBJ01	TCRBJ01-01	01	1	5	3	0	5	8	23	38	47	43	55	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGACAGGGGAACGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	58	5.318612392366874E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	2	2	5	26	42	54	44	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATGGCAGGGGGTTTATTGGGAAACACCATATATTTTGGAGAG	CSARMAGGLLGNTIYF	In	VDJ	2	58	5.318612392366874E-4	6.211379675937329E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	1	4	4	7	26	38	49	42	56		TCRBV20-01,TCRBV20-or09_02												CSARMAGGLLGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCAAGCGGGACGACGGGCAGATACGCAGTATTTTGGCCCA	CASRQAGRRADTQYF	In	VDJ	2	58	5.318612392366874E-4	6.211379675937329E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	6	3	4	3	7	24	35	45	38	52		TCRBV24-01,TCRBV24-or09_02												CASRQAGRRADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCACCGACCCCCCCAAGGGAACCTACGAGCAGTACTTCGGGCCG	CASTDPPKGTYEQYF	In	VDJ	2	58	5.318612392366874E-4	6.211379675937329E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	7	0	8	2	13	1	20	30	47	43	48	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTDPPKGTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCGCCACAGGGACGGATGTGTTGCAGGAGCAGTACTTCGGGCCG	CASATGTDVLQEQYF	In	VDJ	2	58	5.318612392366874E-4	6.211379675937329E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	3	7	3	15	23	32	41	35	56	TCRBV09,TCRBV12													CASATGTDVLQEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTATTGGGCAGACCTACGAGCAGTACTTCGGGCCG	CASSQGIGQTYEQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	8	0	2	5	3	26	42	51	47	54		TCRBV03-01,TCRBV03-02												CASSQGIGQTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAGAGTGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSATRVGSSYEQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	2	0	8	0	26	36	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSATRVGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTTCGGGGGGCAGTCGGTGAACACTGAAGCTTTCTTTGGACAA	CSARGFGGQSVNTEAFF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	0	4	7	26	39	50	43	57		TCRBV20-01,TCRBV20-or09_02												CSARGFGGQSVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTTGAGCCCCCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	59	5.410312606028372E-4		43	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	7	2	4	5	22	34	41	38	46		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTGGGCGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFWADSSYEQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	0	8	0	24	36	-1	44	50		TCRBV24-01,TCRBV24-or09_02												CASSFWADSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCACGGACTAGCTTGGGAGACCCAGTACTTCGGGCCA	CASSHGLAWETQYF	In	VDJ	2	60	5.50201281968987E-4	6.425565182004134E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	7	5	3	4	26	38	49	41	53		TCRBV12-03,TCRBV12-04				01,02								CASSHGLAWETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCATTGGAGCGGATAGCACAGATACGCAGTATTTTGGCCCA	CASSLIGADSTDTQYF	In	VDJ	2	60	5.50201281968987E-4	6.425565182004134E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	5	0	7	2	26	39	51	46	53		TCRBV03-01,TCRBV03-02				01,02								CASSLIGADSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTCAGTCCCTGTCAACTTTCTTTGGACAA		Out	VDJ	2	61	5.593713033351368E-4		41	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	12	3	10	26	43	49	46	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTCAAGCGGGAGGCTGGTATAATGAGCAGTTCTTCGGGCCA	CSARDLQAGGWYNEQFF	In	VDJ	2	61	5.593713033351368E-4	6.532657935037536E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	1	7	6	7	26	40	55	46	62		TCRBV20-01,TCRBV20-or09_02												CSARDLQAGGWYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCTCGGCGGATACGAGCAGTACTTCGGGCCG	CSARVLGGYEQYF	In	VDJ	2	61	5.593713033351368E-4	6.532657935037536E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	5	4	6	1	26	39	49	45	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVLGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTACAGGGGAAAGGAGGCGAGCAGTACTTCGGGCCG	CASSLQGKGGEQYF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	6	0	8	26	-1	47	41	55		TCRBV12-03,TCRBV12-04												CASSLQGKGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCGGGGAACAGGCAGCTACAATGAGCAGTTCTTCGGGCCA	CASSRGTGSYNEQFF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	4	3	4	3	5	3	23	36	46	41	49	TCRBV01,TCRBV23			TCRBD01,TCRBD02										CASSRGTGSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCCGGGCCAGCATTCTGTTTTTTGGCAGT	CASSQTRASILFF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	39	TCRBV03						TCRBJ01	TCRBJ01-04	01	2	8	0	14	4	7	26	41	49	45	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTRASILFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACCCAGGACAGGGGGTTTTGAAAAACTGTTTTTTGGCAGT	CSAREPRTGGFEKLFF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	1	7	5	3	26	40	55	45	58		TCRBV20-01,TCRBV20-or09_02												CSAREPRTGGFEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGGACAAGTCAATTACGAGCAGTACTTCGGGCCG	CSAEGQVNYEQYF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	4	2	7	26	35	43	37	50		TCRBV20-01,TCRBV20-or09_02												CSAEGQVNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTTACCCTGACTAGCGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	63	5.777113460674364E-4		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	3	4	0	26	41	-1	45	56	TCRBV09,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCTTCGGTTACTCAGGGAGAGGAGTCTACGAGCAGTACTTCGGGCCG	CASSQVFGYSGRGVYEQYF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	57	unresolved						TCRBJ02	TCRBJ02-07	01	1	4	3	3	12	8	23	39	56	51	64	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVFGYSGRGVYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCTGGTCGGGGGGTAGGAAAACTGTTTTTTGGCAGT	CASSHPGRGVGKLFF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	10	7	4	26	40	54	47	58		TCRBV03-01,TCRBV03-02												CASSHPGRGVGKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACTAGCGGGGTCCAAAAACATTCAGTACTTCGGCGCC	CSARDQLAGSKNIQYF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	3	3	2	3	1	26	40	53	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDQLAGSKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCAGGGGCTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPGAATNEKLFF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	0	1	3	18	30	37	31	40	TCRBV07,TCRBV11													CASSPGAATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAAGAGGGACTAGCGGGAGGGGGCCTTGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	63	5.777113460674364E-4		61	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	0	1	2	8	20	35	53	37	61	TCRBV04,TCRBV23													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACTTGATTACAATGAGCAGTTCTTCGGGCCA	CSAGLDYNEQFF	In	VDJ	2	64	5.868813674335861E-4	6.853936194137742E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	10	4	1	4	26	34	40	35	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGGACAGGGAGGTATGGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	65	5.960513887997359E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	6	1	9	26	40	50	41	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGGGACTAGTTGCTTACAATGAGCAGTTCTTCGGGCCA	CASSWGLVAYNEQFF	In	VDJ	2	65	5.960513887997359E-4	6.961028947171145E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	8	4	2	5	24	36	46	38	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSWGLVAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCCACTTTTCGAAACACTACGAGCAGTACTTCGGGCCG	CASSPHFSKHYEQYF	In	VDJ	2	65	5.960513887997359E-4	6.961028947171145E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	3	6	3	14	0	18	30	-1	44	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHFSKHYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGGATGGGTTACACTGAAGCTTTCTTTGGACAA	CSARGGMGYTEAFF	In	VDJ	2	66	6.052214101658857E-4	7.068121700204548E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	3	0	7	26	-1	44	37	51		TCRBV20-01,TCRBV20-or09_02												CSARGGMGYTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTAACCCGGGACAGGGAAACTATGGCTACACCTTCGGTTCG	CSASNPGQGNYGYTF	In	VDJ	2	67	6.143914315320355E-4	7.175214453237949E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	2	8	1	26	35	52	43	53		TCRBV20-01,TCRBV20-or09_02												CSASNPGQGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGACTAGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CSARDGLADTGELFF	In	VDJ	2	69	6.32731474264335E-4	7.389399959304753E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	1	5	3	1	0	26	40	-1	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGLADTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTACGGGAGTGACAACTACGAGCAGTACTTCGGGCCG	CSASYGSDNYEQYF	In	VDJ	2	69	6.32731474264335E-4	7.389399959304753E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	3	3	6	26	37	46	40	52		TCRBV20-01,TCRBV20-or09_02												CSASYGSDNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCATAGGACTAGCGGGGACGAGCAGTACTTCGGGCCG	CSAHRTSGDEQYF	In	VDJ	2	70	6.419014956304848E-4	7.496492712338156E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	5	5	0	26	34	-1	39	51		TCRBV20-01,TCRBV20-or09_02												CSAHRTSGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTAACTTGGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSLTWGYGEQYF	In	VDJ	2	70	6.419014956304848E-4	7.496492712338156E-4	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	6	1	6	8	5	24	35	48	43	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTWGYGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCGGGGACCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGDPYNEQFF	In	VDJ	2	70	6.419014956304848E-4	7.496492712338156E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	0	7	2	7	1	24	36	48	43	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGDPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGTCAGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLGQGTYEQYF	In	VDJ	2	70	6.419014956304848E-4	7.496492712338156E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	2	6	1	24	36	48	42	49		TCRBV24-01,TCRBV24-or09_02												CASSLGQGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCGGCCGGGACAGCGAATGAGCAGTTCTTCGGGCCA	CASSSAGTANEQFF	In	VDJ	2	71	6.510715169966346E-4	7.603585465371559E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	7	7	2	26	37	51	44	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSAGTANEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTACCCCCCCAGCGGGGTAACAGATACGCAGTATTTTGGCCCA	CASSPYPPSGVTDTQYF	In	VDJ	2	71	6.510715169966346E-4	7.603585465371559E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	3	11	2	26	39	57	50	59		TCRBV03-01,TCRBV03-02												CASSPYPPSGVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGCAGCAGGGGGCGTATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSDSQQGAYSGANVLTF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	57	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	0	1	7	4	24	38	53	45	57		TCRBV24-01,TCRBV24-or09_02												CATSDSQQGAYSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGGGCCTAGCGGTTACAATGAGCAGTTCTTCGGGCCA	CATGPSGYNEQFF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	4	5	4	5	1	24	32	44	37	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATGPSGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGGCTACTCCCCCTCTGGGCCAACGTCCTGACTTTCGGGGCC	CASSVGLLPLWANVLTF	In	VDJ	2	72	6.602415383627844E-4	7.71067821840496E-4	51	unresolved						TCRBJ02	TCRBJ02-06	01	0	9	0	5	0	12	23	-1	42	39	54	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGLLPLWANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGCTAGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSQEARVTGELFF	In	VDJ	2	77	7.060916451935333E-4	8.246141983571972E-4	45							TCRBJ02	TCRBJ02-02	01	0	5	3	4	4	1	18	35	43	39	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEARVTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCGGAGCGGGAGTTCTACCTACGAGCAGTACTTCGGGCCG	CASSRSGSSTYEQYF	In	VDJ	2	79	7.244316879258328E-4	8.460327489638776E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	2	4	5	22	33	45	37	50	TCRBV02,TCRBV12													CASSRSGSSTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTCAGGGGTTCCCCTCAGTTAGGCGAGCAGTACTTCGGGCCG	CSARVRGSPQLGEQYF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	6	3	15	26	37	46	40	61		TCRBV20-01,TCRBV20-or09_02												CSARVRGSPQLGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATATTCGGGGAAAAACTGTTTTTTGGCAGT	CSAIFGEKLFF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	8	4	0	26	36	-1	40	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIFGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAAACCGGGACAGTAGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	80	7.336017092919826E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	6	5	4	24	35	47	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCTTGGGACAGGTACCTACGAGCAGTACTTCGGGCCG	CASRLGTGTYEQYF	In	VDJ	2	81	7.427717306581324E-4	8.67451299570558E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	4	2	4	2	24	35	47	39	49		TCRBV24-01,TCRBV24-or09_02												CASRLGTGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCGACTCCGGGAGTTCAGATACGCAGTATTTTGGCCCA	CAIDSGSSDTQYF	In	VDJ	2	82	7.519417520242823E-4	8.781605748738983E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	2	4	5	2	24	33	44	38	46	TCRBV06,TCRBV10													CAIDSGSSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDRTSGANVLTF	In	VDJ	2	83	7.61111773390432E-4	8.888698501772385E-4	48	TCRBV03						TCRBJ02	TCRBJ02-06	01	0	1	7	0	2	0	26	43	-1	45	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRTSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATCCGGGACAGGGTCTACGAGCAGTACTTCGGGCCG	CSAIRDRVYEQYF	In	VDJ	2	84	7.702817947565818E-4	8.995791254805787E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	5	1	26	34	48	39	49		TCRBV20-01,TCRBV20-or09_02												CSAIRDRVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCGGGACGCCCTAAGGTACAATGAGCAGTTCTTCGGGCCA	CSARPRDALRYNEQFF	In	VDJ	2	85	7.794518161227316E-4	9.10288400783919E-4	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	0	7	4	4	9	26	38	47	42	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPRDALRYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCGGGAGAAGCTTAACTATGGCTACACCTTCGGTTCG	CASSPREKLNYGYTF	In	VDJ	2	86	7.886218374888814E-4	9.209976760872592E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	2	1	3	5	26	38	47	41	52		TCRBV12-03,TCRBV12-04												CASSPREKLNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGACTACAATGAGCAGTTCTTCGGGCCA	CSAGLDYNEQFF	In	VDJ	2	86	7.886218374888814E-4	9.209976760872592E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	8	3	0	1	26	-1	42	35	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCTACTCTGGGAGTAATGAAAAACTGTTTTTTGGCAGT	CASYSGSNEKLFF	In	VDJ	2	86	7.886218374888814E-4	9.209976760872592E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	9	2	4	6	0	22	31	-1	37	42		TCRBV12-03,TCRBV12-04												CASYSGSNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*02	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGGACAGGGGTATTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	87	7.977918588550311E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	4	2	3	26	39	51	41	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGGCTTCCGGGAACTACGAGCAGTACTTCGGGCCG	CASSLGASGNYEQYF	In	VDJ	2	87	7.977918588550311E-4	9.317069513905994E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	6	0	3	2	9	24	36	44	38	53		TCRBV24-01,TCRBV24-or09_02												CASSLGASGNYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCTGGGACAGGGTTATGAGCAGTTCTTCGGGCCA	CASSLGQGYEQFF	In	VDJ	2	88	8.069618802211809E-4	9.424162266939396E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	2	2	23	35	46	37	48	TCRBV24,TCRBV27													CASSLGQGYEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGGCGGGAGGCCTCCCTACGAGCAGTACTTCGGGCCG	CASSQEGGRPPYEQYF	In	VDJ	2	90	8.253019229534805E-4	9.6383477730062E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	1	2	2	4	23	40	50	42	54	TCRBV01,TCRBV04													CASSQEGGRPPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTATAGGATAGACGGGATCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	90	8.253019229534805E-4		52	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	3	2	10	3	24	41	56	51	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTAGCGCGTATCTGGGTTCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	90	8.253019229534805E-4		49							TCRBJ02	TCRBJ02-03	01	0	0	9	5	8	5	18	35	46	43	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03			TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGGGTGGAGGGGGCGGCTTTCTTTGGACAA	CASSPPGVEGAAFF	In	VDJ	3	91	8.344719443196302E-4	9.745440526039603E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	11	12	1	26	39	58	51	59		TCRBV03-01,TCRBV03-02												CASSPPGVEGAAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTAGCGGGAGTGGGGTGAGCAGTTCTTCGGGCCA	CSARD*REWGEQFF	Stop	VDJ	3	92	8.4364196568578E-4		42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	2	9	0	5	26	-1	50	40	55		TCRBV20-01,TCRBV20-or09_02												CSARD*REWGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGGACCTCTTCTCCTACGAGCAGTACTTCGGGCCG	CASSSDLFSYEQYF	In	VDJ	3	94	8.619820084180796E-4	0.001006671878513981	42	unresolved						TCRBJ02	TCRBJ02-07	01	4	1	7	0	1	5	18	31	36	32	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDLFSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCTCTGCCAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	95	8.711520297842294E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	2	7	0	26	42	-1	49	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTCGACTACTCCCCTGGTGAGCAGTTCTTCGGGCCA	CASSVDYSPGEQFF	In	VDJ	3	95	8.711520297842294E-4	0.0010173811538173212	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	9	9	2	9	23	36	43	38	52	TCRBV02,TCRBV12					01,02								CASSVDYSPGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGACGGCAACGATCTCCCCCATGAGCAGTTCTTCGGGCCA	CASSQDGNDLPHEQFF	In	VDJ	3	96	8.803220511503792E-4	0.0010280904291206615	48	unresolved						TCRBJ02	TCRBJ02-01	01	0	9	0	8	1	13	23	40	44	41	57	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGNDLPHEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGAGACAGGGGTGGACGGCTACACCTTCGGTTCG	CASSRETGVDGYTF	In	VDJ	3	99	9.078321152488285E-4	0.001060218255030682	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	8	4	5	26	39	51	43	56		TCRBV03-01,TCRBV03-02												CASSRETGVDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGCGCCCGACAGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CSARDRARQGGANVLTF	In	VDJ	3	101	9.261721579811281E-4	0.0010816368056373626	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	2	3	4	8	1	26	40	55	48	56		TCRBV20-01,TCRBV20-or09_02												CSARDRARQGGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAACCTCTAGCGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	101	9.261721579811281E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	6	0	6	4	26	35	47	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTTAGTTGGGGGGTGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	101	9.261721579811281E-4		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	1	1	7	2	23	35	48	42	50	TCRBV06,TCRBV10													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAAGCACTAGCGGGGGTAACAATGAGCAGTTCTTCGGGCCA	CASSLSTSGGNNEQFF	In	VDJ	3	101	9.261721579811281E-4	0.0010816368056373626	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	2	5	3	2	18	33	47	36	49	TCRBV07,TCRBV11													CASSLSTSGGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAACGGGGGTTTGATCAGCCCCAGCATTTTGGTGAT	CSAQRGFDQPQHF	In	VDJ	3	102	9.353421793472778E-4	0.0010923460809407028	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	2	5	3	4	26	35	44	38	48		TCRBV20-01,TCRBV20-or09_02												CSAQRGFDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCAGGCAGGGGGTCGTTCCTACGAGCAGTACTTCGGGCCG	CASSRQAGGRSYEQYF	In	VDJ	3	103	9.445122007134276E-4	0.0011030553562440429	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	1	1	6	4	26	39	52	45	56		TCRBV03-01,TCRBV03-02												CASSRQAGGRSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGGAGTCGGTGATACGCAGTATTTTGGCCCA	CSARVGVGDTQYF	In	VDJ	3	104	9.536822220795775E-4	0.0011137646315473831	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	2	6	2	5	26	39	45	41	50		TCRBV20-01,TCRBV20-or09_02												CSARVGVGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCAGGGACAAAATGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	104	9.536822220795775E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	6	1	3	4	24	41	50	44	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGATTTGCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	107	9.81192286178027E-4		41	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	1	8	2	2	6	26	37	42	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTACTTGACAGGGTCAATACGCAGTATTTTGGCCCA	CASSLLDRVNTQYF	In	VDJ	3	109	9.995323289103263E-4	0.0011673110080640842	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	7	6	3	24	36	49	42	52	TCRBV24,TCRBV27													CASSLLDRVNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCCGGGGACAGGGGGAACTCAGCCCCAGCATTTTGGTGAT	CASSPGTGGTQPQHF	In	VDJ	3	112	0.0010270423930087756	0.001199438833974105	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	1	6	4	3	20	31	46	35	49	TCRBV01,TCRBV23													CASSPGTGGTQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGAGCACAGGGATGGACTGAAGCTTTCTTTGGACAA	CASRGAQGWTEAFF	In	VDJ	3	113	0.0010362124143749255	0.0012101481092774452	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	6	4	26	37	49	43	53		TCRBV03-01,TCRBV03-02												CASRGAQGWTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCCGTACTCGCGGGCGGAGATACGCAGTATTTTGGCCCA	CASSPVLAGGDTQYF	In	VDJ	3	113	0.0010362124143749255	0.0012101481092774452	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	4	5	9	3	23	35	49	44	52	TCRBV24,TCRBV27					01,02								CASSPVLAGGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCCCCGGGACAGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	114	0.0010453824357410752		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	2	7	1	26	37	51	44	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGACCCCTACGGGGGGCTCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	114	0.0010453824357410752		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	9	8	1	0	7	2	18	26	40	33	42	TCRBV07,TCRBV11,TCRBV12													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCCCATAGCGGGCACACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	116	0.0010637224784733749		49	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	4	2	9	4	24	36	52	45	56		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGACTAGCCAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	117	0.0010728924998395246		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	7	4	1	3	26	39	48	40	51		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATAAAGGACGCGGGAGATACGCAGTATTTTGGCCCA	CSAIKDAGDTQYF	In	VDJ	3	117	0.0010728924998395246	0.001252985210490806	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	7	4	5	10	0	26	34	-1	44	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIKDAGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGAAGGGACAGGTTACAATGAGCAGTTCTTCGGGCCA	CASSEEGTGYNEQFF	In	VDJ	3	121	0.0011095725853041238	0.001295822311704167	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	4	6	1	22	34	48	40	49		TCRBV12-03,TCRBV12-04												CASSEEGTGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGGTAGCGGGAGGGCCGGAAGATTCTTCGGGCCA	CASSEGSGRAGRFF	In	VDJ	3	124	0.0011370826494025731	0.0013279501376141877	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	16	5	8	22	34	50	39	58	TCRBV02,TCRBV12													CASSEGSGRAGRFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCACAGGGGGCGCTCCTACGAGCAGTACTTCGGGCCG	CASSQDHRGRSYEQYF	In	VDJ	3	125	0.0011462526707687228	0.001338659412917528	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	0	0	2	1	23	40	51	42	52	TCRBV01,TCRBV04													CASSQDHRGRSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCTCCGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARELRGSGANVLTF	In	VDJ	4	129	0.001182932756233322	0.0013814965141308888	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	8	3	0	4	0	26	40	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSARELRGSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACAACTACACGCATGAAGGGGAACACTGAAGCTTTCTTTGGACAA	CATTTRMKGNTEAFF	In	VDJ	4	129	0.001182932756233322	0.0013814965141308888	45	unresolved						TCRBJ01	TCRBJ01-01	01	10	5	3	1	15	0	23	30	-1	45	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATTTRMKGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGGATGGGGGACAGGGGGCGTTAACACTGAAGCTTTCTTTGGACAA	CSARGWGTGGVNTEAFF	In	VDJ	4	130	0.0011921027775994718	0.001392205789434229	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	0	2	5	3	26	39	56	44	59		TCRBV20-01,TCRBV20-or09_02												CSARGWGTGGVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGTCCGCGGGACTGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	133	0.0012196128416979211		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	10	3	6	2	26	31	43	37	45		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTTGGACTAGCGGGAGTAACGAGCAGTACTTCGGGCCG	CASSWTSGSNEQYF	In	VDJ	4	135	0.0012379528844302207	0.00144575216595093	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	2	5	1	2	23	35	49	36	51	TCRBV02,TCRBV09													CASSWTSGSNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCGGGACTAGCGGGATCAATGAGCAGTTCTTCGGGCCA	CASSSGTSGINEQFF	In	VDJ	4	138	0.00126546294852867	0.0014778799918609507	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	3	6	2	1	18	31	46	33	47	TCRBV07,TCRBV11													CASSSGTSGINEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAATCGACGACAATCAGCCCCAGCATTTTGGTGAT	CASSQIDDNQPQHF	In	VDJ	4	142	0.001302143033993269	0.0015207170930743117	42	unresolved						TCRBJ01	TCRBJ01-05	01	2	2	7	3	3	2	23	38	44	41	46	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQIDDNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCGCCTGGGACAGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	143	0.001311313055359419		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	4	3	7	1	26	43	58	50	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGGGGGAAGAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	4	144	0.0013204830767255687		46	unresolved						TCRBJ01	TCRBJ01-02	01	0	6	1	4	1	7	23	40	46	41	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGCGGACCATAATGAAAAACTGTTTTTTGGCAGT	CASSPADHNEKLFF	In	VDJ	4	145	0.0013296530980917186	0.0015528449189843323	42	TCRBV24						TCRBJ01	TCRBJ01-04	01	7	1	7	4	6	2	24	35	45	41	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPADHNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACCCTGGGCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDPGLSNQPQHF	In	VDJ	4	155	0.0014213533117532163	0.0016599376720177346	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	1	7	0	0	8	26	-1	41	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPGLSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCTCAGGGCTGGATCGATCGATGAGCAGTTCTTCGGGCCA	CSARLRAGSIDEQFF	In	VDJ	5	169	0.0015497336108793132	0.0018098675262644976	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	8	3	12	26	37	45	40	57		TCRBV20-01,TCRBV20-or09_02												CSARLRAGSIDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCACCGGGAGCGCAGATACGCAGTATTTTGGCCCA	CASSFTGSADTQYF	In	VDJ	5	177	0.0016230937818085115	0.0018955417286912195	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	2	4	3	2	26	40	49	43	51		TCRBV12-03,TCRBV12-04												CASSFTGSADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATACCCGGCCTCGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	179	0.0016414338245408111		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	5	12	0	26	38	-1	50	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAACTTCCGGAGCAATGGGCAAGAGACCCAGTACTTCGGGCCA	CASNFRSNGQETQYF	In	VDJ	5	187	0.0017147939954700094	0.0020026344817246217	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	10	2	2	6	7	23	33	43	39	50	TCRBV06,TCRBV10													CASNFRSNGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTAGACAGGGTCAGAACTACGAGCAGTACTTCGGGCCG	CASSPRQGQNYEQYF	In	VDJ	5	189	0.001733134038202309	0.002024053032331302	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	3	4	6	24	36	47	40	53		TCRBV24-01,TCRBV24-or09_02												CASSPRQGQNYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTGTTAGCGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLLAGGSYEQYF	In	VDJ	5	190	0.0017423040595684587	0.0020347623076346424	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	1	0	2	0	36	50	-1	52	62	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												CASSLLAGGSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAAGCGGGAGAGAGAGACCCAGTACTTCGGGCCA	CASSRKRERETQYF	In	VDJ	6	200	0.0018340042732299566	0.0021418550606680446	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	6	2	4	3	2	26	39	50	42	52		TCRBV03-01,TCRBV03-02												CASSRKRERETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCACCTGGGGAAGAGTGGATACGCAGTATTTTGGCCCA	CASSPTWGRVDTQYF	In	VDJ	6	211	0.0019348745082576042	0.002259657089004787	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	0	8	6	8	6	24	36	48	44	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTWGRVDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGCCGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSLAGPGELFF	In	VDJ	6	215	0.0019715545937222033	0.002302494190218148	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	8	0	6	5	0	26	39	-1	44	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGPGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGATTTAGCGGGAGTAGCTTTCTTTGGACAA	CASSLDLAGVAFF	In	VDJ	6	228	0.0020907648714821505	0.002441714769161571	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	5	2	10	6	1	22	35	50	41	51	TCRBV07,TCRBV11													CASSLDLAGVAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGCTATCTGCAGGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSLGLSAGVNEKLFF	In	VDJ	7	240	0.002200805127875948	0.0025702260728016537	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	2	4	9	1	18	34	49	43	50	TCRBV07,TCRBV11													CASSLGLSAGVNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCGTACAGCGGGAGTTGTGAAAGATGTCTTCGGGCCA		Out	VDJ	7	263	0.002411715619297393		44				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	17	5	12	18	32	45	37	57	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAAGGGCAGGGATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASKGRDYSNQPQHF	In	VDJ	8	277	0.00254009591842349	0.0029664692590252416	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	3	0	4	4	22	32	41	36	45	TCRBV02,TCRBV12													CASKGRDYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCTTTAAAATGACAGAACTCTACGAGCAGTACTTCGGGCCG	CSARDPFKMTELYEQYF	In	VDJ	8	299	0.0027418363884787853	0.003202073315698727	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	5	3	12	4	26	40	57	52	61		TCRBV20-01,TCRBV20-or09_02												CSARDPFKMTELYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAACCGGGGGAGCAATGAGCAGTTCTTCGGGCCA	CASNRGSNEQFF	In	VDJ	9	323	0.00296191690126638	0.003459095922978892	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	8	2	6	5	2	24	31	42	36	44		TCRBV24-01,TCRBV24-or09_02												CASNRGSNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCCGGGACAGGGCCAACGAGCAGTACTTCGGGCCG	CASSPRDRANEQYF	In	VDJ	9	337	0.003090297200392477	0.003609025777225655	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	5	4	3	18	30	43	34	46	TCRBV07,TCRBV11													CASSPRDRANEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCTTCTTGATGGCGGGACCGGTTCTTCGGGCCA		Out	VDJ	11	399	0.0036588385250937634		44				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	3	15	11	3	18	35	52	46	55	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAACCCTCGGGACATCTCACACTGAAGCTTTCTTTGGACAA	CASRTLGTSHTEAFF	In	VDJ	11	414	0.00379638884558601	0.004433639975582852	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	3	7	4	26	37	50	44	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRTLGTSHTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGTCCCCCCTAATAGGTCTCCGGGGACAGATACGCAGTATTTTGGCCCA	CAVPPNRSPGTDTQYF	In	VDJ	12	438	0.004016469358373605	0.004690662582863017	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	8	3	3	19	0	24	30	-1	49	54		TCRBV24-01,TCRBV24-or09_02												CAVPPNRSPGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGCGGGATATCAATGAGCAGTTCTTCGGGCCA	CATSEGRDINEQFF	In	VDJ	15	536	0.004915131452256284	0.005740171562590359	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	6	3	3	24	38	47	41	50		TCRBV24-01,TCRBV24-or09_02												CATSEGRDINEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCACGAGGGGACTACTATGGCTACACCTTCGGTTCG		Out	VDJ	16	593	0.005437822670126821		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	0	10	3	7	0	26	39	-1	46	52		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAGGGGGTTGGAGGGCATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGVGGHSNQPQHF	In	VDJ	18	641	0.005877983695702011	0.006864645469441083	51	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	3	10	0	0	7	2	23	37	50	44	52	TCRBV01,TCRBV23			TCRBD01,TCRBD02										CASSQGVGGHSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACCGGGACAGGGGGCTAATGAGCAGTTCTTCGGGCCA	CASSEPGQGANEQFF	In	VDJ	18	654	0.005997193973461958	0.007003866048384506	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	7	6	1	23	34	52	40	53	TCRBV02,TCRBV09													CASSEPGQGANEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGCTTGGGACGCCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSAWDASSYEQYF	In	VDJ	30	1095	0.010041173395934012	0.011726656457157545	45	unresolved						TCRBJ02	TCRBJ02-07	01	4	0	7	0	3	5	23	36	44	39	49	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAWDASSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGCTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSQELAGYNEQFF	In	VDJ	47	1683	0.015433145959230085	0.018023710335521595	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	4	1	0	23	40	-1	41	50	TCRBV01,TCRBV04													CASSQELAGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAGGGGATTAGCGGGATCGTTGCAGATACGCAGTATTTTGGCCCA	CASSQGISGIVADTQYF	In	VDJ	120	4341	0.03980706275045621	0.04648896409179991	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	3	4	9	6	20	31	48	40	54	TCRBV01,TCRBV23													CASSQGISGIVADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGTTAGCGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLLAGGSYEQYF	In	VDJ	153	5515	0.050572667834316055	0.05906165329792133	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	1	0	4	0	24	36	-1	40	50		TCRBV24-01,TCRBV24-or09_02												CASSLLAGGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGCCGCCCTGGACGAACACTGAAGCTTTCTTTGGACAA	CASRGPPWTNTEAFF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	7	0	1	0	10	23	-1	39	34	49														CASRGPPWTNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATGGGGTGAGTACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	9.170021366149783E-5		44	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	6	2	5	2	5	23	38	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACGGCCAGGGCTGGAAACACCATATATTTTGGAGAG	CASSYSTARAGNTIYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	2	6	0	23	40	-1	46	51														CASSYSTARAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGGCACCCCTCACAACAGATACGCAGTATTTTGGCCCA	CAISGAPLTTDTQYF	In	VDJ	1	10	9.170021366149783E-5	1.0709275303340223E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	3	0	10	23	-1	40	35	50														CAISGAPLTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCACACGTTGAACCGGGACAGGGTATCCAGATACGCAGTATTTTGGCCCA	CATTR*TGTGYPDTQYF	Stop	VDJ	1	11	1.0087023502764761E-4		51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	0	3	4	14	4	23	30	53	44	57														CATTR*TGTGYPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCCGGGACAGGGGGATTTGAAGCTTTCTTTGGACAA	CASSYSGTGGFEAFF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	7	4	3	23	37	52	41	55														CASSYSGTGGFEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCCCAGGGTGGCGGGAGTGGTGCAGATACGCAGTATTTTGGCCCA	CASSAQGGGSGADTQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	7	2	4	11	5	23	34	52	45	57														CASSAQGGGSGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCGGGGGCCGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.100402563937974E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	6	0	8	1	4	23	40	47	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCCGAGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSYSPEGGETQYF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	7	4	5	8	0	23	40	-1	48	53						01,02								CASSYSPEGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAATCCTTGGCACTTCTGACTATGGCTACACCTTCGGTTCG	CASKILGTSDYGYTF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	9	0	3	8	7	23	33	44	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKILGTSDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGGAGTAACTATGGCTACACCTTCGGTTCG	CASKGSNYGYTF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	5	2	1	0	2	23	-1	38	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKGSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGGGACAGGGGTTGGGAGCAGTACTTCGGGCCG	CASSDWDRGWEQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	2	7	0	4	23	-1	49	39	53														CASSDWDRGWEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATCCTTGAAACAGAGATCTATGGCTACACCTTCGGTTCG	CASSYSILETEIYGYTF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	4	10	4	23	40	54	50	58														CASSYSILETEIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGCTGAGTGGCCCGCGTGAGACCCAGTACTTCGGGCCA	CASSYWLSGPRETQYF	In	VDJ	1	13	1.1921027775994718E-4	1.392205789434229E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	1	9	0	5	0	14	23	-1	42	39	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWLSGPRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGATCAGCCCCAGCATTTTGGTGAT	CASSYADQPQHF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	7	5	5	0	0	23	-1	-1	38	42						01,02								CASSYADQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGAACTGGGACAGCTACGAGCAGTACTTCGGGCCG	CASSLNWDSYEQYF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	3	6	0	23	36	-1	42	49														CASSLNWDSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGCGCCAGGAATCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	1.2838029912609695E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	4	4	5	5	23	32	41	37	46														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGGAGGGACAGCACTTACACCGGGGAGCTGTTTTTTGGAGAA	CASWRDSTYTGELFF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	3	4	5	23	32	43	36	48														CASWRDSTYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACCAGGACAGGGGACTGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDQDRGLSNTGELFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	2	0	6	5	23	34	49	40	54														CASSDQDRGLSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCTTCCGACTAGCGGGAGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSPLPTSGRVYNEQFF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	0	3	8	1	23	35	57	43	58														CASSPLPTSGRVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGAAACACCATATATTTTGGAGAG	CASSYGGNTIYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	2	0	9	4	0	0	23	-1	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTYTGATCATTAATCCAAGGGACACACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	1.3755032049224674E-4		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	3	15	1	23	36	57	51	58														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCGACCGGGACAGATACTACGAGCAGTACTTCGGGCCG	CAITDRDRYYEQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	5	3	9	3	23	30	46	39	49														CAITDRDRYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAATGACAGGGTAGGGATCTACACCTTCGGTTCG	CASTNDRVGIYTF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	3	10	5	7	23	33	45	38	52														CASTNDRVGIYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGAGCGTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	16	1.4672034185839652E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	6	6	0	2	1	23	37	43	39	44						01,02								X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAACAGGGACCTACGAGCAGTACTTCGGGCCG	CASSRTGTYEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	2	3	1	23	35	44	38	45														CASSRTGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATATAAGGCCGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.558903632245463E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	5	4	2	6	5	23	35	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCATCGACTCCGCGCCACTACGAGCAGTACTTCGGGCCG	CASASTPRHYEQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	2	10	3	5	8	23	32	41	37	49						01,02								CASASTPRHYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACAGCTACCTTTGGCCCCAGCATTTTGGTGAT	CASNSYLWPQHF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	5	9	0	9	23	-1	37	33	46														CASNSYLWPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGCCCGGGGACTAGCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASRARGLAVTGELFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	5	4	6	1	23	34	51	40	52						01,02								CASRARGLAVTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGGGGCTCACAGGGCTTACAAATGAGCAGTTCTTCGGGCCA	CASSLGLTGLTNEQFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	7	9	6	23	35	50	44	56														CASSLGLTGLTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGGGTGAACGAGGAGACCCAGTACTTCGGGCCA	CASSYDRVNEETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	3	5	0	8	23	-1	45	38	53														CASSYDRVNEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGCGACACCGGACTACCAAGAGACCCAGTACTTCGGGCCA	CASSYSATPDYQETQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	1	10	0	9	0	23	40	-1	49	54						01,02								CASSYSATPDYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGACAGAGGATTCCTACGAGCAGTACTTCGGGCCG	CASSWTEDSYEQYF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	1	0	5	23	-1	42	36	47														CASSWTEDSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCTGGGACAGCCAGGCAGATGGCTACACCTTCGGTTCG	CAISVWDSQADGYTF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	6	4	8	23	35	46	39	54														CAISVWDSQADGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCCCGGGCCCCAATGAGCAGTTCTTCGGGCCA	CASSRPGPNEQFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	8	0	6	6	2	23	34	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPGPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGAGACAGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVETGNTGELFF	In	VDJ	1	19	1.7423040595684587E-4	2.0347623076346423E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	4	2	5	1	23	35	46	40	47														CASSVETGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGACTAGCGGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSRLAGTQETQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	1	1	2	23	35	47	36	49														CASSRLAGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCCAGGGGGGTCTCACTGAAGCTTTCTTTGGACAA	CASSVQGGLTEAFF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	3	4	23	35	45	38	49														CASSVQGGLTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGACGGGGAGCAGTACTTCGGGCCG	CASSYLDGEQYF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	1	7	7	2	3	23	38	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLDGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGACAGGTCTTTGGCCAGCCCCAGCATTTTGGTGAT	CASSSRQVFGQPQHF	In	VDJ	1	20	1.8340042732299566E-4	2.1418550606680447E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	4	7	3	8	23	36	45	39	53														CASSSRQVFGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATGGGTCTACAAGAGACCCAGTACTTCGGGCCA	CASSYMGLQETQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	0	9	2	2	4	23	38	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYMGLQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGCTAGCGGGAGGATACGAGCAGTACTTCGGGCCG	CASSYVLAGGYEQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	1	4	3	1	23	38	52	41	53														CASSYVLAGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGTGCAGGGCAATGCTAACTATGGCTACACCTTCGGTTCG	CASSLVQGNANYGYTF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	0	5	5	23	36	46	41	51														CASSLVQGNANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGTCTGGGGGCCCTATGGCTACACCTTCGGTTCG	CASSFVWGPYGYTF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	4	6	1	23	36	48	42	49														CASSFVWGPYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAGGGCTAGCGGTTAAGAGACCCAGTACTTCGGGCCA	CATRASG*ETQYF	Stop	VDJ	1	23	2.10910491421445E-4		39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	5	3	2	2	23	34	43	36	45						01,02								CATRASG*ETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAGGACAGCTCGGCACAGATACGCAGTATTTTGGCCCA	CASSPGQLGTDTQYF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	1	4	4	23	34	44	38	48														CASSPGQLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGTGACAGGGGATACACTGAAGCTTTCTTTGGACAA	CASSRDRGYTEAFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	3	4	2	23	34	46	38	48														CASSRDRGYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGATGGGGTAGCATGAACACTGAAGCTTTCTTTGGACAA	CASRGWGSMNTEAFF	In	VDJ	1	23	2.10910491421445E-4	2.463133319768251E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	0	8	0	0	10	23	-1	38	34	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGWGSMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCACTGTGGTTGGGGAAGGCTACACCTTCGGTTCG	CASSPTVVGEGYTF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	8	8	13	1	23	35	52	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTVVGEGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGTACTTTCCTTTACAGGGGTCGAGCAGTACTTCGGGCCG	CASSVVLSFTGVEQYF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	6	15	1	23	35	57	50	58														CASSVVLSFTGVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCAAAGTCTAGGACCCCTGGCGACCGGGGAGCTGTTTTTTGGAGAA	CASSFQSLGPLATGELFF	In	VDJ	1	24	2.200805127875948E-4	2.5702260728016537E-4	54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	4	1	7	5	11	8	23	36	51	47	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQSLGPLATGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAACAGGGGGCAGATTTACAATGAGCAGTTCTTCGGGCCA	CASRNRGQIYNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	0	4	2	5	23	34	45	36	50														CASRNRGQIYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACGGGACAGTCCGTGAAAAACTGTTTTTTGGCAGT	CASRDGTVREKLFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	7	4	4	23	34	45	38	49														CASRDGTVREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTAGGAGCCGTGGGGACAATGAGCAGTTCTTCGGGCCA	CASSYFRSRGDNEQFF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	1	6	2	5	11	0	23	39	-1	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYFRSRGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGAGGGACAGGTACATCTCCTACGAGCAGTACTTCGGGCCG	CASMRDRYISYEQYF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	4	0	3	5	23	33	44	36	49														CASMRDRYISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAAACTCCTAGCGGGAGGGCAGGATACGCAGTATTTTGGCCCA	CASKLLAGGQDTQYF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	4	0	6	5	3	23	33	50	38	53														CASKLLAGGQDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCCCCCCCTCCGGGGACCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	2.3842055551989436E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	8	0	7	5	13	2	23	32	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACAGGGGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSRQGGSYEQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	1	1	2	23	35	45	36	47														CASSRQGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTCCTCCGGCCGAGACCCAGTACTTCGGGCCA	CASSRPPAETQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	9	0	5	8	1	23	35	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPPAETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCAGGGAGATCAGCCCCAGCATTTTGGTGAT	CASSYSQGDQPQHF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	4	3	5	1	2	23	40	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSQGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCCAGCGGGAGGCTTACGAGCAGTACTTCGGGCCG	CASSSQREAYEQYF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	1	4	4	2	23	35	48	39	50														CASSSQREAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGCTGGCAGTACAATCAGCCCCAGCATTTTGGTGAT	CASSYSSWQYNQPQHF	In	VDJ	1	28	2.567605982521939E-4	2.9985970849352625E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	4	5	3	7	2	23	40	50	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSWQYNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACAGTACAGAATGAACACTGAAACTTTCTTTGGACAA	CASSYGQYRMNTETFF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	12	0	19	23	-1	44	38	63														CASSYGQYRMNTETFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATATGTGGACAGGGGGGACCCACGAGCAGTACTTCGGGCCG	CASSYMWTGGTHEQYF	In	VDJ	1	29	2.659306196183437E-4	3.1056898379686645E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	1	5	5	5	23	37	52	42	57														CASSYMWTGGTHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCAACCACGGGGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	2.659306196183437E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	3	3	7	1	23	33	45	40	46														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGDSNQPQHF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	0	7	1	1	0	23	35	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATACTAGAGTTGTCACTATACGCAGTATTTTGGCCCA	CASS*Y*SCHYTQYF	Stop	VDJ	1	30	2.751006409844935E-4		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	8	7	2	10	23	37	44	39	54						01,02								CASS*Y*SCHYTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAAACCGGACAGGGTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSYQTGQGSSYEQYF	In	VDJ	1	30	2.751006409844935E-4	3.212782591002067E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	0	6	3	23	38	52	44	55														CASSYQTGQGSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCACCAGGGGTCGGGAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	30	2.751006409844935E-4		50	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	2	4	2	4	4	7	23	38	48	42	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCTGACGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFLTGNTEAFF	In	VDJ	1	31	2.842706623506433E-4	3.319875344035469E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	1	6	0	23	36	-1	42	46						01,02								CASSFLTGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGGCCAACAGAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	2.9344068371679304E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	3	5	5	7	2	23	40	51	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAATAGCCCCAATCAGCCCCAGCATTTTGGTGAT	CASSYSNSPNQPQHF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	7	3	3	2	23	40	47	43	49						01,02								CASSYSNSPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAAAACGACAGGCCCTCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	2.9344068371679304E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	2	4	1	6	6	23	32	44	38	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGGGACTAGCTACCAACGAGCAGTACTTCGGGCCG	CASEGLATNEQYF	In	VDJ	1	32	2.9344068371679304E-4	3.426968097068871E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	7	5	2	5	23	32	43	34	48						01,02								CASEGLATNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCTAGGGACAGACGAAACCGTACGAGCAGTACTTCGGGCCG	CASSG*GQTKPYEQYF	Stop	VDJ	1	34	3.117807264490926E-4		48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	4	5	9	23	35	47	40	56														CASSG*GQTKPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCTCTAGCGGGACTCGGGATGAGCAGTTCTTCGGGCCA	CASSVSSGTRDEQFF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	8	4	6	23	35	48	39	54														CASSVSSGTRDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACGATTGGGACTAGCGGGGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	3.117807264490926E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	0	3	0	8	1	23	30	51	38	52														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGCCAAGACTGGGTCGACTAGCGGGAGTAGCAATGAGCAGTTCTTCGGGCCA	CAIAKTGSTSGSSNEQFF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	2	2	6	16	3	23	30	58	46	61														CAIAKTGSTSGSSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTACGACAGGGGCCGGGGCAGATACGCAGTATTTTGGCCCA	CASSDSTTGAGADTQYF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	2	4	3	6	23	40	51	43	57														CASSDSTTGAGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATCAGTAGGAGCGAGCAGTACTTCGGGCCG	CASSYISRSEQYF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	6	7	0	23	38	-1	45	49														CASSYISRSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATTTCTATTCGGTTCTTCGGGCCA	CASSYSISIRFF	In	VDJ	1	35	3.209507478152424E-4	3.748246356169078E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	15	5	4	23	40	48	45	52						01,02								CASSYSISIRFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTTTAGTAAGTAACCAAAAACATTCAGTACTTCGGCGCC	CASSYL**VTKNIQYF	Stop	VDJ	1	36	3.301207691813922E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	5	8	2	3	7	23	38	44	41	51						01,02								CASSYL**VTKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCCATAGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	37	3.39290790547542E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	6	0	7	23	-1	44	40	51														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGCGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSVAESTDTQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	5	0	1	2	23	35	42	36	44						01,02								CASSVAESTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCTGGGGTGGTCCCAAAAACATTCAGTACTTCGGCGCC	CASSWGGPKNIQYF	In	VDJ	1	40	3.668008546459913E-4	4.2837101213360893E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	8	6	2	2	4	5	23	32	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGGPKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGCCTATCCTACGAGCAGTACTTCGGGCCG	CASSSSLSYEQYF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	4	5	1	1	4	23	36	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGAGGGTAGCGGGGGACAATGAGCAGTTCTTCGGGCCA	CASMRVAGDNEQFF	In	VDJ	1	41	3.7597087601214113E-4	4.3908028743694914E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	5	6	0	23	33	-1	39	48														CASMRVAGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGTTGGGACAAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	41	3.7597087601214113E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	3	4	2	23	34	44	38	46														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACGAGCGATATGGCTACACCTTCGGTTCG	CASSNERYGYTF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	6	5	4	1	23	35	43	39	44						01,02								CASSNERYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCCGGGACGCTTCCTACGAGCAGTACTTCGGGCCG	CASSSRDASYEQYF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	7	1	4	3	23	35	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRDASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAGGCCGCGGGAGGGTCTGAGCAGTTCTTCGGGCCA	CASQAAGGSEQFF	In	VDJ	1	43	3.943109187444407E-4	4.604988380436296E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	7	0	9	6	2	23	32	47	38	49														CASQAAGGSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGCTAGCGGAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	4.1265096147674027E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	2	3	2	23	40	50	43	52						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCCAGTTTCAGGACGGCTACGAGCAGTACTTCGGGCCG	CASSLQFQDGYEQYF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	1	7	3	11	2	23	35	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQFQDGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGGCAGGGGGACTATGGCTACACCTTCGGTTCG	CASSYSGQGDYGYTF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	3	4	0	23	40	-1	44	51														CASSYSGQGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGTCCAGGTGGGCACTGAAGCTTTCTTTGGACAA	CASSPVQVGTEAFF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	4	6	4	23	35	45	41	49														CASSPVQVGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGTTCGGTGCAAGGCTACACCTTCGGTTCG	CASRGSVQGYTF	In	VDJ	1	51	4.676710896736389E-4	5.461730404703514E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	0	9	8	0	10	23	-1	37	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGSVQGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGACCGAGGGAGGTATATGGCTACACCTTCGGTTCG	CAIGPREVYGYTF	In	VDJ	1	51	4.676710896736389E-4	5.461730404703514E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	9	1	5	9	2	23	30	45	39	47														CAIGPREVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTTTGACGTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	52	4.7684111103978873E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	2	7	0	5	2	23	34	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGTGGACTACAATGAGCAGTTCTTCGGGCCA	CASS*VDYNEQFF	Stop	VDJ	1	53	4.860111324059385E-4		39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	3	1	8	3	3	0	23	37	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*VDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATACTCAGGACCTACGAGCAGTACTTCGGGCCG	CASSILRTYEQYF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	4	2	6	1	23	34	44	40	45														CASSILRTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCAGGGGGCGAGGACCGAGCAGTACTTCGGGCCG		Out	VDJ	2	58	5.318612392366874E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	6	3	6	23	34	45	37	51														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGCGGGATACGAGCAGTACTTCGGGCCG	CASSPAGYEQYF	In	VDJ	2	61	5.593713033351368E-4	6.532657935037536E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	4	3	0	23	35	-1	38	44														CASSPAGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACGGGACAGGGGATAAAACTGTTTTTTGGCAGT	CASSYSTGQGIKLFF	In	VDJ	2	61	5.593713033351368E-4	6.532657935037536E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	2	10	3	2	23	40	53	43	55														CASSYSTGQGIKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTGATAGGGACAGGGGGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	2	62	5.685413247012866E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	0	5	7	1	23	36	55	43	56														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGCCGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	63	5.777113460674364E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	2	0	5	0	23	35	-1	40	44														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGGGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSYPGGNNEQFF	In	VDJ	2	65	5.960513887997359E-4	6.961028947171145E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	1	5	2	1	23	38	47	40	48														CASSYPGGNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCCCCCACGCGCGGGAGTAGGCCACGAGCAGTACTTCGGGCCG	CASPPRAGVGHEQYF	In	VDJ	2	65	5.960513887997359E-4	6.961028947171145E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	7	2	5	9	6	23	32	48	41	54														CASPPRAGVGHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTATAGCGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASRYSGASYEQYF	In	VDJ	2	67	6.143914315320355E-4	7.175214453237949E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	3	0	3	1	23	34	45	37	46														CASRYSGASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGACAGGGCCCCCCAAATGAGCAGTTCTTCGGGCCA	CASSPGQGPPNEQFF	In	VDJ	2	74	6.78581581095084E-4	7.924863724471765E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	7	2	7	23	35	46	37	53														CASSPGQGPPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAAGGAGCGGGAGAGACAGATACGCAGTATTTTGGCCCA	CASSKGAGETDTQYF	In	VDJ	2	82	7.519417520242823E-4	8.781605748738983E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	3	5	2	23	35	48	40	50														CASSKGAGETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTAGGCCCCGAGGGAAATGAGCAGTTCTTCGGGCCA	CASSYVGPEGNEQFF	In	VDJ	2	83	7.61111773390432E-4	8.888698501772385E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	7	9	1	23	38	52	47	53														CASSYVGPEGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCGGGACAGGGGGCGCAAACTGCCCTACGAGCAGTACTTCGGGCCG	CASSYTRDRGRKLPYEQYF	In	VDJ	2	85	7.794518161227316E-4	9.10288400783919E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	0	2	4	9	23	38	54	42	63														CASSYTRDRGRKLPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATCGGGGGCCGTTAGATACGCAGTATTTTGGCCCA	CASRDRGPLDTQYF	In	VDJ	2	90	8.253019229534805E-4	9.6383477730062E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	6	0	5	5	4	23	34	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDRGPLDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGAAGGACAGGGAGTTACGAGCAGTACTTCGGGCCG	CASSYRRTGSYEQYF	In	VDJ	3	99	9.078321152488285E-4	0.001060218255030682	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	4	4	3	23	38	50	42	53														CASSYRRTGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAAATCCGACAGGGACGGGGGAGCAGTACTTCGGGCCG	CASSYPNPTGTGEQYF	In	VDJ	3	103	9.445122007134276E-4	0.0011030553562440429	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	7	8	6	23	38	53	46	59														CASSYPNPTGTGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCCACAGGACTAGCGGGAGTGGGGCTTTTCAATGAGCAGTTCTTCGGGCCA	CAISSTGLAGVGLFNEQFF	In	VDJ	3	107	9.81192286178027E-4	0.001145892457457404	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	2	6	7	10	23	34	54	41	64														CAISSTGLAGVGLFNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAGGTGGGGGACTCCACACAGATACGCAGTATTTTGGCCCA	CASTGGGLHTDTQYF	In	VDJ	3	114	0.0010453824357410752	0.0012208573845807855	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	10	2	7	3	23	33	46	40	49						01,02								CASTGGGLHTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGACTAGCGGGAGTTTTTTTGAGGGCAATGAGCAGTTCTTCGGGCCA	CASSYWTSGSFFEGNEQFF	In	VDJ	3	116	0.0010637224784733749	0.0012422759351874658	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	2	6	0	12	23	-1	52	39	64														CASSYWTSGSFFEGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGACAAGGCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVDKANTGELFF	In	VDJ	4	129	0.001182932756233322	0.0013814965141308888	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	6	2	3	5	23	35	42	38	47														CASSVDKANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGCTTAGGGGCTTCCACTGAAGCTTTCTTTGGACAA	CASSDRLGASTEAFF	In	VDJ	4	131	0.0012012727989656215	0.0014029150647375693	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	4	8	4	23	35	48	43	52														CASSDRLGASTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGGACTACTTACAATGAGCAGTTCTTCGGGCCA	CASSAGTTYNEQFF	In	VDJ	5	171	0.0015680736536116129	0.0018312860768711782	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	4	3	2	23	35	45	38	47						01,02								CASSAGTTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSEVSYEQYF	In	VDJ	9	321	0.0029435768585340805	0.0034376773723722117	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	1	0	0	1	23	-1	39	35	40														CASSEVSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTAGCGGGTCGTACACAGATACGCAGTATTTTGGCCCA	CASSSSGSYTDTQYF	In	VDJ	15	541	0.0049609815590870325	0.005793717939107061	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	4	2	0	5	23	-1	44	36	49						01,02								CASSSSGSYTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGCCGGGACAGGGAAGGGTTGTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	63	2266	0.02077926841569541		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	4	4	9	23	36	49	40	58														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCGGGGGGGCTGCGGAGACCCAGTACTTCGGGCCA	CASSTGGAAETQYF	In	VDJ	1	11	1.0087023502764761E-4	1.1780202833674245E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	2	5	24	36	46	38	51													Vb 18	CASSTGGAAETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTCCGAGCGAGGATGAAGCTTTCTTTGGACAA	CASSPLPSEDEAFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	6	6	7	5	4	24	40	49	45	53						01,02							Vb 18	CASSPLPSEDEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAACGGTGGTTTTAATGAAAAACTGTTTTTTGGCAGT	CASSLNGGFNEKLFF	In	VDJ	1	12	1.100402563937974E-4	1.2851130364008269E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	5	4	4	6	24	37	44	41	50						01,02							Vb 18	CASSLNGGFNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGSNQPQHF	In	VDJ	1	14	1.2838029912609695E-4	1.4992985424676312E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	3	1	8	1	1	0	24	38	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGCGGGAGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSPQAGGLTDTQYF	In	VDJ	1	15	1.3755032049224674E-4	1.6063912955010336E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	0	2	2	2	24	40	51	42	53													Vb 18	CASSPQAGGLTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCGGCAGCGGTTCTGCCTACGAGCAGTACTTCGGGCCG	CASSTGSGSAYEQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	5	2	6	5	24	36	47	42	52						01,02							Vb 18	CASSTGSGSAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTAGCGGGATGACCTACGAGCAGTACTTCGGGCCG	CASSPPSGMTYEQYF	In	VDJ	1	16	1.4672034185839652E-4	1.7134840485344356E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	3	2	0	3	24	-1	49	41	52													Vb 18	CASSPPSGMTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGGGGCACAGATACGCAGTATTTTGGCCCA	CASSWGTDTQYF	In	VDJ	1	17	1.558903632245463E-4	1.820576801567838E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	5	0	9	1	1	0	24	36	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSWGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGTGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	1.650603845906961E-4		40	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	6	2	3	4	0	24	40	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACAGTAGCTATGGCTACACCTTCGGTTCG	CASSPDSSYGYTF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	4	0	3	24	-1	44	38	47													Vb 18	CASSPDSSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGGGGGCAACACTGAAGCTTTCTTTGGACAA	CASSLGGNTEAFF	In	VDJ	1	18	1.650603845906961E-4	1.92766955460124E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	2	1	0	24	37	-1	38	45													Vb 18	CASSLGGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPRGPYEQYF	In	VDJ	1	21	1.9257044868914544E-4	2.2489478137014467E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	0	2	0	0	24	-1	-1	39	46													Vb 18	CASSPRGPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGACAGGGGACTGAAGCTTTCTTTGGACAA	CASSPGQGTEAFF	In	VDJ	1	22	2.0174047005529523E-4	2.356040566734849E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	2	5	1	0	24	38	-1	39	48													Vb 18	CASSPGQGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTCGCCCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	2.10910491421445E-4		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	4	9	0	6	0	24	39	-1	45	48						01,02							Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGTTTAACTATGGCTACACCTTCGGTTCG	CASSPGFNYGYTF	In	VDJ	1	25	2.2925053415374458E-4	2.677318825835056E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	2	0	9	1	0	2	24	-1	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGFNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGACAGGGAGCGTTCTATGGCTACACCTTCGGTTCG	CASSPPGQGAFYGYTF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	4	0	6	24	-1	50	41	56													Vb 18	CASSPPGQGAFYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGCCCAGGGGAGGACTACGAGCAGTACTTCGGGCCG	CASSPRPGEDYEQYF	In	VDJ	1	27	2.4759057688604415E-4	2.8915043319018604E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	4	2	3	5	4	24	38	49	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRPGEDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCTGTGCCAGCTGACGACGGAGGGGACAGGGTTTATATCTCCCAACTCGGTTTTTGATGGCTACACCTTCGGTTCG		Out	VDJ	1	33	3.0261070508294286E-4		68	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	6	10	25	2	12	31	22	56													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTAGCGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSPLAGAYEQYF	In	VDJ	1	34	3.117807264490926E-4	3.641153603135676E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	2	1	0	24	38	-1	39	49													Vb 18	CASSPLAGAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGCGGGAGGGCTCCGAAATGAGCAGTTCTTCGGGCCA	CASSPPAGGLRNEQFF	In	VDJ	1	37	3.39290790547542E-4	3.9624318622358826E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	0	7	1	6	24	41	51	42	57													Vb 18	CASSPPAGGLRNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCTTGGACTTTAGCGGGAGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSPPWTLAGGPGELFF	In	VDJ	1	38	3.4846081191369175E-4	4.0695246152692847E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	5	0	6	11	1	24	38	60	49	61													Vb 18	CASSPPWTLAGGPGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTAGGGGGAGTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGGVGNTEAFF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	1	2	6	24	36	44	38	50													Vb 18	CASSLGGVGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGCCATTAGGGGGGTCGATGCTTTCTTTGGACAA	CASSAIRGVDAFF	In	VDJ	1	42	3.851408973782909E-4	4.4978956274028934E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	5	1	11	7	6	24	35	48	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSAIRGVDAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTAGATCACGTACGCGATGGCTACACCTTCGGTTCG	CASSLDHVRDGYTF	In	VDJ	1	46	4.2182098284289E-4	4.926266639536502E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	8	6	1	12	24	36	40	37	52						01,02							Vb 18	CASSLDHVRDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCTGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPSGRNTEAFF	In	VDJ	1	47	4.309910042090398E-4	5.033359392569905E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	2	1	4	0	24	38	-1	42	47													Vb 18	CASSPSGRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGACGATAGGGGGAACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	4.309910042090398E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	1	0	6	2	24	35	47	41	49													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGGTGGACTGAAGCTTTCTTTGGACAA	CASSPQGWTEAFF	In	VDJ	1	48	4.401610255751896E-4	5.140452145603307E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	5	0	3	24	-1	45	40	48													Vb 18	CASSPQGWTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGACAGGGAACGAGCAGTACTTCGGGCCG	CASSPTGNEQYF	In	VDJ	1	50	4.5850106830748916E-4	5.354637651670112E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	5	3	1	24	35	45	38	46													Vb 18	CASSPTGNEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGCGGGAGTCGCTACGAGCAGTACTTCGGGCCG	CASSPGGSRYEQYF	In	VDJ	1	52	4.7684111103978873E-4	5.568823157736916E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	2	3	1	3	24	39	47	40	50													Vb 18	CASSPGGSRYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTGGACTAGCCTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	52	4.7684111103978873E-4		37	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	7	9	2	1	24	37	47	39	48						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCTTATGGACAGGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	53	4.860111324059385E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	1	4	7	0	24	35	-1	42	52													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCGGCCCAGGGAGGGGAGCAGTACTTCGGGCCG	CASSAAQGGEQYF	In	VDJ	2	56	5.135211965043878E-4	5.997194169870525E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	7	8	0	24	36	-1	44	51													Vb 18	CASSAAQGGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGGGAGGGTTGGAGACCCAGTACTTCGGGCCA	CASSPPGGLETQYF	In	VDJ	2	57	5.226912178705376E-4	6.104286922903928E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	0	5	2	3	24	38	48	40	51													Vb 18	CASSPPGGLETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCTTCTTCCGGGACAGGGACCTACGAGCAGTACTTCGGGCCG	CASSASSGTGTYEQYF	In	VDJ	2	59	5.410312606028372E-4	6.318472428970732E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	9	1	24	36	54	45	55													Vb 18	CASSASSGTGTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACAGGGACAGGGGTTGCCGAAAATCAGCCCCAGCATTTTGGTGAT	CASSTGTGVAENQPQHF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	4	3	8	24	36	49	39	57													Vb 18	CASSTGTGVAENQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGGAAATCAGCCCCAGCATTTTGGTGAT	CASSPRGNQPQHF	In	VDJ	2	62	5.685413247012866E-4	6.639750688070938E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	1	0	8	4	1	0	24	40	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATTGCTCGCCCAACCTACGAGCAGTACTTCGGGCCG	CASSPIARPTYEQYF	In	VDJ	2	63	5.777113460674364E-4	6.746843441104341E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	4	6	2	10	1	24	39	51	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPIARPTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGAGCGGGAGGGGATCAAGAGACCCAGTACTTCGGGCCA	CASSPRAGGDQETQYF	In	VDJ	2	66	6.052214101658857E-4	7.068121700204548E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	6	0	2	3	3	24	38	51	41	54													Vb 18	CASSPRAGGDQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
TCTGTGCCAGCTCACCACCTAGTAGCGGGAGGGCCAGTAGGATTGGAGATGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	70	6.419014956304848E-4		68	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	0	3	3	18	2	19	33	22	51													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGAAGGAGGGACTAGCGCTCCAGATACGCAGTATTTTGGCCCA	CASSPEGGTSAPDTQYF	In	VDJ	2	80	7.336017092919826E-4	8.567420242672179E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	6	4	7	3	24	38	55	45	58						01,02							Vb 18	CASSPEGGTSAPDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCATTATGGACAGGGTTCTTCTAGGCTATGGCTACACCTTCGGTTCG	CASSAIMDRVLLGYGYTF	In	VDJ	2	87	7.977918588550311E-4	9.317069513905994E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	8	10	24	36	52	44	62													Vb 18	CASSAIMDRVLLGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTTCCGAGGGGAGGGTGAGACCCAGTACTTCGGGCCA	CASFRGEGETQYF	In	VDJ	2	89	8.161319015873307E-4	9.531255019972799E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	9	0	5	6	1	24	34	47	40	48													Vb 18	CASFRGEGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCGGACAGCTCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGQLSSGANVLTF	In	VDJ	3	92	8.4364196568578E-4	9.852533279073004E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	5	0	2	5	24	37	45	39	50													Vb 18	CASSLGQLSSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCGTCAGAGGCGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPPVRGEGNTEAFF	In	VDJ	3	93	8.528119870519299E-4	9.959626032106407E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	0	1	10	0	24	41	-1	51	56													Vb 18	CASSPPVRGEGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGGGACGAGCAGTACTTCGGGCCG	CASSPQGDEQYF	In	VDJ	3	104	9.536822220795775E-4	0.0011137646315473831	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	5	0	0	24	-1	-1	40	46													Vb 18	CASSPQGDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGGGACTAGCGGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPPGLAGSSTDTQYF	In	VDJ	3	104	9.536822220795775E-4	0.0011137646315473831	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	0	3	0	3	3	24	38	54	41	57													Vb 18	CASSPPGLAGSSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCTAGACAGGGTTCCTATGGCTACACCTTCGGTTCG	CASSPARQGSYGYTF	In	VDJ	3	115	0.001054552457107225	0.0012315666598841256	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	4	4	3	24	39	50	43	53													Vb 18	CASSPARQGSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAGACAGGGGGTGACCACGAGCAGTACTTCGGGCCG	CASSQTGGDHEQYF	In	VDJ	4	133	0.0012196128416979211	0.0014243336153442496	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	5	3	5	24	35	47	38	52													Vb 18	CASSQTGGDHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGACAGGGTCGACTATGGCTACACCTTCGGTTCG	CASSPRDRVDYGYTF	In	VDJ	4	146	0.0013388231194578683	0.0015635541942876725	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	3	2	3	24	38	49	40	52													Vb 18	CASSPRDRVDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTTGAGACGGGCGGGGTATGAGCAGTTCTTCGGGCCA	CASSLRRAGYEQFF	In	VDJ	5	197	0.0018064942091315073	0.002109727234758024	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	3	8	10	1	24	35	51	45	52													Vb 18	CASSLRRAGYEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGTCGGGGTGGATACGCAGTATTTTGGCCCA	CASSPPVGVDTQYF	In	VDJ	8	293	0.0026868162602818866	0.0031378176638786853	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	6	6	2	24	38	49	44	51													Vb 18	CASSPPVGVDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGCAGACCTAACTATGGCTACACCTTCGGTTCG	CASSLGRPNYGYTF	In	VDJ	8	304	0.002787686495309534	0.0032556196922154277	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	8	0	0	1	4	24	37	42	38	46													Vb 18	CASSLGRPNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2359B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				3344	2863	458	21	0	1388	1137	233	18	0	109051	93377	14968	706	0	0.17592378	8.36521149	0.164344504	8.72323418				75331	0.037444111	0.0590616539	0.0505726673	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:58	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 1382,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 522,treatment:nact,type of chemo:carbo/taxol	0.8561602637454739	MSKCC- Snyder- P01-01		2821.0	
